0001193125-13-016595.txt : 20130118 0001193125-13-016595.hdr.sgml : 20130118 20130118061419 ACCESSION NUMBER: 0001193125-13-016595 CONFORMED SUBMISSION TYPE: 485BPOS PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20130118 DATE AS OF CHANGE: 20130118 EFFECTIVENESS DATE: 20130118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PUTNAM GLOBAL HEALTH CARE FUND CENTRAL INDEX KEY: 0000357295 IRS NUMBER: 046471950 STATE OF INCORPORATION: MA FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 485BPOS SEC ACT: 1933 Act SEC FILE NUMBER: 002-75863 FILM NUMBER: 13536168 BUSINESS ADDRESS: STREET 1: ONE POST OFFICE SQ STREET 2: MAILSTOP A 14 CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 8002251581 MAIL ADDRESS: STREET 1: ONE POST OFFICE SQ STREET 2: MAILSTOP A 14 CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: PUTNAM HEALTH SCIENCES TRUST DATE OF NAME CHANGE: 19920703 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PUTNAM GLOBAL HEALTH CARE FUND CENTRAL INDEX KEY: 0000357295 IRS NUMBER: 046471950 STATE OF INCORPORATION: MA FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 485BPOS SEC ACT: 1940 Act SEC FILE NUMBER: 811-03386 FILM NUMBER: 13536169 BUSINESS ADDRESS: STREET 1: ONE POST OFFICE SQ STREET 2: MAILSTOP A 14 CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 8002251581 MAIL ADDRESS: STREET 1: ONE POST OFFICE SQ STREET 2: MAILSTOP A 14 CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: PUTNAM HEALTH SCIENCES TRUST DATE OF NAME CHANGE: 19920703 0000357295 S000005666 PUTNAM GLOBAL HEALTH CARE FUND C000015515 Class A Shares PHSTX C000015516 Class B Shares PHSBX C000015517 Class C Shares PCHSX C000015518 Class M Shares PHLMX C000015519 Class R Shares PHSRX C000015520 Class Y Shares PHSYX 485BPOS 1 d459978d485bpos.htm PUTNAM GLOBAL HEALTH CARE Putnam Global Health Care

As filed with the Securities and Exchange Commission on January 18, 2013

Registration No. 811-03386

2-75863

 

 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM N-1A

   REGISTRATION STATEMENT   
   UNDER   
   THE SECURITIES ACT OF 1933    x
   Pre-Effective Amendment No.    ¨
   Post-Effective Amendment No. 35    x
   and   
   REGISTRATION STATEMENT   
   UNDER   
   THE INVESTMENT COMPANY ACT OF 1940    x
   Amendment No. 36    x
   (Check appropriate box or boxes)   

 

 

PUTNAM GLOBAL HEALTH CARE FUND

(Exact name of registrant as specified in charter)

 

 

One Post Office Square, Boston, Massachusetts 02109

(Address of principal executive offices)

Registrant’s Telephone Number, including Area Code

(617) 292-1000

It is proposed that this filing will become effective

(check appropriate box)

 

 

 

¨ immediately upon filing pursuant to paragraph (b)
x on January 18, 2013 pursuant to paragraph (b)
¨ 60 days after filing pursuant to paragraph (a) (1)
¨ on (date) pursuant to paragraph (a) (1)
¨ 75 days after filing pursuant to paragraph (a) (2)
¨ on (date) pursuant to paragraph (a) (2) of Rule 485.

If appropriate, check the following box:

¨ this post-effective amendment designates a new effective date for a previously filed post-effective amendment.

 

 

ROBERT T. BURNS, Vice President

PUTNAM GLOBAL HEALTH CARE FUND

One Post Office Square

Boston, Massachusetts 02109

(Name and address of agent for service)

 

 

Copy to:

JOHN W. GERSTMAYR, Esquire

ROPES & GRAY LLP

Prudential Tower

800 Boylston Street

Boston, Massachusetts 02199-3600

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, the Registrant certifies that it meets all of the requirements for effectiveness of this Registration Statement under Rule 485(b) under the Securities Act of 1933 and has duly caused this Amendment to its Registration Statement to be signed on its behalf by the undersigned, duly authorized, in the City of Boston, and The Commonwealth of Massachusetts, on the 18th day of January, 2013.

 

PUTNAM GLOBAL HEALTH CARE FUND
By: /s/ Jonathan S. Horwitz,
Executive Vice President,
Principal Executive Officer and Compliance Liaison

Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated:

 

Signature

    Title

Jameson A. Baxter*

    Chair, Board of Trustees

Robert L. Reynolds*

    President and Trustee

Jonathan S. Horwitz*

   

Executive Vice President, Principal Executive

Officer and Compliance Liaison

Steven D. Krichmar*

    Vice President and Principal Financial Officer

Janet C. Smith*

   

Vice President, Assistant Treasurer and

Principal Accounting Officer

Liaquat Ahamed*

    Trustee

Ravi Akhoury*

    Trustee

Barbara M. Baumann*

    Trustee

Charles B. Curtis*

    Trustee

Robert J. Darretta*

    Trustee

Katinka Domotorffy*

    Trustee

 

1

John A. Hill*

    Trustee

Paul L. Joskow*

    Trustee

Elizabeth T. Kennan*

    Trustee

Kenneth R. Leibler*

    Trustee

Robert E. Patterson*

    Trustee

George Putnam, III*

    Trustee

W. Thomas Stephens*

    Trustee

 

By:  

/s/ Jonathan S. Horwitz, as Attorney-in-Fact

January 18, 2013

 

* Signed pursuant to power of attorney filed in Post-Effective Amendment No. 34 to the Registrant’s Registration Statement on December 28, 2012.

 

2

EX-101.INS 2 pghcf1-20121228.xml XBRL INSTANCE DOCUMENT 0000357295 pghcf1:S000005666Member 2011-12-31 2012-12-30 0000357295 pghcf1:S000005666Member pghcf1:C000015516Member 2011-12-31 2012-12-30 0000357295 pghcf1:S000005666Member pghcf1:C000015515Member 2011-12-31 2012-12-30 0000357295 pghcf1:S000005666Member pghcf1:C000015517Member 2011-12-31 2012-12-30 0000357295 pghcf1:S000005666Member pghcf1:C000015518Member 2011-12-31 2012-12-30 0000357295 pghcf1:S000005666Member pghcf1:C000015519Member 2011-12-31 2012-12-30 0000357295 pghcf1:S000005666Member pghcf1:C000015520Member 2011-12-31 2012-12-30 0000357295 pghcf1:S000005666Member rr:AfterTaxesOnDistributionsMember pghcf1:C000015515Member 2011-12-31 2012-12-30 0000357295 pghcf1:S000005666Member rr:AfterTaxesOnDistributionsAndSalesMember pghcf1:C000015515Member 2011-12-31 2012-12-30 0000357295 pghcf1:S000005666Member pghcf1:MsciWorldHealthCareIndexMember 2011-12-31 2012-12-30 0000357295 2011-12-31 2012-12-30 pure iso4217:USD <div style="display:none">~ http://www.putnam.com/role/ScheduleShareholderFeesPUTNAMGLOBALHEALTHCAREFUND column period compact * ~</div> <div style="display:none">~ http://www.putnam.com/role/ScheduleAnnualFundOperatingExpensesPUTNAMGLOBALHEALTHCAREFUND column period compact * ~</div> <div style="display:none">~ http://www.putnam.com/role/ScheduleAverageAnnualTotalReturnsTransposedPUTNAMGLOBALHEALTHCAREFUND column period compact * ~</div> 0 0.0575 0 0.035 0 0 0.01 0.05 0.01 0.0065 0 0 -0.01 -0.01 -0.01 -0.01 -0.01 -0.01 0.0064 0.0064 0.0064 0.0064 0.0064 0.0064 0.005 0.0075 0.01 0.01 0.0025 0.0038 0.0038 0.0038 0.0038 0.0038 0.0038 0.0127 0.0202 0.0202 0.0177 0.0152 0.0102 -0.0708 -0.0899 -0.0266 -0.0636 -0.0301 -0.0534 -0.0168 -0.0119 0.0946 -0.0045 -0.0174 -0.0051 -0.0026 -0.0002 -0.0048 0.0048 0.0099 0.0169 0.0146 0.0041 0.0112 0.013 0.013 0.0119 0.0181 0.0232 0.0313 -0.2038 0.185 0.0715 0.1356 0.0299 -0.0063 -0.1712 0.2517 0.0206 -0.0141 697 705 305 524 155 104 955 934 634 888 480 325 1232 1288 1088 1276 829 563 2021 2155 2348 2361 1813 1248 205 205 634 634 1088 1088 2155 2348 Year-to-date performance 0.2111 2012-09-30 Best calender quarter 0.1245 2010-09-30 Worst calender quarter 2011-09-30 -0.1798 2012-12-30 485BPOS PUTNAM GLOBAL HEALTH CARE FUND <br /><br /> 0000357295 2012-12-28 2012-12-30 false 2012-08-31 Putnam Global Health Care Fund seeks capital appreciation. The following hypothetical example is intended to help you compare the cost of investing in the fund with the cost of investing in other funds. It assumes that you invest $10,000 in the fund for the time periods indicated and then, except as indicated, redeem all your shares at the end of those periods. It assumes a 5% return on your investment each year and that the fund&#8217;s operating expenses remain the same. Your actual costs may be higher or lower. For this non-diversified fund concentrating in the health care industries, we invest mainly in common stocks (growth or value stocks or both) of large and midsize companies worldwide that we believe have favorable investment potential. Potential investments include companies that manufacture health care supplies or provide health care-related services, and companies in the research, development, production and marketing of pharmaceuticals and biotechnology products. We may purchase stocks of companies with stock prices that reflect a value lower than that which we place on the company. We also consider other factors that we believe will cause the stock price to rise. We may consider, among other factors, a company&#8217;s valuation, financial strength, growth potential, competitive position in its industry, projected future earnings, cash flows and dividends when deciding whether to buy or sell investments. We may also use derivatives, such as futures, options, certain foreign currency transactions, warrants and swap contracts, for both hedging and non-hedging purposes, and may engage in short sales of securities. The following table describes the fees and expenses you may pay if you buy and hold shares of the fund. You may qualify for sales charge discounts if you and your family invest, or agree to invest in the future, at least $50,000 in Putnam funds. More information about these and other discounts is available from your financial advisor and in How do I buy fund shares? beginning on page 57 of the fund&#8217;s prospectus and in How to buy shares beginning on page II-1 of the fund&#8217;s statement of additional information (SAI). <b>PUTNAM GLOBAL HEALTH CARE FUND</b> <b>Goal</b> <b>Fees and expenses</b> <b>Shareholder fees</b> (fees paid directly from your investment) <b>Annual fund operating expenses</b><br />(expenses you pay each year as a percentage of the value of your investment) <b>Example</b> <b>Portfolio turnover</b> <b>Investments</b> <b>Risks</b> It is important to understand that you can lose money by investing in the fund.<br /><br />The prices of stocks in the fund&#8217;s portfolio may fall or fail to rise over extended periods of time for a variety of reasons, including both general financial market conditions and factors related to a specific company or industry. Growth stocks may be more susceptible to earnings disappointments, and value stocks may fail to rebound. These risks are generally greater for small and midsize companies. The health care industries may be affected by technological obsolescence, changes in regulatory approval policies for drugs, medical devices or procedures and changes in governmental and private payment systems. Our policy of concentrating on a limited group of industries and the fund&#8217;s &#8220;non-diversified&#8221; status, which means the fund has the ability to invest a greater percentage of its assets in fewer issuers than a &#8220;diversified fund,&#8221; can increase the fund&#8217;s vulnerability to adverse developments affecting a single industry or issuer, which may result in greater losses and volatility for the fund. The value of international investments traded in foreign currencies may be adversely impacted by fluctuations in exchange rates. International investments, particularly investments in emerging markets, may carry risks associated with potentially less stable economies or governments (such as the risk of seizure by a foreign government, the imposition of currency or other restrictions, or high levels of inflation or deflation), and may be illiquid. Our use of derivatives may increase these risks by increasing investment exposure or, in the case of many over-the-counter instruments, because of the potential inability to terminate or sell derivatives positions and the potential failure of the other party to the instrument to meet its obligations. Our use of short selling may result in losses if the securities appreciate in value.<br /><br />The fund may not achieve its goal, and it is not intended to be a complete investment program. An investment in the fund is not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency. <b>Performance</b> The performance information below gives some indication of the risks associated with an investment in the fund by showing the fund&#8217;s performance year to year and over time. The bar chart does not reflect the impact of sales charges. If it did, performance would be lower. Please remember that past performance is not necessarily an indication of future results. Monthly performance figures for the fund are available at putnam.com. <b>Annual total returns for class A shares before sales charges</b> <table style="BORDER-BOTTOM: 0px; BORDER-LEFT: 0px; BORDER-TOP: 0px; BORDER-RIGHT: 0px" cellspacing="0" cellpadding="0" width="100%"><tr> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-LEFT: #000000 0px solid" width="20%">Year-to-date<br/>performance<br/><b>through 9/30/12</b> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"></p></td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-LEFT: #000000 0px solid" width="5%">21.11%</td> <td width="40%"></td> <td width="35%"></td></tr> <tr> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-LEFT: #000000 0px solid" width="20%">Best calendar<br/>quarter<br/><b>Q3 2010</b> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"></p></td> <td style="BORDER-BOTTOM: #000000 1px solid; BORDER-LEFT: #000000 0px solid" width="5%">12.45%</td> <td width="40%"></td> <td width="35%"></td></tr> <tr> <td width="20%">Worst calendar<br/>quarter<br/><b>Q3 2011</b></td> <td width="8%">-17.98%</td></tr></table> <b>Average annual total returns after sales charges</b><br />(for periods ending 12/31/11) You may qualify for sales charge discounts if you and your family invest, or agree to invest in the future, at least $50,000 in Putnam funds. More information about these and other discounts is available from your financial advisor and in How do I buy fund shares? beginning on page 57 of the fund&#8217;s prospectus and in How to buy shares beginning on page II-1 of the fund&#8217;s statement of additional information (SAI). 50000 0.25 For this non-diversified fund concentrating in the health care industries, we invest mainly in common stocks (growth or value stocks or both) of large and midsize companies worldwide that we believe have favorable investment potential. It is important to understand that you can lose money by investing in the fund. Our policy of concentrating on a limited group of industries and the fund&#8217;s &#8220;non-diversified&#8221; status, which means the fund has the ability to invest a greater percentage of its assets in fewer issuers than a &#8220;diversified fund,&#8221; can increase the fund&#8217;s vulnerability to adverse developments affecting a single industry or issuer, which may result in greater losses and volatility for the fund. An investment in the fund is not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency. The performance information below gives some indication of the risks associated with an investment in the fund by showing the fund&#8217;s performance year to year and over time. The bar chart does not reflect the impact of sales charges. If it did, performance would be lower. Please remember that past performance is not necessarily an indication of future results. putnam.com After-tax returns reflect the historical highest individual federal marginal income tax rates and do not reflect state and local taxes. Actual after-tax returns depend on an investor&#8217;s tax situation and may differ from those shown. After-tax returns are shown for class A shares only and will vary for other classes. <div style="display:none">~ http://www.putnam.com/role/ScheduleExpenseExamplePUTNAMGLOBALHEALTHCAREFUND column period compact * ~</div> <div style="display:none">~ http://www.putnam.com/role/ScheduleExpenseExampleNoRedemptionPUTNAMGLOBALHEALTHCAREFUND column period compact * ~</div> <div style="display:none">~ http://www.putnam.com/role/ScheduleAnnualTotalReturnsPUTNAMGLOBALHEALTHCAREFUNDBarChart column period compact * ~</div> The fund pays transaction-related costs, such as commissions, when it buys and sells securities (or &#8220;turns over&#8221; its portfolio). A higher turnover rate may indicate higher transaction costs and may result in higher taxes when the fund&#8217;s shares are held in a taxable account. These costs, which are not reflected in annual fund operating expenses or the above example, affect fund performance. The fund&#8217;s turnover rate in the most recent fiscal year was 25%. After-tax returns reflect the historical highest individual federal marginal income tax rates and do not reflect state and local taxes. Actual after-tax returns depend on an investor&#8217;s tax situation and may differ from those shown. After-tax returns are shown for class A shares only and will vary for other classes. These after-tax returns do not apply if you hold your fund shares through a 401(k) plan, an IRA, or another tax-advantaged arrangement.<br/><br/>Class B share performance does not reflect conversion to class A shares. Restated to reflect current fees. Applies only to certain redemptions of shares bought with no initial sales charge. This charge is phased out over six years. This charge is eliminated after one year. This fee applies only to shares purchased before 1/2/2013. Restated to reflect current fees. EX-101.SCH 3 pghcf1-20121228.xsd XBRL TAXONOMY EXTENSION SCHEMA 000000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 000011 - Document - Risk/Return Summary {Unlabeled} - PUTNAM GLOBAL HEALTH CARE FUND link:presentationLink link:calculationLink link:definitionLink 000012 - Schedule - Shareholder Fees {- PUTNAM GLOBAL HEALTH CARE FUND} link:presentationLink link:calculationLink link:definitionLink 000013 - Schedule - Annual Fund Operating Expenses {- PUTNAM GLOBAL HEALTH CARE FUND} link:presentationLink link:calculationLink link:definitionLink 000014 - Schedule - Expense Example {- PUTNAM GLOBAL HEALTH CARE FUND} link:presentationLink link:calculationLink link:definitionLink 000015 - Schedule - Expense Example, No Redemption {- PUTNAM GLOBAL HEALTH CARE FUND} link:presentationLink link:calculationLink link:definitionLink 000016 - Schedule - Annual Total Returns - PUTNAM GLOBAL HEALTH CARE FUND [BarChart] link:presentationLink link:calculationLink link:definitionLink 000017 - Schedule - Average Annual Total Returns {Transposed} {- PUTNAM GLOBAL HEALTH CARE FUND} link:presentationLink link:calculationLink link:definitionLink 000018 - Document - Risk/Return Detail {Unlabeled} - PUTNAM GLOBAL HEALTH CARE FUND link:presentationLink link:calculationLink link:definitionLink 000019 - Disclosure - Risk/Return Detail Data {Elements} - PUTNAM GLOBAL HEALTH CARE FUND link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 pghcf1-20121228_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 5 pghcf1-20121228_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 6 pghcf1-20121228_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 7 pghcf1-20121228_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 8 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } ZIP 9 0001193125-13-016595-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-13-016595-xbrl.zip M4$L#!!0````(`-(Q,D+U*U]VIQH``$?+```3`!P`<&=H8V8Q+3(P,3(Q,C(X M+GAM;%54"0`#FR[Y4)LN^5!U>`L``00E#@``!#D!``#L75MSXS:R?D]5_@.. M]B0ULV5=*%FV[/$DY;'GXEI[[+6=,]FG%$1"$GVGNP'>))*^ M4;(FXVPE:Y$@\*'OW0#!@U]OIPZ[$8&T/?=MPVAU&DRXIF?9[OAM(Y)-+DW; M;OSZRX\_'/Q/L_G[N\M39GEF-!5NR,Q`\%!8;#AGEY?LV'-=X3ABSD[.V$7@ MF4)*+V`[K0[^CT42NF0?HG_;H8S8B1O"F"$?"_;[%^Y:S2:.<#L,'`:`7+GO MCR?FR'C;F(2AO]]NSV:SEA^%+I^V3&_:[G:,KM'M#AJZ]:VT\AE`@7O6@MH=..=MKH9-[6EM]TU=BLZURV2OI>P M:/(8>WM[;;JKFU;U&=,.^,38`3ZT+XFLEV+$J)/]<.Z+MPUI3WT')T;7)H$8 MO6TH;C9CMK5NI=5@;=65Z8$LW(;,MMXVCJ.`AR")?_2,8V%"<^./7D?]U;WJ MX#_]G9V=/\[$="@"!05Z`%FTP[G^!;]M"Z^,;!$P@BAR\XK9=G3RC\8OV&6O MO]O=ZQ^TT\?2KJ08HZ@G%^"2XL:^N/4=V[1#A859-K132@32LW\JQMQY3[@. M;VW9^$518#^=A'KNH%W870J@G4=PT,Y-]L`7@>U9&;PA#\)CT,I?D'A-D,J> M`7TD5Y.&PK7B9EUJUL&NK4RC@W:F\X.V9M,3>7:$OXU^W_B>F'B?\8)@'VRF M](491O)JP@-QY'`I<^.FQ/O.A:?_(CR/%Y[^=RX\NR_"\WCAV?W.A6?P(CR/ M%Y[!=RX\>R_"\WCAV?N^A:?;>1&>1PM/M_-=",_A*!3!-;\5\MP]MF48V,,( MVTHM.B\!]4.$2P0C+YABS>-,K](^SH#@3-IVE\\F/$GP9UP<@1$.G$M5:3UJ&2&_"[%:N9AL"#TB MUU;$\(']R:2G2AQ^P8L'[?B7>AR?6'CVMZOCI4?UVLH^W"OO`820K-C$N.;QLQ.^L>P;)L.Y`TRR;.D[?+[O>JYH M_#P.W_S)BI?,`L\1;5P(LR)'+*"[^.WZ\^'9Q]/S=X>GG]X?GEY_.CJ\?/_A MM\_'@-2)IBY3E(9?4Y^;(?L[^Q-QM`$(CGG0OFO&"5T.73?BSH?(M]) M8=5"LU(*)#0ZX[?V-)I2@'($$CD6)U,:_]R]B`)SPH&\YX#V?#2"X=SQ16"; M@EG"M*?A7&S9M@OG6&KT]_M_U6FN?N7 M9^2@@I&]OPP?]_[J?$S+@RN`&DBJC.S06 MP-]*>]^UG;>-,(C$*N''6^X?`FZ=8J!B[/M">_:Y5.K?[C MYQN;2J6G[SY2Q"A5BM<:,MC3"*OV&DZU1>T-:"(EN!Z`N_YR3:6]J@UW_969 M2MM4&^[ZBS"5`5AMN.O/_"NCW-IPUY_S5QJ8>^(N@+S."G!WEU`^*\`J]G<[ MW><'6*57&P&PRF`9NQO`XBI/8/2?GX*5+M:XF\6Y-7RU?/\OP8..L=8BZ6Y' MV9Q2-*O"6\/FZ:+Y#/;V-FP^#]\N6S2O[L[.\\SKD>7KG=[&X:TL6/=TIK)! M>"M+U/W>]J;AK:Y)[SR3G7EL$=IX)CORX(W(!=YG;_NIRM=?JQ/J;/!6%JP&SZ20CW,]W=ZF M*-HC7$_O_I*W1L9V(0XI`K=7`FZ]L76W4Z02I6;86.\"B!&'R@L@%A>2WM]R/&=U MJ;1W\OG#BC#2Z]`[>[FEN!R*-4,L"!X)XJ[>1[8!$`NB<8+8VQR(!4$M0>QW MMS<%8D$@2Q#AWH9`+`I>%<3.XZC86Y]&[Y53L;=FB&4:O=*Z(99I],[F M0"S3Z,%@L"D0RS1Z>]#9$(BE&MWK/DY=^NO3:"-.EXM@K!ECF4H;W7)I7#?& M,ITV.IN#L4RIC>[NSJ9@+-/J07=O0R"6:G5?YWH/A)A+7%:LU=U.URC!F,E= MUH.Q3*N[Y2'9VC&6:76WMUVFU6O'6*;5W=[.QO"Z-/H>&&4ZLVZ,Y>%W]^&\ M_NRE;W:N.W7M%N:%RXB>$7JI6M4,?8WI17'LOHSH&:$_+.UX//1U1H#%T=4R MI&?$_L#(\-'8-\!'+T-Z1NP/]-T5V/'GM8>G1JI2ZBD?"N`2@8K;KHZ% M$,+T1)B=V/XA2C=R)ODO]J.[QU.AC_9G)Z[G_D-ZW!_UW M%^=7!^W%/M*>U5'4EV*,&\*X&W[FTX>,H$XR9>HH4Z;.,F5XF"FCTTSQT-)A MP-IX:&GV;X6H:.Q%9$>`..`.[2OYAY@_`!IR.3Z:N;2_91(?X8<\H=-',K([ MR%,[V]WR8.]'(^"V?2.>(#:E_:7#'<(]BT[G$&B'7Q?)$+NB\ MVO?J3.J'3J0SH(.O2_M+7PH>_EM-[R(`O0_FUZ*&0W\OZ!Q?]M'QAMQA:BL3 MP[U,#,\C9E*(KQ*LJF^'<)O[?@!&A_IOJ1>"RS"5A8P\0'@W]9Q8?#T1;.0Y MCC?#+\I.YKX73D1H@Q-@0HW';,ELZ!\$WF*AQR;"\=G8QH+9@`?DR70Q.X[6[!9$SA8]_IW2T60*`KIHP[#HX3 M,(FG;DL&PV*?,&/$&DX\F?2=`\A9_R?H@SR)YZHN%%;ZHJ_@YH3-(3;3,'2W MB/MGH.R;OPVZQNX;R;SXQ&H`J5XHA4ZG7$]3@DUKL7]AWQSL.G>(B))-^9P- M!9M@L!`P(`.P4`2MHH!^26`2R;H"4Q:*\;Q>F?I`3`&Q<3VW:4&O@<13[2W% M,NC8)!N:%9.)TAH3Y0D8%.'F8B&WV$S$W$>".'-L#W(W!7++$&!*]FH<>#-X M%,:\X4XDXNOP>PB2]1I9Z."YAL2%J6U)^[]"R:X+0[`9[C^3[#K8"T'[@W2":S/UF(!P29ZE.(P&Z<-?*=*Z)"+(+TF9.MB"NN1&.YR.8 M+>S1BDSDGR(!#[X*HCU0Q@>)GW)31*3RDAH,;9B3.7$]QQO/XZ=!\K\($CI? M'W&;$'J4I29J.MV`!Q&JFG@@1@X8.=`8Q2.25;SE:JI/;-`5H+WO`!A4)F4M ML-LYC0S@/!0=:6-HJDT&D!)"UB7&S6Q0:)-'4MFF#!RT7X$M13*9N$>@*,C4 M.-\Q7(PQY!06YT#ZL,5&M@OY*K(?A@F$.PZ!^EHB$RG9HEZ`YJAA<%G:Q`S@ MFDVR0N(^)T:A*R!%(1D!;KK`*`!B[0BAR).8=G1JI$OQKC^@GL@O;X#7V$Y>KHQSMIL\\,M14KU&69>A%Y-^D,K1*D3*8@`0WW':(/J/`FVIH MB?YPZ\;&3]SCPS#<)V_&+(^=$&'(;RBB_`I:#J+BDOUR@8(P\_YNEE0Y5?63 M?"C;L58/3>;E#D].FD9IES($.2,W`"VX99$RD_U/J?'JZO#D=((R5)F"%5)U;T,8AA\BF()0C+$7.=V#YZW%E`L#C.HM+6.?R' M185+J*-4Z$&6Z)G.1`F*OR'SXW$:K#ZE#")J7FXL=1ZIR$VF2KE'4YIDVGE,WC7^5L(MK#3-2,$3;T@]$B:J562!5! M>*-B`I3-L"29JE.L=)?%PI0?+ZW[@$\#[V%[UZ!['D3*M9J`N',6ZMX7L)6- MOI0?U(GJ)`U&%N`LC)8SD'4BP/X6Q\Z,D1NWWF`!DD?,IJ<^$!ZB)'1$$=9: MP:?$*2)EUA`7.YAU0DPJ(,V;%^?5K;+J&,8D.OS&2$G%Z9D'\RXRD1(,+T:8 M#'L8,]A.'"TS%`U09%T#B--LU$=,NS$2P<`>,K9PCE<#B!TH&%1I$**FJ&\L M7%!.)^/T52Z"%%5N5)GE.*Z/TQZ`P1FZ<<@BS3@B1Y!QZ-QB'U7(K:>J<^.I M1[F5Q,S?QK@#.HI#:@Q-N.][MJM$4463GCE7^%XAQ!-3R@CF5F#R8"7`6/[H']Q&2%4282$R%11U!AJCD@S).4UA1 MH)UBIM,Q,MY%^G`U&Y]2!8&&FB(@.9<0"\&1&D:]*0,FL=95F633C']W.FX520G+'>$,!682I!R614P'I2%H@@DR5?O"A M[=@@GFG,RQ..Y7T,YF1VLLA0CT$'4!]$ M\0QO(@?E)P4'83#T)[(9O-3R0`D3D_!_3B(T2@T(74(`D"'@9>106!_/$1#:)HAXD&0R<:F%030>4/JHS`E*.:;V M8+GGL:9*Z6'15>A:9)*:0V>@3A34HX$0(+G>5%=B4NF7[%6<&%.=!?I4*:C] M7TS3868\H47ZU!8U1F.O$W[4C#AK]N(B!K`*M"!.G^$R5O0`%+!?*CZ,')54 MH!(+_>-UFB$#M6W'L?\3V9;20TSJX<%,7D_MLH*8F+!A0NP<7)> ML!6[#I.KGJ=D?F&:3;C:I`0/=<2%B42:74.AZB\Z9O,S5;*,L,-C4[@0BJ12 MD04=TRTU$&DW:)<)G>I?D1)E1/6+=$_@X)6I`#>#FNT-'7NL)#!'+5U=``Q* MD+(ZI'7'5F.EA8>TF$\%"E*=2I],%@G[=CVP/^:$JE6(:NQAE8@R5(H0\'ZV MYHX:12[$$6&^$AEXXX!/6^S0S5[.ELB3[I"=%@EVQ+%&([2#@88?A$6>^5@0 MT4$1H3%NQ&!'7@`!0B*`Q'DB=BKG#`PGB'0KB:,J*D`#+'2 MH4))5AQ;5<;._S:).I3IC2% MEAW]*L12\$JQ6-XY4J-4 MZP0[Q$^"ZG4G!=[$#WRSP[2@-:+(-\N"$C58E/GX^A'8/+A>B[CCT,J]ZL^B MOCN_/'Y_V7QW?GU]?K;/.O[M&Z:OG;[_<)V_?+QDVK38";8:PDB M!U#?-CKJMX\U.?U[9EOAY&W#Z'1^:L0&.0RHKD)_6B60_D:SZ###OP4M=&QK M`6!\OQ/?3X;JZI&R.]N4&R`OX.<-D[Z:<#B<0'@,[G^OW>NTC6ZF#(1_^C': ML\/+CR>?%6EVD#3Z0H:BR73;?O)7:*URYGTU\:[1,HR?"L;3S;8SK"ANT>LO MM5!_9ABW%AYF]KCQ(,,NO3&JB('_[#'1G`C M7UTLAC=0HS2-W=;>X*=BD.I/-%9+IG+1)!;%";4',OJ8&_!O!::?XWE<968^ M5V5%)Q&7;8"XB,[HMGM&VS!>+SJUPEA(5S'?0:;PE8HFQ\G*SE.V_[ZL:7W+ M:UH%TE`N,&>VBQ^<3*N_EP)25LA(#J?X9&W;WI=>1L3[Q:CO@%1>I+_$C&]U M^\S[Q<7YR^Q.MKA6GK0Z2FMN3UO/^8YV[^16'8HIF5L,./6D.*.2_.:L`219 M=P(NOWZ!I?6$AU=4*GT*^I="[[=?Z$T+-07"L2`]X8FJ&^G*D!?,X4)HA]%3 MSW- MY1-?8Z(3E)LAOTURN*S40=`%EH>69R=J6*+_C6W1OAIM\J8<%[LH.#=1[:DW M5"BU,]3+"3,%]G0#4E9,(/'TYB7&5H9`F?=N.[J?'R@IQIPM9@N".>V><\!T4%AQJHW$SMXT?[YA83H&Q&I20X M=\415E[/1_')V%?8>[T"0OO#J=N"2J_G.FK;*&UYON&!\O3*X5';,FZ78"_9 M)O4%_$;Z5C!U4%MI&`0\+FE!:NT[?+X/,:"@6LV?;!*&_GZ[/9O-6JENMP// M$>TKIG,])QHZNI"B$HB0$7^SOZDJ@G@P"%_ M_.'''PHV;E51X![O=F\TR;)`5T2^L8]/E\+K.;^).W3>@]H_25`$S<(0'1V_SQM0.(A(;17&_UQY68 M[-KX*[!#F?1)&3/:@YC)FS`%2_:?O6Z!8=/O,\4;%LFSZ>T+*J)(6J2(]1M1 ML=%/IHR/X*;Y;%PA,<-G(ENCM*3:? M`>^Z_9]:Q46EN\O9]:Y];T@$Q-86:K!5N'0MC`7HU>2Y[SO)JR7T2HFJ3*?7V-KUZYN`>%G5P>JH*ZJP:%_IO^WR,O!3'=NO9TTG5$NZ[" MI\AMW*?:#*K!ZVYQAWZN,%Z*0$%U;/?K_LCS0J"$.(4?[)8NA7,?W%2\S[:A MKZ(W>MO(>*K;8>"T_K^ZJ^E-&(:A?V7JSJR$,#X.(*%).VVG:6?$6+4A=8`* M2.S?SW82VH8$FJZ0<"M1LVN)*_5+$^40&,+SJE]Q='=W')F_HQ)9<0 M0B#=/-',JW.GE?Q4QT#9A>_\I.`,MP`DR];[6T3O?'9R.YZH&S(Q&Y&9\NZW M[*!BQ-9JN=J"F;05W94E]AT7M$FMV#L`?I20,L(WR-8*(P6GZD=IH=FFTQ52_3N+F?RI73EUP#-)V<5A!AJ,U MWJT,5_3=5O0H-XL]*:/-K>1D#J8K#8\#[D"P;@V"\:L1C/LB&#\B6()K7DOQ MP`G:D@$%)C'L9@C&:Q/L*.`.!.MI\<];!,\)N<@'&J'52?O-D^F4.T$A$(XD MU8M*0TH*]92%3[6;D\4=F`/C07"J`I(E)CE$UH$_?9-PZ'L7#GVK<#@)P\4% MP\`$U\`[7(-`X1J:X!IZAVL8*%RL;<*+M;T#IJ80'F+,B!CSCQ@+%3&]54$: M1#5=<#H3VL_3B%JPVFY>*=A<5>DZ^1<#9X`J\:=BP%PXH=?!F%%XE*EK=JWR3@?X,VQ,]LI M5-/^^^Q`V-@:2#45@`<20B@K>=H*&[R#@1"243]I. MKERL"*7.R:?7KUIO7/?^-.ZA1)`\!:X1D8`U)&CTB.(8G0O.@3%X1-T^NI*" M@%)"H@\-WWY1K@PEZN1?J58YZG)M:FH\`71_AWGBNK8"H_S;""M`1A17;6>J M=7;L>;/9K#$?2=80$NPAI\U"W1P='3D M%4=74$6?`AK:P+OO]Z[)%%+LK@J8:2#4DH)!#&-D?V_C[AI!EFN.TP81J6Y8AR1E$G.>8=7*>##.06!N[+N89<`7JZO9F$/4_]X:G4>_R(NK=7)Y%\47G M=G!N5%JQQ_HQ@[:C:)HQ*/^;2ABWG6PR)>/`#?T@#,+P8V.NDK?_6=);3))@ M1G)F1@G>,_76E,!<`T\@*;78F>[`!:IM&=]\@B9R44EJ-A>\R!*C%3,JJ=$/ M%RWHT8(?+0H@6P'9$C\7R9II,T'6IFKVL19RW?7E3(NS4`%I3,2#)Z5G4S"_ M11JN'[C-H,A#RB\#T*68H;D<(Z5`JY*3X1&PME.!\5Y6V599&S7]<9)$ MEJ1D,IO_G"'K5_`2X:D\30LVEVI(R_%C*=)*?Y8UQ=-*A4Q`FL[GV]8W`SJ9 M:K/WXJ[V,3?-S[;1#FSPMAJV%X#/BF7;P`,/9IO\933-'4H`3:_4NG3XW8X=/A-I)KCID$$]KVO@]^+Z%O76^AK2][0LK)2%SPRA&G_P M(51+W],RL%+6?&8(U?B##Z%:^IX:?D2^YU1"8A^+[!ID;ABV!E%SS`$N!C65 M+[-XO^,LC*([3(V.H8R!IJ-NC*(.@,.\SFLCO+-;:GE_?7VP;X^6KT6 M,CN_`%!+`P04````"`#2,3)"(-GE2J4F``".OP,`%P`<`'!G:&-F,2TR,#$R M,3(R.%]D968N>&UL550)``.;+OE0FR[Y4'5X"P`!!"4.```$.0$``.U=:V_< M.);]OL#^!TWFRRZPCJ-RY^'&9`=^96*L8V=M9WL:BT5#KJ)M35221U(Y-AK] MWY>4BO60^%*YBKPLW?DP[=B7TKD4+P^?Y_[EKT_C)'@D>1%GZ<=7X>LWKP*2 M#K-1G-Y]?#4I=J)B&,>O_OJ?__HO?_G3SL[?#R_/@E$VG(Q)6@;#G$0E&04W MS\'E97">$_Y6B2HN?GV[R9%1^?'5?E@\_[^ZR?[[.\KO=P9LW;W?K M/[[BID4\L_OQX\?K'WO<,MS]^Y>SJ^$]&4<[<5J443HDTU)+)1:?OK?+D?#G MLW]W,']JV4\!A?O[^[O57ZEI$?]<5,#.LF%45E]`^X9`:L'^M=90B[);5"A^+E\?B`?7Q7Q^"%AZ*O?W>?D]N.KA[O[ MX6U('Q0.PL'@`WO,GX^GWY[_-TI')VD9E\^GZ6V6CRLG7@7L#=\N3Y>\>9B4 M:31^/7DW&XRA__I8FT0U)R.CKM^OS@R]_ M.[LX/#C[?')P=OWYZ.#RY-.W\^-N_JSVAG7YR=KY:)*0J_LH)_=9,B+Y)T** MESJWPF/7[=%!FDZBY-,D'5T\L(Z#]C`G3P\D+=;GW8JO6+>GTW>>/$6LW+J< M,W_J9OTYSR[)B(P?6'QOQC?3-VRFA5YG9934'8"BU1Q&^1&-I7*5!MKU#6OW MDPX7HCL!F.L\2HN'K'AY9[JF5VV./8Y)&<7)!LFCPPO6YF5<#).LF.2D">,X M*J.3A#"$+^YL7_Z617^C?&CJLF32;,#TMJJ'>_J(?#BY(3NCF((IJH'( M]$6+WLV>$J?E+C7=G=KL"A^P:=2S5^V,LG$4=X3<+FT1+[F-)DFY,F!>?..( MJYK9&9/Q#\!>LX;YP/05<]J;Z7[`3\#*+/]+R0?V`8/$)%7J. M/\F&2Z`3-@W+ MR+"<%-?1S?P;5CWYQU;1L&P#$]DL8YM_\8-\&25M2OR! MTU9EV.SJ,K=Y-I9BF+XG$]=>EM/IR,=7(;6KXN!GQB]D]/%5F4_(_)=96M)& M.248&F#DCOTP:_:[@A8]#XC3])[D<;5V$-#&Q)8Q2'!:DG'Q\26SFEU M:,)WVPP8MI9XI]SP?L+3::@O\)-O@&64U!O_4$]!*)3;&_@XV]P7%3T.]A M@Q9SWQ3[!S^P-RAQ"GX?+G@!9W(F>F,X11:O&^S1_]!+>K'!_7S@_H%`7M#4+UBFQ>@3$>6"^L,_%<' M3W&A&&-*2VPRH(3K^(VPDM1ULT.0XF^.]S1!=ES%>/"EBO$BP"CRN[UN'/GQ M=#='"O1X:;MG0\34VEQ:#*(.%=V,*@Z^8Q`A4_6>J=2H2%XUPW1(OI"(;54+ MHEUA!YB3%*B;DW=D(C!1LM;V:`NCD'J4EC9P'MR6)+^.GDAQD1ZS!:#X9L(: M:G&0CJZBA!1?EJ9/<]C&!9UZT1F]&+5-_M#%[6_#!QND$__E M/Z^`271TN/[=;U?5.:.W[]Z]$XY#I%9N%Q\DGW)YR\WR6$.^E"_[Q`RNM()Q M@01N3P.3?PU151?"CI*H*"134JDE8#96XFYNM2,KPXN5=;7*S>";OU50]HY M]>JJ88\CS/$=14-LGTEUT%L%;69B`]G%S3_J\\]28&T+J[B^YC%K;M;?+6(ZCW(FY?1(%/6G,+6V(#17 MU3J*1!$GK56YIY2R/7'5,5\L=BEJ,N$]95J99 M23%H(TYD:A%I0>W)T_">_52%F!Z[NI1% M_%.A-AU=-,WL(SQ\_I5$N2'.AK%]M!VH3E'"52U+NV>EL7VTO\3E_5Q@4-=% M=RGKH,4L2"6NT'HTI=WZTZE5*0JZ]:);^U*5M.]'AX&`HH1]W$=)Q@2LC5&W M[:TE796IGEE+03(W?/TJIL&=A$9=)# MJVQMK4DI5Z.LUAQ[H4FMR>QL833I*65VMC#J>T6QE0U\7.SX(!TM7%BH&%#: M&$W*6+XY9=)4->8V:]L$KLK6)E9M,[#ZS?E+=:,[F9U-C"9]D\K6)E9]'R6W MM!SKZLX)2H^D:Z`*4Q=(.W:@TC(VL'^)\N^DK#2\.E2X62D7=6_23YB4<8%= MWV_H2P"6=A+L`CN_QV*"N[U)#%]A4+UU#%]E4+>=#%]J4+#?#%]J4+T+#5]N M4+$]#5]V4+]A#5]^4+F/[84`88?=[)8V(4B'%)O,.D;K#ASOWQ@N,5&_#<#R\X7KHES[V`S>[RK7J.'S;!JS;P MN0>P^;VUP\]APZ9SU;X_]P`VFR\=#N"08=.U[-@`1P^;F&4'"O@:)6P>%A\V MX-AA`-'#YMR58<> MN`>P*5=^&(+CA\V_VLX3-@$K-O#Y+AML#C8Y2L$]@<++TD`7W M!#8QZP]=<#^,Y?BX9@J3*6%IXU&2;\-RM)A#9]UB/W7#78XF^TET,)(P!\C& M2%PK"FLYH M@&CU7PWOR6B2D,8YRFX!-*`QP1_$?IP_*V`/"W[7A^6`#"-[K;&$DSFP72YOJ3+[5,T]'));#,X,2TNIL4%F4$6T^+B M@*N'`RY,?PLU_>UVM?Y>;I@88<(TMYCF%OET6_@4T]GZEWET!;2=*]1\?*\GE+#38:' M*%&M!C'D;+42Z!A=\-JQ%91'63(9I^?16-`;*$SM"'(_Q>/)^&@RGB35+=9J MX['6/+QX)/G%[2UMZNG=USP>"M!W+`["H_)>M"MN6,RB!PL`3L")5M+[S#3L:+_+WCW_1=LEI;%UM!I\=A`M",KJ:D]A:AFI M$IO5>#L8#K-)6DZKY*`H2"E8_58:.T%K@-'%&$O2%0F-W(D_F,UI%$-"YUO4 MQDYT'!E"R'&Q)L?J1@8AZ44GA[J.$R'DQ.CDH-F`$4+6C+6XM=0,G8J*K=H, MNXX:(>3<,/-5.9R$D'9C!3=@)-PP`ZX8D(+(LM'9"R#)-3I%NGA0"R*YQHI^ M`$FGL'T8),8P8O!>)4F$8*GC#!27!L.WCN7.4_O+N M_I(B?V>W^-E;CI_ZN0%[<#![2B%J6VA,RUJR%)G4O`8?[ZU=$M(56)H M2F,[.'+*4-(JPNT_(FK'+!H(A5Y(/NR.5%K"+?ZXY<7L1* MOVB*URG*@^$_)W%.1HP-J[ODZ<@$LV$Q.^)?>KBNL-&J^26*F8!)?DGB\WD9`"2F,BA=TV[TY"8SB4E9NH4S;]\E3-'Y(2+<`^FDY@*:/ M"J;/`AU+W3M#NR:'8TW:*/6T_P4"=XJ.@$PZN/&AE$+=)4+0)19N02WO$I2C, MY*_L9XP2.M>,,;`P6/)^$M;FSY M>&P`;VJKP@+TT;/S[)*,R/B!O:-;]+Q51L]_!.=9,'\TN&`"=L(;+W'[?8E[ MZ\+(>8/MW30?[W?W+LA@_?;[ZG?/PJ272VAX*QQOA:L[+F@'>/%6>!]N MA?>,>Z`N)^"%<1R2X68-WB7'N^2+<'MQEWSKNAJ8#(S7S+?AFGE?@V7;MY+Q M!OH&4.`-=+R!CC?0\0:Z?S[@#708/N`-=``WT/LZYH4T091_$=-KON(R;B^M MJ_SPYP*[R`L,4>^#P3;VKG?AU67=^F)V1UY4`@!N[=UY40D`N+5WZD4EW./6 MW[47E8!RX]B`PKJ$K?/MD/4Z"/>>_LO=`GE__^5N@;S7_V*WO+SOOW6C.KPC M@%(`&$IXQ!E5`GQ4"=BZ&.KEF304$,"@P`,AJ"T`XRCB09I.HN0Z*Z/DDI23 M/"WD0708Y4?4_5(43.^6@ZE^;%`]-Y@^.-!%4/"__`W_M]4;3N:K&NOJ.H.M\MV`L6&5E'IU`CD-G9QGA*(Z^JGN.HU,!L MF-I&&N[O"^ZZMRT]#;7\?.NGO0VU_'SKI M[T-M?Q\ZZ>]#;7\?.NGO0VU_'SKI[T-M?Q\ZZ>]#;7\?.NGO!]K^?N!4J]!D MU5RXT.C\`.4JX-LZBDX%![OB;ZQ.0A`7[.I"O7X)03]P!>2AM6WM=2,?6-O, M7C?RO?86MB?(?YHA;S$B<.1SA<\69P)'_FY.3%[1:KUD6F] MC,VA>\6F]4HWGR9YQ:;U8CB'[A6;UNOE'+I7;%HOJ7/HGK'I@OS[P#,V#1?2 M)WC&IN&<30>>L6DX9].!9VP:SMETX!F;AG,V'7C&IN&<3?<\8]-PSJ9[GK%I M.&?3/<_8-)RSZ9YG;#J8L^F>\0UK!TK=VWT('F51,9D*1M+F+V_U4M81=16CRP>\_=\A.];P15_7QQ M+2Y@SA4,/&\YK3\ZW\9+#,A1 MKCEJ*]<<4/P;Q;^1J2%T/S"9&A7!U8K@8/-T8`!!6!]%.>YN*%".>ZODN'NW MA[`YF6T?I<*;@]%-'ZFS(;/MHU1X4V;;1ZGPILRVAU+A+9EM'Z3"55N;+Y,) MQ\DEN+$QJ,EEG_-Q@TTTA:&#ISD]36]M&;7+U.**B=V78AC_DN7)Z#.)DO+^ MB%+[*>T*GE33/%T9MX,83".^7>G#)3G1G4^\M$X91LM:S@7:R;&#;._!0'GI M*]6U)T]3HC2VG83'`#GD5#P*^!B:ED-S4T%@#>T90V<$=6KI".>O),J%POG MAYA>Z@?O3"`H\;[:/10$U=X7.216?GYGNJ;LXN9F M_X:S>"4&]38PO/`T?^\4!$"K:O0O4"`>F]VF(X$;DA4`K<.!482G!#S5?/), MKH,/1B_CXGL=`<>DC.+D6UI]L*Z!]B%@9XKJ1](?V5-WZ\<&]7.#WV=/_D.K M@;/5>W+.YV^@CK3YK,O1AQARWEI[M]J``AS]BC"8+(5'K&5'K*$I;V",]'*6 MU*-3R>!.A(,[0;K])Y4EAWO]/K$L.ZF,@S,_B`?J$D)_9-"@R:CT(29ZN4.* M>F>H=X;+5FM08'.^ M1K4&!3;GE^C7H,#FHWI94X'-0_6RE@*;#^IE.@6VERF8;52$`0>\(*>&\\\A MOU\NLK&MK2#'"5E2H8T:XPMV2]XTMKKRJB9Z3;_Q(7W^=Q5.L;V[BYS:.-1! M!WR]K`\AA`_<(+,H"O;_8A@'JY7>_%A6:(5S'[$!&X7>:&1OJ5 M$/TX+MA"""7"9BP=1V4T70'OS.GP\MJ("=E,3+EMY< MMNQ7.#EON+U;/L![E[T--C^YJS^G_,%=N>Q7>/1R!0$/_..!?V1D9&0413`1 M10!W#P_#I>>;9'XJ"_1(U0%SS77=075^&!YSS6&N.1PD>\+Z,`?)>$$6W`59 M#)H>;O[C75F\*XMW9?&N+-Z5?;$/>%<6A@]X5Q:$#U[=E<6Q+_`)(UZ;W99K MLQAJ4&[0FIV:N"1W;,4S2LOS:-SL#N1F=E>1Q$F9FW^WVU%])M$H3N]4GW1F M8@/9QL=LV.**@[]H7`\%Z#L6!^%1 M>2_:23"D:'*V#I:#3Y;(P;:A:1WQ*#V%*:6D2JQ68VW@^$PFZ3EM$H.BH*4 M@EU,I;$3M`8878RQ)%V1T,C*C.2!L-%Q>C<=+T[<=%?A6/XR3*S[.TJR>Z MLC9\.E#2*LN@'>A%4N&!2QBGS0';F\B%7D>]V1RXM8Z1=-\3I%>3#\ MYR2FLX=/DW3$8HKV&":8#8M97'=2PG6%C5;-+U',9B5TR!J/;R9Y43&*"JM) M&1O8STEI4K42,QBUR_8&+FZO23Z.TT@\>%KI(59V0+*\O,V2.+N>Y&E&T4A7 M>^663G`J%GY5MDZP7HHWE\1F%GNS3UE6IEE)"OTJNLC49K_+UY_J=1H#P(H2 M-G%?LCG[Q>W"[-T$N[J41?R'.8F^/V1Q6K+M<39OEO.>T-8)UB]QRF;ZI]5* M7B5"1^J!Q,&8P3+P0/L$BW[Q5G"=1Z-Z+$3'GN.X8,>MY%]#4\IJ#)"'G!2T M$@^S\OY+5)24\ZH!W4BT%&)6RB9^^M\DJDGYXI;.#',RG.1L[5ZUVM2IL/69 MPCGYP9K$851MLYP493RFY*.;-DA+.9Y#Z-WH5-CJ?&*Q?C]'%%691UE.!U91 M_CR#2$AZF@Z3R<(Y*<&TH_NC[/8"14GK=W2=79+;A`S+(QH'1-$;*TK8Q'V> ME4<9?6\RA<)"^7A"KK-FFY([TN$15GDE&C\DVN,=33/["`^??R61?&*B-+:/ MML/1%$4)5[4L7?Y7&MM'RU[_)M3!Y%:.\.T9X6M=\["&[ZT1OM;U!UOXPCBJC,J)8%E#;FD+9U4M7Z+\.RG9 MTHD88LO(7BV6IRF[2#@Z)@^T<=&G/M-?E'$YD9S:-2ED+6IDX_ZE/UI#HSCF MU_R[+4QB)';>?TCG5_=17AZDHP6-MNHFL)3$3,I8UN8TH3B-N67$"VD;3I-D M4E0CE^)_HCR.;N(D+I\O;NLKF6I!U"Z/L>SA15JMIUSD9Z10.]&PM(SS8#2J MKI)'2=VY5WJ#2KR2$K9Q/T9Q,OW*7^\I.:DQMZT=XOV%W%S%):O(7-_`U*LKCK-I_H9\\ID\GGR8TN-0UKRAELX?7=N=6^V[^4I..6V5K$^OT(TXW M#ZMK7F=9-!(T7WT)*SO<:3J)DKK[EX["A$;6T2E&93([VQA/:2A7U2.6=E"8 MVD8:[N\+UA_;%@YP"=;/VQ8.<`VTN%H"<%9P"=;MVQ8.GO:PL'N#3]?6WA`)>FOZ\M'.#2]/>UA0-EX3$9Q5)+D M^6M.AH2MUG\E>9P)#BRLXYEV?:\V*3]E>87Q/"LK03LR.DWGHKDJ-XV*V_"( M[61>9VSEMP9UQL"VD4O,;-9Y$X)X85MM[1*O.58[.#_'=_>D*/][0A&0/'E6 M?G^EL=5]02$0=5M0E7&/O2MN.YC/LA_&C4-E:[-^A3C434-1Q#GRCJBMGR]0 M'[N"CG;V3;8"#?9,1E-AI78:5:) M9O/[P%4BV#9ZLU(NZOX;NU%>]\6?F/X"G<>()6T,R[GPH3K7D9#'*"VO,UJ7 M7!]&[X6\I`L_+M(Z>]+%+4\J?'6?_5`G.%<7=.'%@BP&1U,U%($@2(>B3MI5 MMZ.LTC(NL,]F^O6T4WQ.E4_25I[;VGFKT_KK\.U=K:XT<>A76?0EK*RL/5+> MN"-FA^,4MJZPJH[*J26CG#*+G@K3%TB%6V%R$T=(A5N5LI-'2&] MBBN^F![<-$+<+.((N>Y@JK:$#=P+E^>NR".A;W[^-2;)2-KU:@LX1:WHA$W* MN,0NN2JB,7>)V!RL,YQTSG#RSTG\&"5T9&D.6E3,A@?7]W%>/FMC4&+F`*$B MWN26]G%*8DMH9!^=#IAE3"8QHS1>1KOF!-15VNF=\31C=%W:,*FN/`?I-+5N M:^0(!WO>3E(Z!=TZ(`4*M""%J:6L]R_#W6DIROR;\5X)< MJ)92W+_,@V:RU&9.>\B@1X4;+8US+_*G8'-PBNF7N7.P:;J3OE7N4NP:=PH&2MW!3:COSSY*O<3 M-N\K,[)R%V"/`AI)6SEHV-2OR.7*'8!-_TL)7_F!Y2YX0>^+R3DX M<-A4+LP@RZ'#)FIY9EF.'S8K*]/-@L[$L#2W'#YMES=/1(F M&7&Y)[#)7)(LEX.'S>0K9;NE@>7BSNF M/\'F:T4F7NX`;)[69^;E?L`F;+,LO=P7+_A:F+N7>P";M[OG[N5^P69QLSR^ MW!?8I&Z6TY?[`IO%.R7VY2[!)G:S)+_<%]@4WRG3+S_[X@7QKY+@ESOHQ\!` MGO"7^^''P*!#OE_NF!>CA&8J8`[>BP&".#\P=\&3L8`T7S#WPXMQ@#B),'?! M"_IO)!CFV&'SO#CY,,<.F]?%B8GYT4\O"+R1M)AC]X*;#1,7:>P.9436IK[@1L:ETQJS5W#C;WRK-=<_RP M:5B?_9K[`9N.U1FQN0^P>=DP.3:_E`Z;F'.>L\ZS.A+G^8LT[$ M/@/N#W/6F=IGP/UASCJ5^PRX/\Q9YWJ?`?>'.>MD\#/@_C!GG2U^!MP?YJS3 MR<^`^\2<"Z>W0N!*7NV$]#/@/C%GN,"8$+MK5`+[`G,"ENAK`%Y@3N$97`_@"]"UU9;E/`U;F4GBQX M`9O"=>=J0^#27$W\[("1_'11"%RFDL^,2DK.EE<[KI@,WLK.ST[D9>0 MQR@MKS/Z9;A>WX)#L/F]Z=!%2JJ9R,7MP2WME:E+5_?9C\5>&3;1-_U9D![C M#E7-+U_P"#;OMYJ<_"AK"%R=J^G*;+&EGO&+;TGPN7'G)0#@2E[2RA!]5[^& M$O(5*.#B78*$XLVSRB%P"2^1"X)T>,!5O`1>-&9KP.6[!`XT%&9"X.I=,@\6 M-MR`:WA)/%CNY"7PX"JNZ'%ZCG_N"7!=+X$GXLL((7"1+T&J^^44\C,_ M8'.VU`\!60`7]9*YLGSS,00NZ27S8L$!V)PM<$"4VG[F#6P"O[Z/\_)9'MVP MR;N!7A33L+E[V8%F),-F[67L<]C`9;MFL%51.Q?N^LMNPX4S^L_Z+W_:V0F. MXS%)F?)^<$QNHTE2%L'.3OUG0;DEW^FTD:25)G?]VR7O?_SX\?IA4J;1^/4P M&^]6CK-$#'3*.SB\.#L\\G!V?7 MGX\.+D\^?3L_GE5$7+(WO:'_"_<#Y@-_+OT'>_1N_>R@?GC`GA[\SI__!S6J MWQ'4+PGJMP3L-4'UGJ6/3V?&2V[3?T=E-OMP]SFY7?[F!1F^OLL>=T5!A2$$/J3-R%R4G*?7F61)" M+0M+(5._4AHPRW]V'"Z26N3AL8QU&AP##`[7P9'G=0O,\V8#7%[[_4(BAET0 M(`J[-85)1XS">%%:.@P=;2VWE^$;X*>QM(>Q!#N69D<^JQ3EU;:7))JDEC;B M:?Y.61RU+1S'CZ9FN>YO"S;/Y*2+G.GOV?_=1`6AO_E_4$L#!!0````(`-(Q M,D+D][XPQR4``*8^`@`7`!P`<&=H8V8Q+3(P,3(Q,C(X7VQA8BYX;6Q55`D` M`YLN^5";+OE0=7@+``$$)0X```0Y`0``Y5UK;^0VEOV^P/X';N^7!'`_9+=? M0:*!'^V-L6Z[UW8V$S06@5QBV9JNDCR2RFW_^R4I5>G%EZ1+4LY,@&F7>,E+ MWG-X25Y2U,]_>UXNT!-.LRB)?WGCO?OP!N%XEH11?/_+FU7V-LAF4?3F;_Z_ M_]O/__'V[=^/KR]0F,Q62QSG:);B(,^\^T/_0*B-%HK/5/Z(\6Z'S."H[__'L3AV[=4PR**O]T%&4:D M4G'VTW,6_?+F(<\??WK__OOW[^^^[[Q+TOOWVQ\^>.___OGB9O:`E\';*";E MQ#/\!A'YGS+V\"*9!3EK42W[\UVZ6!>P\WZC2RA!?[U=B[VEC]YZVV]WO'?/ M6?BFJ*)&^6_6C2&ID42^UHQ"GA;`:[YW>'CXGJ6^(39#Z.!K/$?TW]^N MSX4Z#M]3B?H701W>$&4T8)^RE\>\2]OLFCYN,#K9P\IGO/+6J1IHRAJ MFT-J&V^/VN8_FQK>%[5D#=L?O&WR[UOZ[]L/7@GM?Z;IGX2^V2.>Y:OL-KBK M3,+:\,N;3NK[36VH0*,^*7P;(-)U]D*"UD"F%8P=7@5[\1?>"""[*F5U10 MF=LL$TX("=-@<4[FGL__C5^X5.C(C.."0"4D&=HJ_/(!8D\0>>2.#X+FMPDA M,;HI1AP1CQ12KW2V".Y;`+;2AC*`JP(&^6;1_N8GHK]=P,UM:P6ST*+&X3W% MV2R-'FE<0(1R0V0TV!R%P)C7-=2@KSUVR@".`3A$$!C=%!]NTX!&MVY>EG?) MH@5@*VTH`[@J8*!O%NV7/U'QVP78W+96*`LM:GH)<$*#DX12DA5`4V3L`H"G M$';^W]!03?_7CYU/_GD6Z,[]158W38A/\SF>Y=$3EC"B)3.6$ER5L)QHJJA( ML7GNG!5<(W1I(32]X0`OAPWMQ/'A77C\6V77@KO.`.*:L`Z!I&RRD5\I;__SZ5K4!BDZR0TH#'-I=-D&43M M!40[<2Q3FDI@B5&67?,8+BG0;&D7\:Y%S8P'.&7,(O7]C(-LE6*.@Q`)#1X? MI$J!Q@F^#K_V')4)#AV"W!*U(42)@"5V<+V`6`R.(28\@U"+?XQ)`D:WP3-V MXB54[9A M^E4+*"ZEJ=1G@@6M$%VXUF51$(>(23N)7?6S6RV<-1%$_]SN@^D33N^2#%]` M04NT^P$#-U^#&W;`S8@\2N9HOJ(_'H+TKPDU12))0YS^\F:;GJMSY8CZ.2!C M-.WO<,:3<^UO9)2<%/5Z4\XP7/V\R8@1HG(?LK'AKX`5O%M0+5TO\'VP*+97 M.:N:3NI0*@G4P!"G7;A_@].(,,3=FD70W(H'$L.:/=S`79PTD\8=93"Q"&F4 M7*+K[K2":)DALJ(.H(_W#[.YQV#SMK[M[7$'ZV[R4/Q$ MBD"'XXX2_\MOMY='G]%_75P='UV@7S\=7=S^BDZ.KC^AL]\N3UW`+#)$!;4Y MHT,/JISR_>H9^EH\=>(D^YM9/#R.-/I.'Z.OWW$)RK,+/8R_HZ([*@1?"1P[ M&SAV+"QBJJ#T#5T7GBR"+.-%8H5BX_?J^(JA=^U:6GSV&[$'+N.P"BOP-O/$ M"!AA2*6..\WI)@]V(`)%0#Z[77J=`6YF/J(&UYR#Q+@C9T`GU.UXN[O>+G<& MU$T>"JM($>RHT-'B%UW["#$;9EN3'2)$]JE88`X+Z(D1IWR_>N9T8M3?S%`3 MHTZYO29&VHL`CIIU'W@E]AXU\]%Q=?S%7C=Y--(F%WL=)27*QTY1%LYOS5G7 MF//:XS@OMZNZ_F8&=UZ&5W4OYX17!\=XZYN7^[J]L$ZX[Z56=U^T]>= MO!Y.["LY`8Z%H1UICIHU'*_#PN`^<7^(3^PQ$.W7?.'FV30&(GVC&W=U!W)7 M=P#6O0[ZN[H>8!]L7-SFR32@/E!"#6[B?AYLP'ART'9AGU_/B**-![B_.QCB M[_J/+P`\TKL;=S5'[G# MMI>[?CU>3AL/<"]W:'A6=\B9U1U.8ZC7-[II5[?]0>KJJN2Q<+<5F>F*&RUE M1_SCU73$MGVZG(#'PO`"MJ9F#3<'4]C&[W0$9U M/]^OF-WDT$*0DS[^BL26*A@6=(NO7Y"(OI9/G=!`V'3>18D<0QN!_NKN'\4; M^7SDN\E#@1>(6=%&S*\QE)C8+^9#GW$IN$02`Z.$0I]>G[$<288:-J)@]]=X"H!>GNA6;9?_G8[ MP/`;7'N906A8DR!?!FD:4)Z)O(1$;B3T8M6@+."HV1!BD^;<.2AMTB&*'!%S MIWT?D@59[YQAG)T$O.L;14*C3OX*E0*>_^WJ\&O/$4U`94I!%S?O<$C-T3H= M+(7!!D78MP-$KD4A"T08?A6,\*:EJDN?KTQB"KSA6T5('S$V9B:QCYCZMOB^ M]'4"5R,6&SQ]52@&FKN*M/B;%+1.FH#+41FE-FO5`,3,=0MQO`H69ZLX[%1! MZH)ZY!O\3G_?JL%P3%^M7X@B*HLX!'3HM'K;KO;>_Q!D3Y,VE9FVV":=F;8<$9.?TTN*=CMR[_=+$TR<%/SP']W*$TYMB6 M&XNU=6@UN2BXTE(B@CF(B?,8 MSH]6224A'961F)5,$<=1;3%/M36!Z)6&A>3^RE8,JZG[]RA_N,8A7C+ETB!6 MGXPP/-.IG`G:2?6V6;B%J#BJY%U&LOK;3T1*77QMC*E)59&^XZLB*]!8JU5! M(^.N7'.7JY=)G:F3'9*U#"H_6%;D@N>LM:&<[%2!5&WT/'+1$=Z MI2%U6.IR!E"O1X_Q7Y8-GJ+VQGZ)5I4WGEM)2(;>YVO,H*G"R2+(KO]3C6%89AF*@2)OC5T=5A5RDQ,6Z) M;"1BE@PK,W?8)FD^3Q91CAC<[*:Q?,0M+EV5E5L7:-8*T->,L&Q##`=SI+HJ7@QG3"5VBQ= MOC@(0='WAL6O;H.\M&WL=>W&B]KNW]"6OIMMRQ5074HW(!(:@[+I[B_046`_ MG6XO-T63$XZZNS)@(A(:0P_3P1&!CH(>TXF#R$W1I(>#F`=5JXAT\$7&4,-L M5(.KH:#%5`(8,B,T*6$]6'$M3WJX020T%GJ3!Q<$.NI$<'ODLT5,CR736T6J[='GC8#V]5JU84XO%QO+&[-I:J*7&F:DLLE46Z?+% M_LD`K14V^++:REI:N(#N+IG+),?+&ODJ>0)+8^DD12('11/SR^'V;*5.%8?S M%:4AQ#1QYTOZ!%*$&:"H8S&D(M+'\3L;J2F0JF=410,R(S3['*3?<'X>A_A9 MUS7I91E*M3X5@B&;ED:_D$),#$W$D?6Q5<6ZOOA9<6_*Q9E.!BCW9GJQIJ&/ MX]XV4E-P;SKKMGZ06:&98AVG%H>BF-EUG5(;AUY36>?I6DK,,^OKOM;5ED=W M69X&L[Q%!*$4T+6D;;5`I_8$2CI7D?XT@3M(VR80WC[*,[ZA^=5SM%PM;X(% MSHK;N,Z7CTF&PZOX"P'V($M%_2J(/VP#*&S\!&5%F'=-I? M4!I6$[_,AC*:#\U81O3#(@G"'U%4%("2&#VNBT`_!!D*T",F%HGSH+B.*RG+ M1(^TT!_=3.]&`%&?[TV?/OT^P:4SIQ]6B0UW6,[R)D!T7I'FBY0TZ^+0EW]) MTH@_&&;2MZXO.ZS5E=4L?^A\ST\KQTCBZU3'A)>4ZMWP.EQ?\/T>P!T_=\H@PMDN\X==D-=,#HD-X9 M/0QY087*#3S()I96H'K0X(Y4`8:2FVMN:J1[,9I7_)IJ,LPWG&GX;R)4?.,&7J02>/7$6;>6&9*O813-[E MM$]FJ,Z,3@65'4*I:`1('L.4X1)E$F30H(#ES13>0I8K`;.!8F"YR5/0WC39 M0NRY^\T2P=).87$[7X`7'-.5R(%]`][,45VQ&LY7X)T!2'-SA]BF;8V[[SI%UCL6-D).,J^HMU"FJZ$I0=&_.?=CQ'>*I=*@D6@C-ULEVFB!.& MNL]#?FAC-2N"@P1U>K\2@0U MUR0N"*=MGHIGO<`R2Z_MGO02RX^FEZHJP/02JJOHM3TE>JG,PZ&7#EAFZ;73 MDUYB^='T4E4%F%Y"=16]=J9$+Y5Y./32`892K->58*AFIY*?RV&J%RQ"TCC\RY)U\M8%?%Z0VB$?$3S[T%$WPU(KW&T MO%NE&=N7%#)/)\-0VNE7!H9S&OI\>KBP$*)K@X:8"[+IFZABFEO(#+U,H*7X M7P,]RZ'^2YPKQR>!S%"6254"QOSY>GSRV.D((VU^Q10;1H>.\XN4-&P^M7#_ M&#S<[,M]>@Z6CPLL.-LI$AJY(2%0"KI!U-:QWB)"98*3O5MY^SN[#Q*[6^#$ M'SA(/WA21JQ%8/C05&AB@ZJIR/?0"_G+/1&:#1?1P(2Q#>W.MG6T.]\6^A[E M#ZAZVVT+>>B/5X>%4Y?-JK"C[IX[H(PQNG_<5.3OL.[I/O3JJ#[FIQ`MC:%CKHKEX'W9U4 M!]4$PWD']3XH.Z@W_@065Z'A#DH4^=Z'*?70JNDR4D";VWP/93ITIK@?IM1% M==%PVD6/7V@EA$??5,(P/!)5P@2?.KJZO#I^833:"S3+5-$*?/'%XFED+B7*43B8\*C:(#IU,@V-V?LG5I_`!TPFF0B`WF?%' M(^#*$S?$.QN!6([2Z01EQ1;1YI9!="Q[!7X0M^45)A/"A8!N6FY!'N;EB1LB MGHWP+T?I=$+!8HMH<\L@.I;=`C]TW'(+DPD<0T`W*;>@""[SQ,T0STK0F:-T M0@%HL4ETR642'KM^01"P;B\B)A.NAL!N,HZA5TA;GA&>C39#W5*]2G9.-0JN M8TT=UKI`VT*D7*%^,E%S4S!:=D/'1/=#D.:WP9WPD*]`9BC=I"IA_`A?A4\> MLX_!Y(@E.`F%2UM?$49I=,%S#!FLR811W$:Y+)^VI*# MX`U7M:'>VM3E;WXB^MLU8;B&X'/&-`PF>W!;4;L3_S5`<=B7O)ZPTEL3,/K,-2/JK>83H6UA&XBWS_)TDX$0[W56IS?B'@=Q;P*(+;8(@;'`M8Z5W$MR>`^+82\6W;B+>/YG23@1#O=?2F-^([',1W M)H`XYXR&S,(V$/\H1_PC&.(?C2+^D8/XQPD@_E&)^$?;B+?/V723@1#O=8ZF M-^*[',1W)X`XY\"%S,(V$-^3([X'AOB>4<3W.(CO30#Q/27B>[81WY+[MA$_D"-^`(;X@5'$#SB('TP`\0,EX@>V$3^4(WX( MAOBA4<0/.8@?3@#Q0R7BAU81)\V0Q=R*9`C$ZXK@$6>EMQ"GSUPC7F\U'_&V MA6T@+HNY%US:1\8Y:OS78UZ'VU:T4?+N!13@K"LR"?T.`]YY9+/>7"'P M@*8UN7=M]U+ MMD]2)`.!WVN?9"CT>PQXYQLD]>8*@0'1:X\[>KT2*[OM7K)-J2(9B`.] M-J6&=J]]UKV<[T;5FRL$'M"TAKO7/K=[O1(KN^U>LAW`(AF(`P9W`%GI7?R= M[P#66RW$']#"=B:'!^7D\)68UVWWDFVW%LE`X!O<;F6E=[N7\^W6>JN%^`-: MV$[W.BR[URLQK]/NU;GFIYL,`[ZA:WPZ2GSZ_^Z!YUWS8LZT9B>'Q94[;>_U M6JSLMGO)#Q)X8`<)/*,'"3S.00)O`@<)/.5!`D@+6QF]F!K_]9C7;?>2G]KP MP,X4>&8=+,^]3N!80=5J(?YVWY0BJ?*#!![8;K?7ZR!!;\0[;TK19Q-`7+G3 MW;2P#<3E>]L>V`:L9_!-*59Z%_$);+YZRLU7S^Z;4B15OMWJ@6T&>D:W6SW. M=JLW@?U`3[D?Z-E]4XJDRG<`/;!M*L_@FU*L]"[B$]BB\I1;5)[=-Z5(JGQ3 MR@/;.?$,OBG%2N\B/H%=$T^Y:^+9?5.*I,KW23RP*+YG=)_$X^R3>!,(Y'O* M0+YG]TTIDBH/W7M@@67/:.C>XX3NO0G$ECUE;-FS_:;4MCR:O`T6\MPV^J;4 M-N=-J>T)A#NWE>'.[=X1F,?[A]G<8\AZV]L'#-?BV9^?LUGT>Y(NPE]QL,@? M3H(4G\*9_Y`^8_/T0Q.P3 MQP_)(HSB^W5BC%(:-8@4>27B:@QD7!RK[N&/6KS"3U$;/&&^S53B1P@9PQ^OU2L MS>&'2Y4FD)+$&`#@9QLDBGQW'Q^%L+[MO5A!/3KA>[$<-%O,?$)0K,WEMP.5 M-E`SQ@0"MOHK>\/*X??_(,P_C0[;/0,HE@.FBZE3@4)M3K_JIS2"DC)&(+#4 M8XMCA"Z_S`=A?_==]J+>,'&/+<4`V=)0;(PJA1:?_3,1DC0:+N5(Q^BV2'$3 MD09M/E.@9D=;'I`F_*H8XTM+G<]^5Y^:F`B%^$:1XCR(%NQC@?3C3<>D_&\MW%7"0YFD M5PD8'BET^33]?;F;6$B@KTS&R?Z#GF4J/NDC9(1-9QC_'D2$TU?I-8Z6=ZLT MPW0K[XH\.LHRG&>4U%?S6YPNHSC@#(AC*NQ'5A2'CD`KX)!,JUW"XX/,+*%;%'\L((V[\D:3Y/%E%R2_H;M?QU=_@5R`QE MK%0E#"?Y*OS-8[1^OH6N'8VS4BM4G%':WN17V8]3''Q[3*(X/XVR6;**\ZR% MJ$QPY'>X)I6(-JGN/Z$N,4WG6]L*:.S0YW,41\O5\ISM=U.7 M=XW_N8I2'!XM:8U4I%)F!Z.:9D4-$5"EG4/++51F0E4NM,Z&OA89I\%53=M* M&-R#!R9Y_>EY]D`0Q;=I$.+P;!6')\ER&649&;`%#E*1921_M2H$REFYQ@U/ MUV*HD$-4$-4DW;M2+=-U**D-ITD:9M?XD;"#=(/C)'_X'&0YF4;&(9EEAIT3 MDWI91M)0JT*@-)1K7-,P0QLQ1.50(8@"0L9"U#T/M6S7X:$VGD9Y2/XE,+'U MRM7\,HE3/%NE:13?'\W8A(-41T!'K9QC6=FC>K#DU%%<<;0F31>\=7E49J!L MG0!5>QBTR]B>D!LA[A4]F;FNT"7^3AWX<9#A\"K^E.71DBRQVN.X7I:A5.U3 M(1B.:FGTF11:BVTA(LC&\"W$9.DIUHVT0V+V,5_%R+Z0FMD)F14S6*J<4#\C MWGM=)04C>^4)=$"T+J$"Y@4H%((E5(3(*?*7+RUF!HZHU2[3/*3A*A?X_F6S)79"#1#3I]T]>)7P4`+K50*&K0I=_CH=5?N:#0F' M!-0S4\4V?;B,G2"Z2#+\.8GQ"^?`4"UMS/F@C@JXXT!5T>ST#Z*_$7O@D`7< M-C=TG.-PI2,QAB8"=7`,:2LHR%'XB>)Q,7]Q2PR! M&9JH/_(S^-L168]I_@QR2)2Z@MYD$?YBC,'T.#9?X`-$[G2;H,V/M/["_:_\\7BU7&UJ39_P9I%-Q%BRA_N9H7 M[R6TUPP#RQA\@'I,E8$.6`^J@E_+AFKY4"TCJN6DYR#*O`[).3TJ,4F!AB<@Y)IVNPBG!]P#-*MFL<9$E\@ZEZ')XL@BP[C>9S3`]+G9'& MG2^7.(Q()UB\?$GQ#--KDTEOB9+V_AM$@6,).[XQL)0>49^*]%NH*`:MRT&L M(+0I"5$2HEI9:%,8*DJ;0-<8#TVW\\!0S7#W8J&CLR1EU2-=_8I5,#R/OZ1) M]DAJWCGUT#/O^$[3HXK0_4-'=;,K%!%(>M=[T0WH:%#F0E&,JGR3('T/T_+X MW9,`1JA,HUFW";T-17P-H4!F*#6E*F$HR%?AL\ACGA17W10I6XBEN>"1U`X5 M7Y36-^KBVMHY=\;)1<):)/J M?KC2,$S%'MO0]+OLFN36N6]I*AME)WX-!#S0'3>K',%,-LLDO,K.EQJB^?C'/I(OFN-QN1"0[E MD%HYX'`G4>9NK%-;H&**702@OZ\AU>07J5.:#\(@XV@.PJV09`HBD1\[/BBK M`CM$B-6).>9Z^J$T47>TT`+,/L7ZT,L0M2S22DBIR9&I)Y%LGEIAE_+3G635 MD0'-/`#G5M15`C^X(E'9.+G"Y(J3!)Q3!([/K*CMQCVTHH>F%1[6SJ2>L'M9 MVP<%=#)`,5!<&3/TX^CC<*]Q"+F4FP+OQ-82DTZ.GA'&,667R>GZP]]G24KO M/%E?DG)+O^G=8H=>EJ&LZU,A&-YI:?0+@ETFZ+3QC?0S]HWTZD(^)NUPM[R/ M^2HB]H74BO/[C=YX5D0ASNBUO\&"]PD/S4Q03E!>*3..4*"3XPQ_8Q?EE=&G M4M;=AT!ZF4[L%=606J$C.UFXP$]!G-\FI$>"XJ:B6F:H*5+*829]0;(X^I;,44"E&3F9_#0.WNN84?Z5NOO2SSK8NQ^*I%MV5I9"% M)(JAF[3DJOSB[ZFP17*WEC821CA3NP[R!C_A^#1X^2/"BY#O6Y320WFC60T8 MYJB4^8V+/9D((C*("6VM[^%S.(QJ6JOB6`_<[+),Y)YT,H!SS9"CTM`G99S[ MZP'U+:9!.?>^C7<1CD(6FFL&KL*1JY(SC,E,B5F"FW"T4;+*)TTJP;/(#H'D MW)D2:_0)XX(KM\'SIW^NHJ=@05:3FL3AY0%DD;A*QBC%42GB%XU"5K*3HIO8 M<%+NR>$T0L3;ARC-7^33>H',4*))5<(0BZ_"+Q[7IT[N@@92*U0L4=K>!BM$ MTW"Q&!`W#$VYA5HX#'$]N5991$@5>Q/IIF+>])DK`<,1`U-EGH(N,YQ-BB7M M%Y'!S@2XJ5-*`2CT30+?Q=P]VBJ@[6&LG*Y*)4>C;WIJ*E-4Y\54)J$:AN%P M1@Q-V88+DI'\)K_('W=!ALF/_P=02P,$%`````@`TC$R0M;=`;8`(0``Y;0" M`!<`'`!P9VAC9C$M,C`Q,C$R,CA?<')E+GAM;%54"0`#FR[Y4)LN^5!U>`L` M`00E#@``!#D!``#M76U3X[B6_KY5^Q^RO5^7!B?A[=;TWJ()W*&6MPW,SKVU MM35E$A%\V[$9VZ&AIN:_KVQ'MB/KS9`^.0+-?(!&1]:CY_A%C\Z1]--?G^=A M[XDD:1!'7SYYGW<^]4@TB:=!-/OR:9%N^>DD"#[]]3__]5]^^K>MK;]_'9_W MIO%D,2=1UILDQ,_(M'?WTAN/>Z,XBD@8DI?>V47O.HDG)$WCI+?W>2?_O[=( MZ25[IXM_!EFZZ)U%&6TS\V>D]_=?_6BZM96W$`;1MSL_)3T**DJ_?'K(LL>_ M;&]___[]\_-=$GZ.D]EV?V=GL,T,/Y66?\E+`X5]$-&VHDEMGU]@Q?[[H+#V M#@\/MXO2RC0-1(;TLM[VWR_.;R8/9.YO50W0;O1Z/R5Q2,;DOI?__&5\MG*! MQT46^?//DWB^G1=OCY9TLI^4C9,H"[*7L^@^3N9^1CU#P>28_I*]/)(OG])@ M_A@2]K>'A-Q_^?0X>YC<>UO]':_O]?L'GY_3Z;^;77G[]9#'0?IM3+)%$MTL MYG,_>?DE"OT[$I+I]2^WET<7?SN_^GIT_O/)T?GMS\='XY/37RY';^O*ZUI\ M11=SOTX7(;EY\!/R$(=3DIP2DJZ[7Z]HY@V=.8JBA1^>+J+IU2-)J/^CVQ5S;YADXN+W_R[.=(?U2_S%M96U)GZ4/L;I^E^7:VIZ+9^& M$+A/`MCOS,/PE)#F;MK].WMZKI:C%>2LGD\RQ^ MVDZ2LJ^BMO3X)5?,^T-_%OW:VO&V!E[1,W$;2[2/"4GS@4O^`CJG+:RT39XS M$DW)E+6>0U[?2"O(\JOM%/_UMGJL3O-76K]77J#7O$(!G8(/X\D*7OIO/XN3 MMY"5)+_1D77Z2";9(KWU[VKJBYO]RZ=6Z?:/15-[[^@NS1)_DG&`1`85IJ9[ MCY)5?'XR89>BO[9\NSJ^7UIL/])15)1M31Z"L+HM[I-X+B!FV58LAA@G="1& M]=!.+HC>SN&4!"6)]!>>1?JGW]@M=4LORQ&X6K0)ZN0^SME;Q;,0,X&+Y,D0 MB-(CZM5I[MG3T)]Q5')E^"CD`"ZIVX6F;D3221(\-C_1/(,K)HB)7,&YY',/ MB$\Z[L^G]FY>YG=QR!')E>%CD`.XI&X?^%MSM#@\Z=M7F#_2-G]IFA!+<<];U6.YY?=+J_;6UZX M]T=UZ3^I17GY7GG]7ME`+V^A5S3QSO2ZZ8W>F+)@?SIZ#E+)/2^U1B;FM7@W MI%!'\=P/^*$K7[@)+@UOAR:W#"XPE>=DYH?E=U9PH[9*D=V8+7QK'AN8C;6$ MM^%JT29XD[BV'EAQM]QKY*=H6KW\VV\WQ2SO[M[>W@69WY&$XZ==O`F.1`[, M"6JC6WDN*<)[DB1D>EYV1HJ@:/Z))'=Q2@K;'S]B)4GQSHDFY(+X>7!#\%S+ MC)`]WC*8:YZ]Z\BG\'&7FVV$4^5-(*:6>QN`D'MTGY'DUG\FZ54TRD5><+?( MZ4F%KPRM-4ZJM;#7/'/Z.L:/HNF-'Y*.S/.U+/,`#W\S4PM%GM)QZ*>IZ%4M M-$[>+T9/-CX\/$)*]KR9[WQJR]SFR#Q&2?:`F^\`:L@]: MR@\AVX=JM@^M8?N09QM::!NPW=]1LET78V>[1LK8[F.?UGCG.7'K2OW0CXWK M]1`%OEORG'VEE_\F&BC+;?'%YS2`JUD-$)$M7Y^A)+U#/7P.Z`">.0-DCFEU M]<6O0?90K[]0>J-+17SNZ(*^FO:`]T=S-4P';ZBJ8?>%"COS!,@,%%N(H^1= M9H2/91E2-OUT`!PN4-*JL,/'K`(L&[^`O,HO_.0;R8J48U.>S:K@H]P,-V,? M9&JU!OPS*7)&I2/PJAP?KP*03`.!O'.O[OY9YH:*.6P7XZ.PC9$Q"'(;5LU? M)T&>ER9[\A5VB#EM@V7D@DC$"L<-F<31U(1>D25B@D5P&<7K6C!@,OX5/_]\ M(3XB>82,NW6M&##A[M)/-T7>LQU.]3?BI$S*K<#!^O7@,HHA/X`L M'&(HYA3FV,E62+L^B+03^5ZL1)26V'GFX#**092>/,;7]0;75,7N!!U^-M8& M48ER:.8/@:*63;X0/QR##>1@F"H?A3EVXA4Z:``Y*E_".0[C?*=H,[[;QMC9 M;B-F7,/DU5%X&9F]B(>)K5)\;+8@,OI@YIV7K6N_DRI#O*2JOH$@(Y,IRA`OJ:K;$V3JG0'1CA)4AGCY58T60(0``Z(9 M,!=F:QH.D/:% M;%(!/^^*%_0NR/B,!Z1Y4>O-\7,N?W$WAQPP>^J^_GBZQD:Z_=Y6CUTH_[6^ M5B^_6.\/W=:Y?[ZWO7.[)!U+%O=+K9"M\)?BW.`R_^,X7,PCP2[P"KM-T*JY M$T0IW0W$H(NX+OSG8+Z8'R_FB[#X4!>;R)5Y>%=/)+FZOR<)?:M=)\&$9[UC M7:2>Z-@+T`5B6FS90VL/%\,ZMGJC1`^ZDFR)J8'D;%ZEZ#=Q>ZMJ;14J1Q476AA_F>_0$<1)D+U\^]?F%:XBW[UGVG:4L=W]?FM7$ M[7FS/H`NJ-,@D[\IU37L]$.)W>1Y@][E<`UOWZMH3(+HB:09F8Z"IV!*M5&^ M_^W*?K@:I[_A$CX"6?C?4VRGM?88>4505BX+W2*AQR3FU@$7C5X?(S M;S=&7"OY=2=`8>':G<& M'%H/N#/@UOBR=F?`=6?1G0'GSH`3D.W.@%LGV>X,.$"RW1EP[@PX=P8<;K9_ MW!EPL,GZBF.GNB7N#U83]\OK]O(+]ZHK]]BE71J_9I]K22*_P@Z9E%$@A4SF M;^^V+4OG5UIN@ESM/2'>37QS2?V1/R-Y&":/,BH"^#(SM!S+(9OD.@ZQSW8W M9W/RR1R2/`43XO7O/*4CS:NA=:QY%TPA'YR&4>=7*VK:(6S M=9T`/=#F.)X_QA'MFEEY. MA6?0D7NY/7[NY=AAS]4Q8MP^GJ6(UY[^OHD/^-'D]T5`D>6BNDCEBZ9:'QK6 M0>M10_S`B?0:TJUB^+6/RVOFN[(X\T.8AX7>++_Z0;[0*!F38'ZW2-)"PTF= M9E(!K1--P(.F]%^23/N82&S0DBS!N^X4?II2Y3&0[5+E$;K`90N"[JVJ_?4KD6>VGTG6Y6WN^;M:#WE[=CCJ1RKB:>@IX)<*HE+)7&I)"Z5 MQ*62O&D"QJ62N%02ETJ"-;KN4DG`J':I)&@]X%))7"H)TK"/2R7I2)A+)=D$ MV2Z5Q*62N%02ETKB4DE<*LF&4TDNX_J\LFYI);O*M)+_Z%W&O?K2+LM$%:=J M.L$HXT1<`9FV,8&\N4R4)IY.62GJBIN/(ZIN)K5;4&6N-($99+&(S&WVQ3O. M=&EU4YWU(C*WWK/O,S.FU4UUEHS(W'K/OL],&KZ;FJP:D;GMGG69-R[SQF7> MN,P;EWGC,F]X*':9=Z@]8#+O'&9-TBC9"[SIB-A+O-F M$V2[S!N7>>,R;USFC\+#+XKJ]Y85[NG2;WO^R%O[O0R7>L%X7K4ER;20VR`2,!"5D1DUYYY6W MW+%?A,5X)2ZRV`212K\7HEN$%#3_906!+!=)9H2?4T%:$@PCUSR?Z]8NMH%$#_@\1:[Y MOIK$OATD-C)+0`Y&Y)KG<_/:Q3:0.``^X9!K?J@F<6@'B4/^L$)8$OE3N&\'B?O`9_)QS1^H23RP@\2#]1_` MUX7$0S6)AW:0>%B3"*Y8:)=4BJ4L1D]B"9.1"*Y8:/,JQ5(6VT!BK5CZX(J% M-J]2+&6Q#236BJ4/KECR+JE)M$&QE#`9B>"*A3:O4BQEL0TD#ALI4AL@4:58 MRF(;2*P5RP!I5C*8AM(K!7+`%RQT.95BJ4L MMH'$6K$,P!4+;5ZE6,IB&TBL%6K%X=B@6 MKU8L@PTH%D^M6#P[%(M7*Y;!!A2+IU8LGAV*Q:L5RV`#BL53*Q;/#L7BU8IE MN`'%XJD5BV>'8O%JQ3+<@&+QU(K%LT.Q>+5B&6Y`L7AJQ>+9H5B\6K$,-Z!8 M/+5B\>Q0+%ZM6(8;4"R>6K%X=B@6KU8LPPTHEKY:L?3M4"S]6K$,UZ58W$XM M;J<6MU,+NAO3[=3B=FIQ.[6XG5I`^70[M:QO^.EV:G$[M;B=6MQ.+6MCU>W4 MXG9J<3NUN)U:W$XM;J<6MU.+VZEEG6R[G5JP[=1"(?@SP88MMXD?I8\4W+3; M84G[W)8MY?7%6[?\43?RISLWB5.93<>4A$DV<5%:(E,X2JR@&[JT@2R?0AVW M_*L1D%B#>T)"\A(T['8D;1C"XXT4=G:1W.4D(_3GWL^GNPFB":DV/])[D;>WRYL\>MA]8=IXE+MI:@UI+DT(&RCL`^4!@0R'_!1TX`\ MF/5-+@\H,9-_Z%\\+L%(!=_$Q>N*Q:SAXWV13H)?XR2<_DS\,'LXIA2=15/R M+/2ASABGZW2H5_<61_S@?;A\,I`LO?>?3_::N9$/G4\&_2;XT/ED0X1DO]M\ M,NBXWH?.)X,.PWWH=#*$.<#O-YML73G`,,ED;.9]'*3?RB#2B&1^$/X2%1[I MFD)VT-OJL4O27_.K;I>7[977[?U17?E/[?E?[RUKS`707`#-!=#0W9AN';U; M1^\":!\U@.;6T;MU].\A?N;6T6,)<[EU]&X=/9)9"K>.?EUQ#X1S:.\W[N'6 MT;MU].\S[N'6T;MU].\U\@&>N]5Y7%='.20+LD4&R$;((HB0RZ_Y2%$!\)8\ M9U_I];])^10;;X);^4VP2J\8\6I&'&BH+D@G89PK4Q[CR,_\DY#D`8"T6[SN M,(_75=<51^SRJ_?^8-=W43L7M7-1.Q>UV_B-Z9:]N65O+FKW4:-V,)/K'S1J M!W,,D(O:F2V)@DX"=]%`Z$5OB#+/W9JW366HN]"O"_V"A'Y?\0X6*_Z^20:J=I$,VD M%%;EF".\%B)C#=C$^"ML85S?HA6+P.@GF?O(BRSY0 MV"'FM`T6=`_="L<-F<31U(1>D25B@D5PU[U7KI+BD^='$J62YY\OQ$$I,>^:,MRF1$^6F5( M&:<@J]-X$'&XF$>7_IS/7%+8X6>V`9:1"Q)$O/"?@_EB?KR8+\+BR2E"+\<4 MW8Q<47EQ=4_E"'U)T6_JA">\8UU\3NC8`>88D&ET+;;LH1U.,JMCH2-*X,P! M(%)MB:F!Y&Q>'-=U%5TODLF#GY+4\`GI>@VT#NK:$8/0;1]]F'#9]]$28/<7 MI%E-M$XW@\_<":)?-M<4,(V>-U>16,21$\DS@!2.STPH_\6;%..I\55WRL9&;XR)5C-9$*T-F9!Z">7<=3)Q[J*N+VL M0\]\":(QC^/Y8QS1/GG%\(*]LZ5N,+#'Q[X!:$8ZB/:L\/0[DBZW1TRZ'#0C M'42]5G@&'4F7VR,F70Z:D0ZB9\VHMHA@*523KS/TRM+N:XAM+=MV4/O:!P1Z6]?._J'WR:]^D,?`DC$)YG>+ M)"W4F-1?)A7P^<\$-?,9B)2_))GVT9#8X&-7`I01"A)/U7MXY&?DZOZ6)/,@ M\@5S?J^Z`CYGO*H;U2H?D'UOXB2[C\,@OJ5=B"DL<::ZW`P?Z7*LC%D0\=N" M(4M?5QE:P&X[@7T7YIP5'LB8/DHZ:DL;"U@M@3)"033L\K-Q&L=9%&9HJ59@9HR#!&H9G'&>SW!UW\ALT+*N MKH*7>35NQCZDUOR:$/_;8QQ$6;[UW5_64<)62R2/*E&-(/YU2_6 M19VD63"G>D,9.9%6P><$,]R,?9AS*^7A`(T3.M7$YXM.\)E+(.5NNG*W_.Q3 M>+03%$D0^#RRB& MUWVA(;GN(5 MX31(N-E'?XB.H&L#O9<&EGAI8.8E]"=Y"KJVJ_?2KB5>VC7S$OH]=]M=\W:T M7O)V[/!2CM/$2^C/[^%&(G&]0K[KP$M3%;M7=?B91R&UM0":^>!,4$%E9/8BGN9OE>)CLP61T0<25F>M:_6DRA`OJ0JM M>`!S:.422+5BX#B.)K1+B6@9E1$T5[W9A]&>E!">5?!3G$$0@%2W+MCOE"Y$2U][4 M]!!,\`@8P\I3S0Z(MOGJ)_F:YNPHFEZ3Y#Y.YC[5IL7)O6*5:%(!'[,FJ!GO M(/JG@4(K+36V^-C6`&9$@XBB!I:SJ/@MI^.,(>!Z*X&QJNHR%2Z2LY)JO`)9X::=@XK.[=W!V9CI!K' MT70:E!&[<@A^%DW)LYQBB3EJJB68*\IA=DQJX'GR@W#Y<%T_4/6CH+MMBIOJ M-MZ*9IB-D\18?B5W-T&6WPF)\@VBJF,-\3SPR@,@JJX!ZMI/LU%404U_PK<%?T@"I$-<-6#=@M&Z/QPW-L!48FL>>U@7&6(EU7% M,-S;`16:RZ=EN>ZW.$WQ//:G_,M9;XZ7;#GFBG(0C7D410L_+/&*)]R$%OB( M%<*LN`21D2L09#-Q,B/DC+9GYKP=$*G71'%&OZ:%9T?M+2\5=KBIY<`R=CT0 MM=<$XE'MKB"U+,;-98FQHA!$O7'M\ZLEVL7H*?0:%,+L$K3:?E]-8=\""OL- M"D&D%=<^O]*C78R>PD�A!YQ+4_5%,XM(#"88-"$(7$M<^O4FD7HZ=PMT$A MB`;BVM]34[AG`85[#0K!-0UM?U]-X;X%%.XW*`27,K3]`S6%!Q90>-"@$%RX MT/8/U10>6D#A84UA'UR=T!95ZJ0LQDUAB;&B$%R=T/95ZJ0L1D]A0YWTP=4) M;5^E3LIB]!3VC19D>GWTFZ]P_5*IGK(8O6O,UJ][??0[KG#]4JFILAB]:X:& MKL%_(.5JOU0JK2Q&[QJSO0*\_IYEKE&IO[(8O6OV#%V#?F\5KE\J55D6HW?- MOJ%KT&^6PO5+I5;+8O2N.3!T#?K=3[A^J51P68S>-8=FKAF@W\YDM5^MC6C: MQ=A=8[C1C#=`OT$KUR^U:OV0YKW@#]KJQDW[P6"4M M5:MVSP+5[C5BE0/P6"4M5:MKSP)U[35BE0/P6"4M5:M@SP(5[#5BE0/P6"4M M5:M5SP*UZC5BE0/P6"4M5:M*SP)5Z35BE0/P6"4M5:L_SP+UYS5BE0/P6"4M M5:LTSP*5YC5BE<,-Q"K[:C75MT!-]1NQRB%(K)+EQFOW?%(9XJ-5A;8B&"22 MR9!H-H"2F^$E5[H1E#<$T30,QYCX:1S=D'Q5!YD>AWZ:CH)[*F9I[TYI?\[F MR"FU%,*@8%2)2O$44]OCH-@!=L0ZJ4X6`NC!N'=L-ID&$ MH]E6B1;MCZC;%-';!9%]/(Q\)PW=3B&&=?!S+@%>>0!$)O*@&ENGT<$`O'#<7O88EH)GPM,D5=.@-[ZLT!5;*(4DB<_RFYC M>EN,EIEC&C?(J^%WA!P[<\4>]%:A!:ZKB!33PU?W1_=TX$61W3S$W_E1I7$M M_(Z00J_\`+U_:`&+OB1#/RKI6N(JGMM$XPE%/?R^4("OO`&]S6CYM';8NEM: M`3__JMT#]Z!W%RT05?'V,M@HWM>:A;1>%Z2%:1*_\W],OZO;9R-Z79N%8E+! M(M>)GMN-"'I-=HK>'#_I\FR5/9C$W2L5()'N M"*JVM8-FP?Z@>S#9OVTPHBB-W,P*?KD(S1Y,5G`;1Q[?;V\B([>S@EP&UF2! MVC[^99V2#K86N,CM[/&:X<8/^_A7?(H[V%Z5*[>SQFNFZW3W\2\&;7?P)BA4 MSW)/9[WW>'LKO,B#KCP&LWZT#4BY,[C6W`K.)?N$[X.(X\9!K#?DB5`,+_\( M2#@5JP:M-3["M9`KOD$TL12.3$285+"(=8&V9(<^B.E:0+@)>>0!$.M\^!$GV MHOY*2FSP,2P!RA@]``DV!=^\`Y#X\2H.T9=.:(&=4.ZK=@`2 M_5V%H*01/X,-\D"$7=6Z]FNEM$1,J^K+=+`N)3174(,LK[XSW*'_];9ZHR"= MA'&Z2`C]1UYQNZS9*ZOV\KJ]/TY",J<`TS\__=A[0$[Q\CX0&;@'?6T/NGO. M7_N'-D550)``.;+OE0FR[Y4'5X"P`!!"4.```$.0$``.U9:V_B.!3]OM+^!V\^ M3PBA6UH0=-06.JU$'Z)44VFU&IGD`MYQ[*SMM%15__O:>?!,"92N%FEI/Y#$ M]YYS;H[C.';CZSB@Z`F$))PU+;=4MA`PC_N$#9M6)&TL/4*LKR>__M+XS;8? MS[H=Y',O"H`IY`G`"GS4?T'=+FIQQH!2>$%7U^A.<`^DY`)52V7SCR*I(=%% M]!=1,D)73&E.A8>`'K]CYMNV89#>"`*,%!9#4#*9-B`*\A-\)1SU$H*C@VP=!8)XEK[E"#4P8UQA MI?V/S\V5,"1LP--3?<$HJV?RNC!`<5EU`]BT)`E":D3$UT8"!DTKN85V=J]^ MA`)*6F06I(BB.O-.@-2VQ=RHHQOD%X3I)$IP"BO*-\U..`/1F0K,(+#PEE"6 M[-$@/`2A",@9#YQ/+-_#-*?\'$O2[#1D5>;"<[A^XGPGSL]+KV:V?(9;72)_=D%%@MU'08#%RP.+.Q;X M=P^]F]/K;YW;L]/.9?NTT[L\/^VV+QYN6O,N?@BAR%W7G7?7D#@)"TIIT.N$ MZ$U')&0H84,)'3)\R!#N[9^WWTQS_(C"_0@+&''J@[@`D$6>;YY6:'1%>Y?! MFL,I,C+0Z+7(VK>]M_G>GNHY(*87$?-O]5"O=;-A>QP"D^O[_#&(0L\/YCU/ M6)"A01,>E!'M>\"'>T!Z"]MC;"8HZYJ^=E:AS[_/^YP"HQ1Y;^PG&7O#N^!# M$!H9'S-Y381"PP]7&OX%W7`T)=K[O^70WM,?ZS29%*T8CL^P.-,URGEVWYL^(0ONA8H3.@6'W3K`Q1VA./WO^<2EOWGW#;>$^E1+B,! MB^:UL,+M9$V\<-:_-4IA+ZB97C!AR>\'A@N]9FS_Z[[0<&;7W_79_/I\@P0A M%PJQW.V1]W8(DIV5#O=BH!4IYLS.\FQSR78K]H%;&DL_6RO<1(*I,%EGW$Q" MEK>QA!A+@E<:\B='B'B_QBZ[.O]="7DI^M>>IGZ`V@>R,7>68PXV9B_>[UG+ M@MG,FR31>%`S'KC5.2GIMENL14\NXO79PVJU>@U!'T0RO"1+XC^6&Y-5]&3/ MJN[S`!-VI2`P#X(6&O6E(BHR,K\)'H5-*]X-JQ,=8B&L6P7V5-,:8&KZ%B-4 MOT;,^K<2D5F4CX-#+9[[O9C(CT2Z&)TK_CSYDCET#W/$+S?NJ/B\.[_KQ!_ON/C:*O&UW19?*:\0/VW<+?'7TB/?N:#^)6"J1N=8P!7S M89Q32E'H?UI8PTG>*/KP'U!+`0(>`Q0````(`-(Q,D+U*U]VIQH``$?+```3 M`!@```````$```"D@0````!P9VAC9C$M,C`Q,C$R,C@N>&UL550%``.;+OE0 M=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`TC$R0N$0;-'[`@``V1(``!<` M&````````0```*2!]!H``'!G:&-F,2TR,#$R,3(R.%]C86PN>&UL550%``.; M+OE0=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`TC$R0B#9Y4JE)@``CK\# M`!<`&````````0```*2!0!X``'!G:&-F,2TR,#$R,3(R.%]D968N>&UL550% M``.;+OE0=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`TC$R0N3WOC#')0`` MICX"`!<`&````````0```*2!-D4``'!G:&-F,2TR,#$R,3(R.%]L86(N>&UL M550%``.;+OE0=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`TC$R0M;=`;8` M(0``Y;0"`!<`&````````0```*2!3FL``'!G:&-F,2TR,#$R,3(R.%]P&UL550%``.;+OE0=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`TC$R0H.8 M/0_=!```22(``!,`&````````0```*2!GXP``'!G:&-F,2TR,#$R,3(R."YX M`L``00E#@``!#D!``!02P4&``````8`!@`F`@``R9$` #```` ` end XML 10 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Label Element Value
Risk/Return: rr_RiskReturnAbstract  
Registrant Name dei_EntityRegistrantName PUTNAM GLOBAL HEALTH CARE FUND

Prospectus Date rr_ProspectusDate Dec. 30, 2012
PUTNAM GLOBAL HEALTH CARE FUND
  
Risk/Return: rr_RiskReturnAbstract  
Risk/Return [Heading] rr_RiskReturnHeading PUTNAM GLOBAL HEALTH CARE FUND
Objective [Heading] rr_ObjectiveHeading Goal
Objective, Primary [Text Block] rr_ObjectivePrimaryTextBlock Putnam Global Health Care Fund seeks capital appreciation.
Expense [Heading] rr_ExpenseHeading Fees and expenses
Expense Narrative [Text Block] rr_ExpenseNarrativeTextBlock The following table describes the fees and expenses you may pay if you buy and hold shares of the fund. You may qualify for sales charge discounts if you and your family invest, or agree to invest in the future, at least $50,000 in Putnam funds. More information about these and other discounts is available from your financial advisor and in How do I buy fund shares? beginning on page 57 of the fund’s prospectus and in How to buy shares beginning on page II-1 of the fund’s statement of additional information (SAI).
Shareholder Fees Caption [Text] rr_ShareholderFeesCaption Shareholder fees (fees paid directly from your investment)
Operating Expenses Caption [Text] rr_OperatingExpensesCaption Annual fund operating expenses
(expenses you pay each year as a percentage of the value of your investment)
Portfolio Turnover [Heading] rr_PortfolioTurnoverHeading Portfolio turnover
Portfolio Turnover [Text Block] rr_PortfolioTurnoverTextBlock The fund pays transaction-related costs, such as commissions, when it buys and sells securities (or “turns over” its portfolio). A higher turnover rate may indicate higher transaction costs and may result in higher taxes when the fund’s shares are held in a taxable account. These costs, which are not reflected in annual fund operating expenses or the above example, affect fund performance. The fund’s turnover rate in the most recent fiscal year was 25%.
Portfolio Turnover, Rate rr_PortfolioTurnoverRate 25.00%
Expense Breakpoint Discounts [Text] rr_ExpenseBreakpointDiscounts You may qualify for sales charge discounts if you and your family invest, or agree to invest in the future, at least $50,000 in Putnam funds. More information about these and other discounts is available from your financial advisor and in How do I buy fund shares? beginning on page 57 of the fund’s prospectus and in How to buy shares beginning on page II-1 of the fund’s statement of additional information (SAI).
Expense Breakpoint, Minimum Investment Required [Amount] rr_ExpenseBreakpointMinimumInvestmentRequiredAmount 50,000
Expenses Restated to Reflect Current [Text] rr_ExpensesRestatedToReflectCurrent Restated to reflect current fees.
Expense Example [Heading] rr_ExpenseExampleHeading Example
Expense Example Narrative [Text Block] rr_ExpenseExampleNarrativeTextBlock The following hypothetical example is intended to help you compare the cost of investing in the fund with the cost of investing in other funds. It assumes that you invest $10,000 in the fund for the time periods indicated and then, except as indicated, redeem all your shares at the end of those periods. It assumes a 5% return on your investment each year and that the fund’s operating expenses remain the same. Your actual costs may be higher or lower.
Strategy [Heading] rr_StrategyHeading Investments
Strategy Narrative [Text Block] rr_StrategyNarrativeTextBlock For this non-diversified fund concentrating in the health care industries, we invest mainly in common stocks (growth or value stocks or both) of large and midsize companies worldwide that we believe have favorable investment potential. Potential investments include companies that manufacture health care supplies or provide health care-related services, and companies in the research, development, production and marketing of pharmaceuticals and biotechnology products. We may purchase stocks of companies with stock prices that reflect a value lower than that which we place on the company. We also consider other factors that we believe will cause the stock price to rise. We may consider, among other factors, a company’s valuation, financial strength, growth potential, competitive position in its industry, projected future earnings, cash flows and dividends when deciding whether to buy or sell investments. We may also use derivatives, such as futures, options, certain foreign currency transactions, warrants and swap contracts, for both hedging and non-hedging purposes, and may engage in short sales of securities.
Strategy Portfolio Concentration [Text] rr_StrategyPortfolioConcentration For this non-diversified fund concentrating in the health care industries, we invest mainly in common stocks (growth or value stocks or both) of large and midsize companies worldwide that we believe have favorable investment potential.
Risk [Heading] rr_RiskHeading Risks
Risk Narrative [Text Block] rr_RiskNarrativeTextBlock It is important to understand that you can lose money by investing in the fund.

The prices of stocks in the fund’s portfolio may fall or fail to rise over extended periods of time for a variety of reasons, including both general financial market conditions and factors related to a specific company or industry. Growth stocks may be more susceptible to earnings disappointments, and value stocks may fail to rebound. These risks are generally greater for small and midsize companies. The health care industries may be affected by technological obsolescence, changes in regulatory approval policies for drugs, medical devices or procedures and changes in governmental and private payment systems. Our policy of concentrating on a limited group of industries and the fund’s “non-diversified” status, which means the fund has the ability to invest a greater percentage of its assets in fewer issuers than a “diversified fund,” can increase the fund’s vulnerability to adverse developments affecting a single industry or issuer, which may result in greater losses and volatility for the fund. The value of international investments traded in foreign currencies may be adversely impacted by fluctuations in exchange rates. International investments, particularly investments in emerging markets, may carry risks associated with potentially less stable economies or governments (such as the risk of seizure by a foreign government, the imposition of currency or other restrictions, or high levels of inflation or deflation), and may be illiquid. Our use of derivatives may increase these risks by increasing investment exposure or, in the case of many over-the-counter instruments, because of the potential inability to terminate or sell derivatives positions and the potential failure of the other party to the instrument to meet its obligations. Our use of short selling may result in losses if the securities appreciate in value.

The fund may not achieve its goal, and it is not intended to be a complete investment program. An investment in the fund is not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency.
Risk Lose Money [Text] rr_RiskLoseMoney It is important to understand that you can lose money by investing in the fund.
Risk Nondiversified Status [Text] rr_RiskNondiversifiedStatus Our policy of concentrating on a limited group of industries and the fund’s “non-diversified” status, which means the fund has the ability to invest a greater percentage of its assets in fewer issuers than a “diversified fund,” can increase the fund’s vulnerability to adverse developments affecting a single industry or issuer, which may result in greater losses and volatility for the fund.
Risk Not Insured Depository Institution [Text] rr_RiskNotInsuredDepositoryInstitution An investment in the fund is not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency.
Bar Chart and Performance Table [Heading] rr_BarChartAndPerformanceTableHeading Performance
Performance Narrative [Text Block] rr_PerformanceNarrativeTextBlock The performance information below gives some indication of the risks associated with an investment in the fund by showing the fund’s performance year to year and over time. The bar chart does not reflect the impact of sales charges. If it did, performance would be lower. Please remember that past performance is not necessarily an indication of future results. Monthly performance figures for the fund are available at putnam.com.
Performance Information Illustrates Variability of Returns [Text] rr_PerformanceInformationIllustratesVariabilityOfReturns The performance information below gives some indication of the risks associated with an investment in the fund by showing the fund’s performance year to year and over time.
Performance Availability Website Address [Text] rr_PerformanceAvailabilityWebSiteAddress putnam.com
Performance Past Does Not Indicate Future [Text] rr_PerformancePastDoesNotIndicateFuture Please remember that past performance is not necessarily an indication of future results.
Bar Chart [Heading] rr_BarChartHeading Annual total returns for class A shares before sales charges
Bar Chart Does Not Reflect Sales Loads [Text] rr_BarChartDoesNotReflectSalesLoads The bar chart does not reflect the impact of sales charges. If it did, performance would be lower.
Bar Chart Closing [Text Block] rr_BarChartClosingTextBlock
Year-to-date
performance
through 9/30/12

21.11%
Best calendar
quarter
Q3 2010

12.45%
Worst calendar
quarter
Q3 2011		 -17.98%
Year to Date Return, Label rr_YearToDateReturnLabel Year-to-date performance
Bar Chart, Year to Date Return, Date rr_BarChartYearToDateReturnDate Sep. 30, 2012
Bar Chart, Year to Date Return rr_BarChartYearToDateReturn 21.11%
Highest Quarterly Return, Label rr_HighestQuarterlyReturnLabel Best calender quarter
Highest Quarterly Return, Date rr_BarChartHighestQuarterlyReturnDate Sep. 30, 2010
Highest Quarterly Return rr_BarChartHighestQuarterlyReturn 12.45%
Lowest Quarterly Return, Label rr_LowestQuarterlyReturnLabel Worst calender quarter
Lowest Quarterly Return, Date rr_BarChartLowestQuarterlyReturnDate Sep. 30, 2011
Lowest Quarterly Return rr_BarChartLowestQuarterlyReturn (17.98%)
Performance Table Heading rr_PerformanceTableHeading Average annual total returns after sales charges
(for periods ending 12/31/11)
Performance Table Uses Highest Federal Rate rr_PerformanceTableUsesHighestFederalRate After-tax returns reflect the historical highest individual federal marginal income tax rates and do not reflect state and local taxes.
Performance Table Not Relevant to Tax Deferred rr_PerformanceTableNotRelevantToTaxDeferred Actual after-tax returns depend on an investor’s tax situation and may differ from those shown.
Performance Table One Class of after Tax Shown [Text] rr_PerformanceTableOneClassOfAfterTaxShown After-tax returns are shown for class A shares only and will vary for other classes.
Performance Table Narrative rr_PerformanceTableNarrativeTextBlock After-tax returns reflect the historical highest individual federal marginal income tax rates and do not reflect state and local taxes. Actual after-tax returns depend on an investor’s tax situation and may differ from those shown. After-tax returns are shown for class A shares only and will vary for other classes. These after-tax returns do not apply if you hold your fund shares through a 401(k) plan, an IRA, or another tax-advantaged arrangement.

Class B share performance does not reflect conversion to class A shares.
PUTNAM GLOBAL HEALTH CARE FUND | Class A
  
Risk/Return: rr_RiskReturnAbstract  
Maximum sales charge (load) imposed on purchases (as a percentage of offering price) rr_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice 5.75%
Maximum deferred sales charge (load) (as a percentage of original purchase price or redemption proceeds, whichever is lower) rr_MaximumDeferredSalesChargeOverOther 1.00% [1]
Redemption fee (as a percentage of total redemption proceeds) rr_RedemptionFeeOverRedemption 1.00% [2]
Management fees rr_ManagementFeesOverAssets 0.64%
Distribution and service (12b-1) fees rr_DistributionAndService12b1FeesOverAssets 0.25%
Other expenses rr_OtherExpensesOverAssets 0.38% [3]
Total annual fund operating expenses rr_ExpensesOverAssets 1.27%
1 year rr_ExpenseExampleYear01 697
3 years rr_ExpenseExampleYear03 955
5 years rr_ExpenseExampleYear05 1,232
10 years rr_ExpenseExampleYear10 2,021
2002 rr_AnnualReturn2002 (20.38%)
2003 rr_AnnualReturn2003 18.50%
2004 rr_AnnualReturn2004 7.15%
2005 rr_AnnualReturn2005 13.56%
2006 rr_AnnualReturn2006 2.99%
2007 rr_AnnualReturn2007 (0.63%)
2008 rr_AnnualReturn2008 (17.12%)
2009 rr_AnnualReturn2009 25.17%
2010 rr_AnnualReturn2010 2.06%
2011 rr_AnnualReturn2011 (1.41%)
1 year rr_AverageAnnualReturnYear01 (7.08%)
5 years rr_AverageAnnualReturnYear05 (0.45%)
10 years rr_AverageAnnualReturnYear10 1.46%
PUTNAM GLOBAL HEALTH CARE FUND | Class B
  
Risk/Return: rr_RiskReturnAbstract  
Maximum sales charge (load) imposed on purchases (as a percentage of offering price) rr_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice none
Maximum deferred sales charge (load) (as a percentage of original purchase price or redemption proceeds, whichever is lower) rr_MaximumDeferredSalesChargeOverOther 5.00% [4]
Redemption fee (as a percentage of total redemption proceeds) rr_RedemptionFeeOverRedemption 1.00% [2]
Management fees rr_ManagementFeesOverAssets 0.64%
Distribution and service (12b-1) fees rr_DistributionAndService12b1FeesOverAssets 1.00%
Other expenses rr_OtherExpensesOverAssets 0.38% [3]
Total annual fund operating expenses rr_ExpensesOverAssets 2.02%
1 year rr_ExpenseExampleYear01 705
3 years rr_ExpenseExampleYear03 934
5 years rr_ExpenseExampleYear05 1,288
10 years rr_ExpenseExampleYear10 2,155
1 year rr_ExpenseExampleNoRedemptionYear01 205
3 years rr_ExpenseExampleNoRedemptionYear03 634
5 years rr_ExpenseExampleNoRedemptionYear05 1,088
10 years rr_ExpenseExampleNoRedemptionYear10 2,155
1 year rr_AverageAnnualReturnYear01 (6.36%)
5 years rr_AverageAnnualReturnYear05 (0.26%)
10 years rr_AverageAnnualReturnYear10 1.30%
PUTNAM GLOBAL HEALTH CARE FUND | Class C
  
Risk/Return: rr_RiskReturnAbstract  
Maximum sales charge (load) imposed on purchases (as a percentage of offering price) rr_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice none
Maximum deferred sales charge (load) (as a percentage of original purchase price or redemption proceeds, whichever is lower) rr_MaximumDeferredSalesChargeOverOther 1.00% [5]
Redemption fee (as a percentage of total redemption proceeds) rr_RedemptionFeeOverRedemption 1.00% [2]
Management fees rr_ManagementFeesOverAssets 0.64%
Distribution and service (12b-1) fees rr_DistributionAndService12b1FeesOverAssets 1.00%
Other expenses rr_OtherExpensesOverAssets 0.38% [3]
Total annual fund operating expenses rr_ExpensesOverAssets 2.02%
1 year rr_ExpenseExampleYear01 305
3 years rr_ExpenseExampleYear03 634
5 years rr_ExpenseExampleYear05 1,088
10 years rr_ExpenseExampleYear10 2,348
1 year rr_ExpenseExampleNoRedemptionYear01 205
3 years rr_ExpenseExampleNoRedemptionYear03 634
5 years rr_ExpenseExampleNoRedemptionYear05 1,088
10 years rr_ExpenseExampleNoRedemptionYear10 2,348
1 year rr_AverageAnnualReturnYear01 (3.01%)
5 years rr_AverageAnnualReturnYear05 (0.02%)
10 years rr_AverageAnnualReturnYear10 1.30%
PUTNAM GLOBAL HEALTH CARE FUND | Class M
  
Risk/Return: rr_RiskReturnAbstract  
Maximum sales charge (load) imposed on purchases (as a percentage of offering price) rr_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice 3.50%
Maximum deferred sales charge (load) (as a percentage of original purchase price or redemption proceeds, whichever is lower) rr_MaximumDeferredSalesChargeOverOther 0.65% [1]
Redemption fee (as a percentage of total redemption proceeds) rr_RedemptionFeeOverRedemption 1.00% [2]
Management fees rr_ManagementFeesOverAssets 0.64%
Distribution and service (12b-1) fees rr_DistributionAndService12b1FeesOverAssets 0.75%
Other expenses rr_OtherExpensesOverAssets 0.38% [3]
Total annual fund operating expenses rr_ExpensesOverAssets 1.77%
1 year rr_ExpenseExampleYear01 524
3 years rr_ExpenseExampleYear03 888
5 years rr_ExpenseExampleYear05 1,276
10 years rr_ExpenseExampleYear10 2,361
1 year rr_AverageAnnualReturnYear01 (5.34%)
5 years rr_AverageAnnualReturnYear05 (0.48%)
10 years rr_AverageAnnualReturnYear10 1.19%
PUTNAM GLOBAL HEALTH CARE FUND | Class R
  
Risk/Return: rr_RiskReturnAbstract  
Maximum sales charge (load) imposed on purchases (as a percentage of offering price) rr_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice none
Maximum deferred sales charge (load) (as a percentage of original purchase price or redemption proceeds, whichever is lower) rr_MaximumDeferredSalesChargeOverOther none
Redemption fee (as a percentage of total redemption proceeds) rr_RedemptionFeeOverRedemption 1.00% [2]
Management fees rr_ManagementFeesOverAssets 0.64%
Distribution and service (12b-1) fees rr_DistributionAndService12b1FeesOverAssets 0.50%
Other expenses rr_OtherExpensesOverAssets 0.38% [3]
Total annual fund operating expenses rr_ExpensesOverAssets 1.52%
1 year rr_ExpenseExampleYear01 155
3 years rr_ExpenseExampleYear03 480
5 years rr_ExpenseExampleYear05 829
10 years rr_ExpenseExampleYear10 1,813
1 year rr_AverageAnnualReturnYear01 (1.68%)
5 years rr_AverageAnnualReturnYear05 0.48%
10 years rr_AverageAnnualReturnYear10 1.81%
PUTNAM GLOBAL HEALTH CARE FUND | Class Y
  
Risk/Return: rr_RiskReturnAbstract  
Maximum sales charge (load) imposed on purchases (as a percentage of offering price) rr_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice none
Maximum deferred sales charge (load) (as a percentage of original purchase price or redemption proceeds, whichever is lower) rr_MaximumDeferredSalesChargeOverOther none
Redemption fee (as a percentage of total redemption proceeds) rr_RedemptionFeeOverRedemption 1.00% [2]
Management fees rr_ManagementFeesOverAssets 0.64%
Distribution and service (12b-1) fees rr_DistributionAndService12b1FeesOverAssets   
Other expenses rr_OtherExpensesOverAssets 0.38% [3]
Total annual fund operating expenses rr_ExpensesOverAssets 1.02%
1 year rr_ExpenseExampleYear01 104
3 years rr_ExpenseExampleYear03 325
5 years rr_ExpenseExampleYear05 563
10 years rr_ExpenseExampleYear10 1,248
1 year rr_AverageAnnualReturnYear01 (1.19%)
5 years rr_AverageAnnualReturnYear05 0.99%
10 years rr_AverageAnnualReturnYear10 2.32%
PUTNAM GLOBAL HEALTH CARE FUND | after taxes on distributions | Class A
  
Risk/Return: rr_RiskReturnAbstract  
1 year rr_AverageAnnualReturnYear01 (8.99%)
5 years rr_AverageAnnualReturnYear05 (1.74%)
10 years rr_AverageAnnualReturnYear10 0.41%
PUTNAM GLOBAL HEALTH CARE FUND | after taxes on distributions and sale of fund shares | Class A
  
Risk/Return: rr_RiskReturnAbstract  
1 year rr_AverageAnnualReturnYear01 (2.66%)
5 years rr_AverageAnnualReturnYear05 (0.51%)
10 years rr_AverageAnnualReturnYear10 1.12%
PUTNAM GLOBAL HEALTH CARE FUND | MSCI World Health Care Index (ND) no deduction for fees, expenses or taxes other than withholding taxes on reinvested dividends)
  
Risk/Return: rr_RiskReturnAbstract  
1 year rr_AverageAnnualReturnYear01 9.46%
5 years rr_AverageAnnualReturnYear05 1.69%
10 years rr_AverageAnnualReturnYear10 3.13%
[1] Applies only to certain redemptions of shares bought with no initial sales charge.
[2] This fee applies only to shares purchased before 1/2/2013.
[3] Restated to reflect current fees.
[4] This charge is phased out over six years.
[5] This charge is eliminated after one year.
EXCEL 11 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\S,&1F-S,Q,U\X,V4V7S0Y,3A?865C,5\Y9C`Q M-65A-69F-CDB#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O6QE#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O M=&5C=%-T#I0#I0#I0&UL/CPA6V5N9&EF72TM/@T*/"]H96%D M/@T*("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S:&]U;&0@8F4@;W!E;F5D M('=I=&@@36EC'1087)T7S,P9&8W,S$S7S@S M939?-#DQ.%]A96,Q7SEF,#$U96$U9F8V.0T*0V]N=&5N="U,;V-A=&EO;CH@ M9FEL93HO+R]#.B\S,&1F-S,Q,U\X,V4V7S0Y,3A?865C,5\Y9C`Q-65A-69F M-CDO5V]R:W-H965T'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^,#`P,#,U-S(Y-3QS<&%N/CPO'0^1&5C(#,P+`T*"0DR,#$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\S,&1F-S,Q,U\X,V4V7S0Y,3A?865C,5\Y9C`Q-65A M-69F-CD-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,S!D9C'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^/&(^1V]A;#PO8CX\'0^/&(^1F5E'0^5&AE(&9O;&QO=VEN9R!T86)L92!D97-C2!F=6YD('-H87)E'0^/&(^4VAA2!F&EM=6T@&EM=6T@ M9&5F97)R960@2!T;R!C97)T86EN M(')E9&5M<'1I;VYS(&]F('-H87)E'0^/&(^06YN=6%L(&9U;F0@;W!E'!E;G-E65A'0^)FYB'!E;G-E'0^/&(^17AA;7!L93PO8CX\&%M<&QE(&ES(&EN=&5N9&5D('1O(&AE;'`@>6]U M(&-O;7!A6]U(&EN=F5S="`D,3`L,#`P(&EN('1H92!F=6YD(&9O M'!E;G-E2!B92!H:6=H97(@;W(@;&]W97(N/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$&%M<&QE#0H-"@T*#0I0551.04T@1TQ/0D%,($A%04Q42"!# M05)%($953D0-"@T**%531"`D*3QB65A'!E;G-E($5X86UP;&4L($YO(%)E M9&5M<'1I;VX-"@T*#0H-"E!55$Y!32!'3$]"04P@2$5!3%1(($-!4D4@1E5. M1`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`Z(#9P>#L@34%21TE.+4)/5%1/33H@ M,'!X)SX\+W`^/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P M,#`P,#`@,7!X('-O;&ED.R!"3U)$15(M3$5&5#H@(S`P,#`P,"`P<'@@6QE M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!"3U)$15(M M3$5&5#H@(S`P,#`P,"`P<'@@6QE M/3-$)TU!4D=)3BU43U`Z(#9P>#L@34%21TE.+4)/5%1/33H@,'!X)SX\+W`^ M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X M('-O;&ED.R!"3U)$15(M3$5&5#H@(S`P,#`P,"`P<'@@65A65A&5S(&]N(&1I&5S(&]N(&1I'!E;G-E&5S(&]N(')E:6YV97-T960@ M9&EV:61E;F1S*3PO=&0^#0H@("`@("`@("`@("`@(#QT9"!C;&%S'0^069T97(M=&%X(')E M='5R;G,@"!R971U2!A;F0@=VEL;"!V87)Y(&9O6]U(&AO;&0@ M>6]U3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S,&1F-S,Q,U\X,V4V7S0Y M,3A?865C,5\Y9C`Q-65A-69F-CD-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO,S!D9C'0O:'1M M;#L@8VAA5)E9VES=')A;G1.86UE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#Y0551.04T@1TQ/0D%,($A%04Q42"!#05)%($953D0@/&)R("\^ M/&)R("\^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^1&5C M(#,P+`T*"0DR,#$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/&(^1V]A;#PO8CX\2!;5&5X="!";&]C:UT\+W1D/@T* M("`@("`@("`\=&0@8VQA'!E;G-E M(%M(96%D:6YG73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'!E;G-E'!E;G-E M2!I9B!Y;W4@8G5Y(&%N9"!H;VQD('-H87)E2!Q=6%L:69Y(&9O6]U2!S:&%R97,@8F5G:6YN:6YG M(&]N('!A9V4@24DM,2!O9B!T:&4@9G5N9"8C.#(Q-SMS('-T871E;65N="!O M9B!A9&1I=&EO;F%L(&EN9F]R;6%T:6]N("A304DI+CQS<&%N/CPO'!E;G-E M'!E;G-E6]U('!A>2!E86-H('EE87(@87,@82!P97)C96YT86=E(&]F('1H92!V M86QU92!O9B!Y;W5R(&EN=F5S=&UE;G0I/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0@0FQO8VM=/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&@^7,@=')A;G-A8W1I;VXM&%B;&4@86-C;W5N="X@5&AE'!E;G-E'!E;G-E($)R96%K<&]I;G0@1&ES M8V]U;G1S(%M497AT73PO=&0^#0H@("`@("`@(#QT9"!C;&%S2!F=6YD M('-H87)E'!E;G-E($)R96%K<&]I;G0L($UI M;FEM=6T@26YV97-T;65N="!297%U:7)E9"!;06UO=6YT73PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'!E;G-E17AA;7!L94AE861I;F<\+W1D/@T*("`@("`@("`\=&0@8VQA'!E;G-E($5X86UP;&4@3F%R&%M M<&QE3F%R&%M<&QE(&ES M(&EN=&5N9&5D('1O(&AE;'`@>6]U(&-O;7!A'!E M;G-E2!B M92!H:6=H97(@;W(@;&]W97(N/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S4AE861I;F<\+W1D/@T*("`@("`@("`\=&0@ M8VQAF4@8V]M<&%N:65S('=O M2P@<')O:F5C=&5D(&9U='5R92!E87)N:6YG2!T5!O'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&@^'1";&]C:SPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^270@:7,@:6UP;W)T86YT('1O('5N9&5R2!F86QL(&]R(&9A:6P@=&\@ M2!B92!M;W)E('-U2!O2!R97-U;'0@:6X@9W)E871E2!B92!A9'9E2!L97-S('-T86)L92!E8V]N;VUI97,@;W(@9V]V97)N;65N M=',@*'-U8V@@87,@=&AE(')IG5R92!B>2!A(&9O2!B92!I;&QI<75I9"X@3W5R('5S92!O M9B!D97)I=F%T:79E2!T:&4@1F5D97)A;"!$97!O'1=/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&@^3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^270@:7,@:6UP;W)T86YT('1O M('5N9&5R'1=/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&@^2!O2!R97-U;'0@:6X@9W)E871E4EN'1";&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^5&AE M('!E65A'1=/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&@^2!796)S:71E($%D9')E'1=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&@^'0^<'5T;F%M+F-O;3QS<&%N/CPO'1=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&@^2!A;B!I M;F1I8V%T:6]N(&]F(&9U='5R92!R97-U;'1S+CQS<&%N/CPO'0^/&(^06YN=6%L('1O=&%L(')E='5R M;G,@9F]R(&-L87-S($$@'1=/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&@^#L@ M0D]21$52+5))1TA4.B`P<'@G(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN M9STS1#`@=VED=&@],T0Q,#`E/CQT6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!"3U)$15(M3$5&5#H@(S`P,#`P M,"`P<'@@"!S;VQI9"<@=VED=&@] M,T0U)3XR,2XQ,24\+W1D/B`\=&0@=VED=&@],T0T,"4^/"]T9#X@/'1D('=I M9'1H/3-$,S4E/CPO=&0^/"]T"!S;VQI9"<@=VED=&@],T0R,"4^0F5S="!C86QE;F1A"!S;VQI9"<@=VED=&@],T0U)3XQ,BXT M-24\+W1D/B`\=&0@=VED=&@],T0T,"4^/"]T9#X@/'1D('=I9'1H/3-$,S4E M/CPO=&0^/"]T'0^4V5P(#,P+`T*"0DR,#$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^0F5S="!C86QE;F1E2!2971U M5)E='5R;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^5V]R2!2971U5)E='5R;D1A=&4\+W1D M/@T*("`@("`@("`\=&0@8VQA2!2971U5)E='5R;CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^069T97(M=&%X(')E='5R;G,@ M'0^06-T=6%L(&%F=&5R+71A M>"!R971U"!S M:71U871I;VX@86YD(&UA>2!D:69F97(@9G)O;2!T:&]S92!S:&]W;BX\'1=/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&@^%-H;W=N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#Y!9G1E2!F;W(@;W1H97(@8VQA"!R971U"!R871E&5S+B!!8W1U86P@869T97(M=&%X(')E='5R M;G,@9&5P96YD(&]N(&%N(&EN=F5S=&]R)B,X,C$W.W,@=&%X('-I='5A=&EO M;B!A;F0@;6%Y(&1I9F9E2!F;W(@;W1H97(@8VQA&%M<&QE665A65A'!E;G-E17AA;7!L95EE87(P-3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M65A65A&%M<&QE M665A65A'!E;G-E17AA;7!L95EE87(P-3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'!E;G-E17AA;7!L94YO4F5D96UP=&EO;EEE87(P,3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S&%M<&QE3F]2961E;7!T:6]N M665A65A'!E;G-E17AA;7!L94YO4F5D M96UP=&EO;EEE87(Q,#PO=&0^#0H@("`@("`@(#QT9"!C;&%S65A65A&%M<&QE665A65A'!E;G-E17AA;7!L95EE87(P-3PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'!E;G-E M17AA;7!L94YO4F5D96UP=&EO;EEE87(P,3PO=&0^#0H@("`@("`@(#QT9"!C M;&%S&%M<&QE3F]2961E;7!T:6]N665A65A'!E;G-E17AA;7!L94YO4F5D96UP=&EO;EEE87(Q,#PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S65A65A&%M<&QE665A65A'!E;G-E17AA;7!L95EE87(P-3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S65A&EM=6T@&EM=6U386QE&EM=6U$969E M'!E;G-E'!E;G-E'!E M;G-E17AA;7!L95EE87(P,3PO=&0^#0H@("`@("`@(#QT9"!C;&%S&%M<&QE665A65A65A'0^)FYB'!E;G-E'!E;G-E'!E;G-E17AA;7!L95EE87(P,3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S&%M<&QE665A&5S(&]N(&1I'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S65A&5S(&]N(&1I'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S65A&5S(&]T:&5R('1H M86X@=VET:&AO;&1I;F<@=&%X97,@;VX@'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!T;R!S:&%R M97,@<'5R8VAA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA5)E9VES=')A;G1. M86UE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y0551.04T@1TQ/ M0D%,($A%04Q42"!#05)%($953D0@/&)R("\^/&)R("\^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^1&5C(#,P M+`T*"0DR,#$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$4IX1D1+0FMA14E),$MX M=U)64S!F06M-,DIY9V=K2T9H8UE'4F]L2FEC;TM3;S!.5%DS#0I/1&LV43!2 M1E)K9$E357!45D965U8Q:%I7;4YK6E=:;F%';'%C,U(Q9&YD-&58<41H25=' M:#1I2FEP2U1L2E=7;#5I6FUQ2VIP2U=M#0IP-FEP<7)+>G1,5S)T-VDU=7-, M1'A-6$=X.&I*>71,5#%.6%#AV4#`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`R8E(O0W5J85IC=$&ME9W!*9#!/5'1S>6HO=V=V:%`O;U8Y0R\X04)F1"]!4$4P#0IF.$E, M-%0O-D9F478O0F9$+W=$13%E,6)3#(W2U1K M+TUF36EC-35X,7AW3T]U96,X2E='&)R4WHS=&Q$8WE, M2$):0E%Z;T=)1V)C;D=4-FUN<#)%5!2+W=J,G`O=T11,S8Y+S,U3="9"]W03,U:68X24PT5"]W0VA8 M,$PO#0I!348X4"]X3D@O0T,K12\K:%@P3"]W048X4#A!.%175C13#16,&)5-VYX8G)3>C-T;$1C>4Q(0EI"47IO#0I'24=B8VY'5#9M M=&(O:$AT5"\V1R]8=BLO3FPO.&HP861G9#%P>F9M2B]W9W9H4"]!2T9F478X M07=8=R\O13!F.$E,-%0O-D9F478O#0I!05AW+W=$>$Y,+W=J,G`O.41F3="9"]Z9FU*+W=G=FA0+V]6.4,O.$%"9D0O05!%,&8X24PT5"\V1F91=B]" M9D0O=T1%,6QE17)$5TY9.$LV3G%D>C1T,7!:-S)Y#0IH=5I&:F=S9V]:,$1% M1$YU5&I*.517="]W:C)P+W=$43,V.2\S-7-V+VME:E1S1'5T3V(X>%`X06A" M9D-F+U%R-D8O-$PT9B]!26UJ#0HO:$)F0V8X03!+*VAF*T,K2"\T;6PO-%(W M52\K:'8Q-R]V>EIF+TDY2"]#4&%N+S!.*W9F.2MB3"]W0U(V3$QS1C,O3BM9 M;B]!06=V#0IH4#A!-D9F478O0F9$+SA!13!F.$E,-%0O=T-H6#!,+T%-1CA0 M+WA.3"]W:C)P+SE$9G(S+V9M>2]W1&ME:B]H2'14+T%/:'8Q-R]V#0IZ6F8O M04-04EID9W4O=T-B.'A0*T5&.$HO=T11')(:%A2=%1U#0IF1G5T3%!E,E5.>DES8T9K M1D1/9UEG6G1Y8UI0<6$Q=BM%93%0+V]B.64O-S@R6"]!36HP861G9#%P>F9M M2B]W9W9H4"]O5CE#+SA!#0I"9D0O05!%,&8X24PT5"\V1F91=B]"9D0O=T1% M,'8X07=J,G`O=T11,S8Y+S,U6AU M6D9J9W-G;UHP1$5$3G54:DHY5%=T+W=!23EQ9B]!14XK=F8X069M>2\K4C9. M3W=/-C`U=GI%+S11#0I8=VXO04Y#=F]8+V=V:"\K2F\O-%%8=VXO=T)#=F]8 M+T%)3#1F+VEA6"]H2'14+S9'+UAV*R].;"]W1$DY2"]#4&%N+T%.1&9R,R]F M#0IM>2\K4C9,3'-&,R]!1&9M2B]W9W9H4"]!2T9F478X07=8=R\O13!F.$E, M-%0O-D9F478O04%8=R]W1'A.3"]W:C)P+SE$9G(S+V9M#0IY+SA!:V5J+T%) M4C=5+SA!;V(Y92]W0R].;"\X:C!76%E,=BMB.'A0*T5&.$HO.$%1DES8T9K1D1/9UEG6G1Y8UI0<6$Q=BM%93%0.$$V1R]8=BLO M3FPO.$%).4=N#0I92&1A8S,U:68X24PT5"\V1F91=B]"9D0O=T1%,&8X04-# M*T4O=T1O5CE#+SA&.%`O=T%44R\X04-086XO=T)$9G(S+T%(-7-V+VME#0IJ M+VA(=%0O-DD4O-%%8=VXO=T)#=F]8+T%)3#1F M+VEA4"M%1CA*+SE#=F]8+V=V:"]W1&EA6"]H2'14+T%/:'8Q-R]V#0IZ6F8O M04-04B]W04DY<68O045.*W9F.$%F;7DO*U(V3$QS1C,O3BM9;B]#0RM%+RMH M6#!,+W=!1CA0.$$X5%(O=V=V:%`O;U8Y0R\X#0I&.%`O04U44R]W1$-086XO M04Y$9G(S+V9M>2\K4C90*T5E,5`O;V(Y92\W.#)8+WE04EID9W4O-79Z12\T M45AW;B\P2RMH9BM#*T@O#0I!3TIO+W=#148X2B\Y0W9O6"]G=F@O.$%I87EV M0U9HEIF+TDY1VY92&1A8S,U:68X04-#*T4O=T1O M5CE#+SA&.%`O=T%44B]W9W9H4"]!2T9F478X07=8=R\O13!V#0HO0U!A;B\P M3BMV9CDK8DPO04]2-E`K164Q4#A!-D&)R4W5L-V0R=T-15U%',DLT:VE5 M#0HX,C4U,F]#9F905'!7="]W:C)P+SE$9G(S+V9M>2\X06ME:E1S1'5T3V(X M>%`K148X2B\Y0W9O6"]G=F@O=T1I85`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`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`V#0IA=FQ$.7)$+T%*2TQP,R]92VHO.4A45CE967(U42]A=R]W M0U-I-F0O,D-O+R]2,#%:,69H3G-..%HY1R]$668X5S8X3&8Y9W$Q+SA!#0I2 M2S%R83%"67HV5F-P<35J1VYH3CEX-7-M>5!9=GI.=D]13FU".'=0>6QC9S5" M27),*T=O+W=#3&,K1F8K=U9A+W=$;VQA,CE2'9H=4EX26I924EY<$)"=U%$*T97=&I.+T5E6F%.<$=N6"]!271J,#8T,"LP M9E%*179B<3(P:65&5$AA-U9S#0I&571!4FE*>G9L:T-K0F=T=U-1%(K5C5M3G4O8G1X=7AX;D=C8U9T M-&]3&Y)=U!&;FAF571F=G)'.&4R,#`S359U M:7=34WI-5'!6>'9$=%!$*S$1J<$DT<5AX+W=#2718,&I6 M.4AS#0ID1V%W:BLQ=S-%,&HS9'4X,E!,845!2T9K5$=F3D]C-39#5=Y,C1).')A=V9E8E5%')F:39(4"]!0DUD0E`X03-#<&@O=T,S3E1E1'9%*W4S,VDU M3DLQ95142F)E4WEM#0IU5F$Q=%I)5U9K:VA80C-3=4-#2E0R2%%54V'HP3E!X4FEG0FU/ M=D)O-T$T4#!P*TM-54%->'HP3D=/=D)P*TM-54%--T$T4#!O>'HP3E!X4FEG M1$PQ:E5,#0IQ=SAR-TQO,F]A;G9Z=2MY=D%V;#1X:E!M>4HQ>65M96AZ:FI/ M5#A/2&%B=S%,3$I$2D$W-FYQ3$Y&259,4FLS%)L43!H02LV3GA!>65N2D$Y4TLU>C1B>5!.-%IL M;&MH:V=D.50Q1FUI:TML;WEB,F9+;F%336IP#0IW4U!1;7`V;&9:3VUX6'ED M*S%J+T%-;$8P-R]S1E(O*VIP<2MS.%8X;2]T6B]W1$I2=$\O-T)59B]O-F%O M<2]#831F-'HV4"M'=CA!#0IY5&YWFQU>$M+6$9'2UI);&,S.$YF*U-C*T9F*W=6868K M:59R#0IP8U9Z9GC16+S="3G`O-DI7;#%+-DA2,%5U2TU5>5)+2UA& M1TM!16]P8U59;T$X,"M*+R]),RM'+SA!$%U8G5X.$0V M.64V9&135VPU85=5#0HQ>D9-:6]X5F\P3&=99%="0C(T4$A1;D=$9VEJ-"]U M3E5AY-6A!5E%6:$%K=U=X M#0IU2D&]$8DI03D)U1$=Y3%`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`Y M9DIN-U=F.$%Y56)4=BMW5D@O-D]M%AY6BLQ<"]Y56)4#0IV*W=42"\V M3VUR3W(X2G)H+VI0<$@T840O:3-(:%@OG!V:%),1CE070R-UIV44YT>F=:>&Y'8T-H3S1/3FI1>%A.+T119CA7-#A++SA! M#0I92G10+U)+,68Q9GA,;T]J6$LR*W-A,W!L:&--9VM72S9U-#1M2VMK0F=' M24]-9VI0G`Y=6IX5U8S9GIY#0I. M4M,#0IJFQX-'

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`T8G9W>DQC5W-S8S%V3G%E;WE2 M>7AS1U8Q3C=/47=)-$E)-7I7=G)'#0IV-DYO;FQF,GIQ,FXV9C5U9DPK,3-+ M4F(X67IJ8U)N1U)N-FES;C1B5'$-534@O8WAF3G9X.2]W M0UAK8F5K,%!4261',%14.4QT#0I7:V4S7)Q6790-TYU+S=,*WHO=T)O954O,F8W4FYY=DUW9'4O8GIT>FI/ M3V-64C`W5#5T1#!3>#!V#0I366\W:3-S8D57.$Q83352;6%.5E=-3591:D1! M2&-W2$=":%=Z>'HS>$0X4V%X;S)R-E!9-DLR;G`YC!&6DYV-&@X6519+S`O44(O=T)W=5DO*S-.3E)C=&M2 M3W)#;G!*+VUB;6QA6G(R;65"=$8P4G1+,%156&=S5G-B>4]E#0HO:U-&,5)! M9W@K-&)E1U5%:T5$1V-F3C%Q>F)E1TIM:C!Q,C%'-&IU;V)+,W128UA:0BLP M,S@X1&)O>DEX>5926$AM63-%E!,6$MO<$\S:6QX4FEK5SE4>D0T M#0IP+SA!23-E1W8K=DLK+SA!4FQR55=N9'%M*TMN+TDS94=V.$%R>79V+U)L M'1Y-C10>DPX-F-J:C5H#0HV M:6DT5TQ'2TU62$901$Y*36M-,&-J=U`U8W%Q=TIJ8F%',G-/>#)S<'=E>D$Y M-FQX5$%41D=+6$9'2T)#66]X4S1O>%%!;4M-575+#0I-54%*:6I&3&EJ1D%# M66]X4S1O>%%!;4M-575+355!95@O1E@O:V)V1%@O6&QF9BMJ3%=O9$\W5E`X M5G8K4G4X3F8X05AL9F8K:DQ7#0IO3D\W5G914$]X=GA&;2\V5E,X168X;$UT M9CA!B]W0DA7=%98,DEW6#A2 M9E`X:C%N#0I&1TM81D=+-6HQ0DU567!C55EO051&1TM81D=+045X4FEL>%)I M9T)-55EP8U59;T%41D=+6$9'2T%%>%A.9D0X9CA31S8O-T,R<"\K#0IL,#EB M=7!A9EHV;EI35V5P5VQV95=K;4XX1GA'2D5B0D)'5D]18T5!+U56>B]W04YB M94"\K:G!Q*W0X5CAK9G1C9CA!2E-.3B]W0W=4 M2"\V3VUQ2W9W;6Q$-'HV#0I5*T=1+W=#3&(K1E`K=U1A9BMI57)P8U9Z9G=Y M+W=#4V)E12\K=U1A9BMI57)P<7!B15!C8FEJ1D]O<&MJ8U9Z6'=Y2"]&="]# M;B]9#0I*=%`O0453;&106$TO1$PO04I*=#14+S="3G`O-DI3;#%+-DA366]X M5'%+6DDS1D=+9%)103-&1TMD4E%"-60X5F8X06MB+T18+UAL#0IF9CA!;WDQ M<4A4=3%4+T9B+VMB+T%!>B]!3F56.2\V371A9S`W=%A245!->'9X1#E1-S%5 M.$-F.&Q-='8K=U1D+W=$;S8Q<3-Q2&5Q#0IV9U`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`Q5&IE-TA7>6I% M56%4FI02#%P,6%Q;71%3$0T5U9+4V-M=C8K4C-L1F,S+T%-235Q;B]1-F5) M4"LO3F@O=T1),4@O0T]A<"\P3VYI1"]V>EEF.$%Y3E=.#0IZ='0U;DIF1F8O M:V)V1%`O048U6#,O;WDQ<79P+V%U9S%B-&5N5C=Y,G5T43A6*TE*<#=:2DDT M;3)783=68V]71T)B9TA*:E1R-F4U#0IPB\P9&$Q M,&MN=S=-;C,O#0I!0E8T9U`X07='>B]!4&ME;3)(=S-85#E46%5,5'A4-&=J M=D9H94%38F)--%(R4FU'1&(T-4UA8S1Z>#EA9%=Q<')20WG1T-6Y*9D9F+T%*1S=W M>B\Q-5@S+T%+371A5DP-BMN=6%B2#A/4D@Y>GA6-&=(+T%B4"\U2')7;%55 M3C!C;4EW,'%R=D9R*W9K#0I9*V]D1%94=THO>54R,B\W0DXU+S9/=&$V5U0T M9&U4-R]I4UW=V)F2$IJ5&Y'95!R5'$Q5DYA26Y$-%=62U-L2G(K=FMD-5)8 M3B\X04-/87`O=T)$<#1G+S70K:4]I;FAU95!.>GA8<7HQ>6EV2G!V*T4Y+S59+SA*;B]W M4"MX2VXX3E=8:C8O#0HQ,WET63%0>$1P;6Q#,VM9>E-R<&)/,#(U3FEJ>3!F M:F%:0V-JE90.$%O9%!%2"]F;7D]K;W)Y;GAR2C1H,%!8=$AS8E1X9G)$>%AL=F-Y>4=7#0HS&I%B\P9&$Q,&MN M=SA-;C,O04)6-&=0.$%W1WHO#0I!4&ME;5=(=S1&:'%A-FIA94MF145D-'-, M=T-48EIN0T]Y37=W8F9(2FI4;D=E4')4<3%63F%);D0T5U9+4VQ*71A#0HS36M$ M3V]TC1HGA4-&=(+T%B4"\U2'$T4VEV:5)H6'`Q2G1E>FQB-WIL-W93:$=0:S%0 M>$%0*S0S968O2&%H.$Q8#0I.-7`O:FY124ED5#%35T,Y;FQG;FIU69F.$%&6&E!+W=$06)0.$$K M4C9G#0IH*T=554]O5VPY2#1O.%%,9%=J;5-&.%=:,G-56D-C9EHX2#5866,K M=$]C;U`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`R2TU504YX4FEN66]X44)Z;FHP851&-%=V8C=8.4=J,6UW,#E$9'9B M3D)&35%&0C-/#0IQ>45,;%9,2')N1U%-:S1.838X165#3%,R;75BD5R9T%$:VLP=FER44Y5=G9#,VEA=W,Y4VMV#0IR M:E9B95,S9VEV,FII:'1224=5-U=I:3-%04XP8F-4=$%Y36LQ93%Z4W)N>$)O M;S`R*U`R2TLU:$)U<$Q38T]Y3T=2=DQ54$56:VIB#0I$<3(Y44-V0E5H:G12 M4SE4:C0W2'=&3F]D;G$P2&=F5#-T3&Y54G!V>F%28GAV135U1&)H,U(YBLP.3DY#0I/259%479F=$E!36-0,VTR:DDR-$133U%D<7%T9$YQ;6EF,FYR M155L=VQU;&I(-4TP:%%F=G)M5TM1>5)+-UDK5T].=FY!0DI:;2]H#0I534I% M3FPR,W5:=%(P:S-&<$A*6E13;S-K9F))5&QE;U(S:D1"$MH,$HS:U-3 M8E%W15IK,DQL63%Z1CA-#0HQ;5AW=DMT,4I(2F-$5DY316IX;U56;2LS5#5+ M<5-3;THV06LT.50Q<#,Q1C!/<'A8>4@K,355R5&8K=U)&+W=#:G!Q*W9S M5CAH#0IF=&9F.&Q+,#,O$0S17A2 M:6QX4FEG46U+-6XT640O:3)V:$PO04Q"1G`O-DI3=6YX6$TO1$%F.$%&=%!# M6"]92710.$$P4VQ(5691-50T<68X:FPT#0I9+S8X3A-9CEE5B]W1"MJ3%-P=$@O:'(U9DY0.35F;VHW6$HO.$%C5C9S M9G)(.%99+V=B+VMQ#0I&="\R0TQZ+T%.2%=T8D=S9GA6:V5"9BM3;S(S+UE) M=E`O4C%R5V589C%%! M;4M-575+355!2FEJ1DQI:D9!0UEO>%,T;WA106U+355U#0I+355!2FEJ1DQI M:D9!0UEO>%,T;WA106U+355U2TU504II:D9,:6I&04-9;WA3-&]X44%M2TU5 M=4M-54%E5V9&9B]K8V9$2"]!1C58#0HO=T0V371+:S!F=%10:7@O>4]0:&HO M'9"2"]*56)8+T%,0D8U+S9/=&%J3'8Y M-F@X+WE:95HO-VA5*U@U;SEB>%)I;'A2:79R1#155$9'2UA&1TM!17A2#0II M;'A2:6="3559<&-566]!5$9'2UA&1TM!17A2:6QX4FEG0DU567!C55EO051& M1TM81D=+045X4FEL>%)I9T-'-DUY,C!Z5W-C8VQW#0I%2FI34GEI4LT;F%'3G52;DQQ:FMC M6E`S5'IX>#%(4&9$27I.-%AL839J:FIU1'%M<$=223-,<7)F8G`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`V#0II M9T)U5'1",FY*>'AX:U5C-V=-2$AR5'%+04=J2DHT27@K=$=4=$(R;DIX>'AK M539I9T1Y=C1T9CAJ:C18+S8XE9U:')(.$1F.&Q2 M=&8K=U)E9BMJ61O3S`U3T]/36EN558Y669$1&5D M=T=$:C%O#0I'4U1W4FHY861244$S2C)G-U1K-#0T>4M/9'='1&HQ<#%&0412 M:VLX15DO5VI*,F61O3S`U3T]/36EN M555!3C4S05E/4%=G6DI00D=0,7`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`V2F1,8F$Q2]22#)7568W:W96:CE9+VER3#A! M9CAL4W1V.$%S1#-N+V\V,7)5,6HK2W-V#0HT9CA!+TI5-V(OB]*;75:9C=H52M8-6\Y:GA2:6=%16M!9VM(0CEQ5&-U,$YU6&%C M64]E1&YP6#%:.$],#0II:D9'4G5#-4#%3-3%I4TA4-T]D&IJ>G9W:3%Z5DU.4G%3-7!X=7IR<%EY=E-H>5%N6D5D M>#1-.%0S02MF>$AO=RMM:7DO+T%#5E4S:$1W3G%':F5+0G)/<&%Z#0IA6'!7 M>FQT16AT-T)R9DAM4$5X66MY=FY(;$%9=T]T3RM+96\V26UG5U4Y+V4V878R M4%AD34MY5%-O4$EK1GI#-UE*4'ET-4Q->#&IQ2&A.9DA6 M:EIF8DY/="]&2#)Y>F53.&ML1%A-0T=606QV14UL+S-W>7!234EQ4U-34&IC M0DEO65=J5&QZ4FI:;V,X#0IB:4MS2%1N3G1-.4YX4FEV2B]S9S!J4F12=$DW M;30Q:G'I#1S586DI(=D%)5C$W34TT23EA-E5Z M:V%,5TM-55I'-$QK8FE-9U5!9VMG145G-%!T5$5'2TU5;35D#0IO8F-U,#1W M8SA(4%-L>4YW6$DS15I!;T%-55EO0D)*04E*0G=F86LS3'1$8FPR;D=$;F4YW6$DS15I!;T%-55EO0D)*04E*0G=F86LS3'1$8FPR;D=$;F4YW6$DS15I!;T%Q-FYQ1FQP5FI*939P9#(Q;%IX63-Z,T5Q>'AP M#0IK9T1,35%":VM$-FUU9"M'13A.,S17;'5B4U=/93-M,515-4EP66U$239M M+VY)6E-/0T-/45)7>G)8:4Q23D--43%V5TY.,#1Y:VE0#0HW6&1*1'9X:D]. M>$=C8FQZ.5(V,6HO1$,T:'4O0W-T>F%44GHR.#)Q-FY*1DQ%=UI(53,X-41+ M4G=146-G:6PQ2&)1-G9&9DAF-UEN#0HO2E1.32\W0D58+V\V979S6$9F2&8W M678O2E1D32\W03A8+V\V97!NB\Y17!7 M>G%/;%#-!84A3>D=F3VEN:FUT=WAA6FE9;WI'5D5A8DUI4C),8C), M,3%(:'92-3E,6%5*#1"04'5+-6HT5R\X:WDX22]W1%E(D1S='9N2UI74$Q%8E%3;WE#=WIH4F%(-$)& M.4)B5SDU#0IR36YN95=%=4E.5S%&-UE'44%X<3`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`R2TU504YX4FEN66]X44$S1D=+9&EJ1D%$8U59<#)+355! M3GA2:6Y9#0IO>%%!,T9'2V1I:D9!1&-567`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`O=T0X#0II M,%A#>#`R2TU6=TAG&LX6DIR6B\T4FI6=BMH-#A29CDK3E`O#0I!4&M7:3173VUX4FEU M6B\T4FI6=BMH-#A29CA!9FI4+T%0-49O+S12:E9V*V@T.%)F.2M.4"\X06M7 M:3173VUX4FEU6B]W0T59,6(O#0I!2TAJ>$8O,S0P+R]!3U)A4"M%63%B+V]E M4$58+V9J5"]W1#5&;W5&:G!S55ER9U!"5VUA-7)N9S-19%=U+T=U=DIC,SEH M0F134Q2+W=J#0I'#1I+S'`O.$$X:3!8#0I#>#`R2TU6=TAG&LX6DIR6B]W0T59 M,6(O04M(:GA&+S,T,"\O#0I!3U)A3&A9-F)&1TLU;B]H1TY7+S9(:GA&+S,T M,"\X02M285`K15DQ8B]O95!%6"]!2#0P+W=$*U)A3&A9-F)&1TLU;B]H1TY7 M+S9(#0IJ>$8O,S0P+R]W0U)A4#A!:$=.5R]W0V@T.%)F.2M.4"]W1&M7:317 M3VUX4FEU03A&85IR;75E1&1",6$W.&$V.&QZ9C)%1C%+'%X M0V$]-;FI*3F)0+T%!:D=R9CA!43AE278K+T=N+SA!>4Q28TQ(5%EO>%A- M+W=$0TUA="\P4$AI3"]V>'`O.$$X:3!F#0HX27AQ,R]1.&5)=BLO1VXO05!Y M3%)C3$A466]X6$TO.$EX<3,O43AE278X079X<"\O=T%I,&8X04--870O=T)$ M>#1I+S$8O,S0P+R]W0U)A3&A9-F)&1TLT1'=6<&UU834T M3C!(5G)V>')R>5A.+UE16%5Q>%#`R2TU6>E`O04%J1W)F.$%1.&5)=BLO M1VXO.$%Y3%(O#0IW:D=R9CE$>#1I+S$8O M=T(K3E`X02]K5VDT5T]M>%)I=4$X1F%:F8R148Q M2W-6=EE"#0I!>GAQ>$-G,GA/36YJ2DYB4"]#36%T+S!02&E,+W9X<"]W1#AI M,%A#>#`R2TU6>E`O0TUA="\P4$AI3"]!3#AA9B\X04ET2"]!06I'#0IR9CA! M43AE278K+T=N+SA!>4Q28TQ(5%EO>%A-+W=$0TUA="\P4$AI3"]V>'`O.$$X M:3!F.$EX<3,O43AE278K+T=N+T%0>4Q28TQ(#0I466]X6$%E171-,7I73DMN M=6)N>')R>7E2,SDW86=2,CEG0G1H=7!95E!.'$S+T%%4$AI3"]V M>'`O+T%-:3!F.$EX<3,O43AE278K+T=N+W=$>4Q28TQ(5%EO>%A-+SA)>'$S M+U$X#0IE278K+T=N+T%0>4Q2+W=J1W)F.41X-&DO=T,O1VXO+T%#3%)C3$A4 M66]X6$%E171-,7I73DMN=6)N>')R>7E2,SDW86=2,CEG0G1H#0IU<%E64$YS M95-S64HY.#E/;&)0+T%!:D=R9CA!43AE278K+T=N+SA!>4Q28TQ(43-6=6PQ M87I7.'!K5T]61$=X:6MA3G=#34AA>6M-#0IP.4-#0T]O3F-V.$%#-C-3,3A+ M>3(X6FMA3TQ69%1J57EY3DDU078W9T1C>D5S>#E34U-E<$Y4+T%00TUA="\P M4$AI3"]V>'`O=T0X#0II,7%E1W1&:C!(4U9S67)M-74O,S`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

3DT6$5J27!73$Q836)&-4-Q M:W5X>G=X0F-A4%%:=%=S-'199S!S=DDY.4UH:S)2479)#0I),35W,&I+0W-9 M8F%W5756,T970S5)27$O:79,+T1&:G%.;#1W=T1R4C%'8E=,-F95>D]K9W10 MD%)I9U%M2W=.43A7-E!9,T9X8GE46$TQ,4)-64I,93%S M-7)M54U)-#5#9&MA37A53$Y�IL=TYO36EG:T5G5C!'2S1Z>$%K5VDK3G1- M,3%R0S5.;3%N95%8371J6E-816I4>4YA95=84TI78S53,UEB>4U!26]*1U9" M3&I.3F9�HR:'9F45=S5CDU,VXK5T5U25EP2DQ91U%!>'$P-G%9;%IW>496 M6F=7.'A-03G8T4M7#0IX5T=3 M4S)U:DA!:79D>7IP;4):651N87)(3&9:;"LX5W0R:3EM>%%M1%%M2TU5=4M- M54-%>%="<4AI,U(W1S1U3&53835M=6]*:D)*#0IB,G1N3F-Y:&A(2$E4%A'94E%:3!8>'1P;75T65A*$MY;V5-9T1*2DDQ,#0I0&Y2='$K;G)R,&5I;3=I+W17 M4S)A.$9S1&QX0W)+:&,K9S--04TY#0IE8UHR;D8O1F-L<6-P2'A5,$)28EAR M4FI3#EM558X#0I:+SA!1%5V:F(O;T8K M2%`O04%(;B]W1&HQ2"]$579J8B]O1BM(4#A!=TAN+T%0:C%/-')(,EI26'AN M+WB]W2&XO*U!59CA.4RM.#0IV*V=8-&,O.$(U+R]!23E2 M8TQ(,EI26'AN+WB]W04(U+SA!-#E2 M+W&XO04U.4RM.=BMG6#1C M+W=$065F.$$K4%5F#0HX3E,K3G8X06]&*TA0+T%E9B\T.5)C3$@R6E)8>&XO M=S%,-#(O=T-G6#1C+SA"-2\O:C%(+T15=FIB+V]&*TA0+T%E9B]W0U!56$-X M#0HY;556.%HO.$Y3*TYV*V=8-&,O.$(U+R]!23E2+W=!3E,K3G8K9U@T8R\X M04%E9B]!3U!56$-X.6U55CA:+SA!1%5V:F(O;T8K2%`O#0I!04AN+W=$:C%( M+T15=FIB+V]&*TA0.$%W2&XO05!J,49WB]W M04(U+SA!-#E28TQ(,EI26'AN+W=!3E,K3G8K9U@T8R\X04%E9B]!3U!5#0IF M.$Y3*TYV*V=8-&,O=T1!968X02M055A#>#EM558X6B]W1$15=FIB+V]&*TA0 M.$%W2&XO05!J,4@O1%5V:F(O04M"9FAZ+W=(;B\K#0I055A#>#EM558X6B\X M3E,K3G8X06]&*TA0+T%E9B\T.5(O=S%,-#(O-D)F:'HO=TAN+SA!:C%&=W-F M6FQ&9D=F+T15=FIB+V]&*TA0#0HO065F+W=#4%5F.$%$579J8B]O1BM(4"]! M04AN+W=$:C%&=W-F6FQ&9D=F+T%!,4PT,B\V0F9H>B]W04(U+SA!-#E2+W&XO=S%,-#(O-D)F:'HO=TAN+SA!:C%(+T%!,4PT,B\V#0I"9FAZ+W=! M0C4O.$$T.5)C3$@R6E)8>&XO=T%.4RM.=BMG6#1C+SA!065F+T%/4%5F.$Y3 M*TYV*V=8-&,O=T1!968X02M055A#>#EM#0I6.%HO=&TO.&Q1,'8O'1087)T7S,P9&8W,S$S7S@S939?-#DQ.%]A96,Q7SEF,#$U M96$U9F8V.0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\S,&1F-S,Q M,U\X,V4V7S0Y,3A?865C,5\Y9C`Q-65A-69F-CDO5V]R:W-H965T XML 12 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
PUTNAM GLOBAL HEALTH CARE FUND
PUTNAM GLOBAL HEALTH CARE FUND
Goal
Putnam Global Health Care Fund seeks capital appreciation.
Fees and expenses
The following table describes the fees and expenses you may pay if you buy and hold shares of the fund. You may qualify for sales charge discounts if you and your family invest, or agree to invest in the future, at least $50,000 in Putnam funds. More information about these and other discounts is available from your financial advisor and in How do I buy fund shares? beginning on page 57 of the fund’s prospectus and in How to buy shares beginning on page II-1 of the fund’s statement of additional information (SAI).
Shareholder fees (fees paid directly from your investment)
Shareholder Fees PUTNAM GLOBAL HEALTH CARE FUND
Class A
Class B
Class C
Class M
Class R
Class Y
Maximum sales charge (load) imposed on purchases (as a percentage of offering price) 5.75% none none 3.50% none none
Maximum deferred sales charge (load) (as a percentage of original purchase price or redemption proceeds, whichever is lower) 1.00% [1] 5.00% [2] 1.00% [3] 0.65% [1] none none
Redemption fee (as a percentage of total redemption proceeds) [4] 1.00% 1.00% 1.00% 1.00% 1.00% 1.00%
[1] Applies only to certain redemptions of shares bought with no initial sales charge.
[2] This charge is phased out over six years.
[3] This charge is eliminated after one year.
[4] This fee applies only to shares purchased before 1/2/2013.
Annual fund operating expenses
(expenses you pay each year as a percentage of the value of your investment)
Annual Fund Operating Expenses PUTNAM GLOBAL HEALTH CARE FUND
Class A
Class B
Class C
Class M
Class R
Class Y
Management fees 0.64% 0.64% 0.64% 0.64% 0.64% 0.64%
Distribution and service (12b-1) fees 0.25% 1.00% 1.00% 0.75% 0.50%   
Other expenses [1] 0.38% 0.38% 0.38% 0.38% 0.38% 0.38%
Total annual fund operating expenses 1.27% 2.02% 2.02% 1.77% 1.52% 1.02%
[1] Restated to reflect current fees.
Example
The following hypothetical example is intended to help you compare the cost of investing in the fund with the cost of investing in other funds. It assumes that you invest $10,000 in the fund for the time periods indicated and then, except as indicated, redeem all your shares at the end of those periods. It assumes a 5% return on your investment each year and that the fund’s operating expenses remain the same. Your actual costs may be higher or lower.
Expense Example PUTNAM GLOBAL HEALTH CARE FUND (USD $)
Class A
Class B
Class C
Class M
Class R
Class Y
1 year 697 705 305 524 155 104
3 years 955 934 634 888 480 325
5 years 1,232 1,288 1,088 1,276 829 563
10 years 2,021 2,155 2,348 2,361 1,813 1,248
Expense Example, No Redemption PUTNAM GLOBAL HEALTH CARE FUND (USD $)
Class B
Class C
1 year 205 205
3 years 634 634
5 years 1,088 1,088
10 years 2,155 2,348
Portfolio turnover
The fund pays transaction-related costs, such as commissions, when it buys and sells securities (or “turns over” its portfolio). A higher turnover rate may indicate higher transaction costs and may result in higher taxes when the fund’s shares are held in a taxable account. These costs, which are not reflected in annual fund operating expenses or the above example, affect fund performance. The fund’s turnover rate in the most recent fiscal year was 25%.
Investments
For this non-diversified fund concentrating in the health care industries, we invest mainly in common stocks (growth or value stocks or both) of large and midsize companies worldwide that we believe have favorable investment potential. Potential investments include companies that manufacture health care supplies or provide health care-related services, and companies in the research, development, production and marketing of pharmaceuticals and biotechnology products. We may purchase stocks of companies with stock prices that reflect a value lower than that which we place on the company. We also consider other factors that we believe will cause the stock price to rise. We may consider, among other factors, a company’s valuation, financial strength, growth potential, competitive position in its industry, projected future earnings, cash flows and dividends when deciding whether to buy or sell investments. We may also use derivatives, such as futures, options, certain foreign currency transactions, warrants and swap contracts, for both hedging and non-hedging purposes, and may engage in short sales of securities.
Risks
It is important to understand that you can lose money by investing in the fund.

The prices of stocks in the fund’s portfolio may fall or fail to rise over extended periods of time for a variety of reasons, including both general financial market conditions and factors related to a specific company or industry. Growth stocks may be more susceptible to earnings disappointments, and value stocks may fail to rebound. These risks are generally greater for small and midsize companies. The health care industries may be affected by technological obsolescence, changes in regulatory approval policies for drugs, medical devices or procedures and changes in governmental and private payment systems. Our policy of concentrating on a limited group of industries and the fund’s “non-diversified” status, which means the fund has the ability to invest a greater percentage of its assets in fewer issuers than a “diversified fund,” can increase the fund’s vulnerability to adverse developments affecting a single industry or issuer, which may result in greater losses and volatility for the fund. The value of international investments traded in foreign currencies may be adversely impacted by fluctuations in exchange rates. International investments, particularly investments in emerging markets, may carry risks associated with potentially less stable economies or governments (such as the risk of seizure by a foreign government, the imposition of currency or other restrictions, or high levels of inflation or deflation), and may be illiquid. Our use of derivatives may increase these risks by increasing investment exposure or, in the case of many over-the-counter instruments, because of the potential inability to terminate or sell derivatives positions and the potential failure of the other party to the instrument to meet its obligations. Our use of short selling may result in losses if the securities appreciate in value.

The fund may not achieve its goal, and it is not intended to be a complete investment program. An investment in the fund is not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency.
Performance
The performance information below gives some indication of the risks associated with an investment in the fund by showing the fund’s performance year to year and over time. The bar chart does not reflect the impact of sales charges. If it did, performance would be lower. Please remember that past performance is not necessarily an indication of future results. Monthly performance figures for the fund are available at putnam.com.
Annual total returns for class A shares before sales charges
Bar Chart
Year-to-date
performance
through 9/30/12

21.11%
Best calendar
quarter
Q3 2010

12.45%
Worst calendar
quarter
Q3 2011		 -17.98%
Average annual total returns after sales charges
(for periods ending 12/31/11)
Average Annual Total Returns PUTNAM GLOBAL HEALTH CARE FUND
1 year
5 years
10 years
Class A
 (7.08%) (0.45%) 1.46%
Class A after taxes on distributions
 (8.99%) (1.74%) 0.41%
Class A after taxes on distributions and sale of fund shares
 (2.66%) (0.51%) 1.12%
Class B
 (6.36%) (0.26%) 1.30%
Class C
 (3.01%) (0.02%) 1.30%
Class M
 (5.34%) (0.48%) 1.19%
Class R
 (1.68%) 0.48% 1.81%
Class Y
 (1.19%) 0.99% 2.32%
MSCI World Health Care Index (ND) no deduction for fees, expenses or taxes other than withholding taxes on reinvested dividends)
 9.46% 1.69% 3.13%
After-tax returns reflect the historical highest individual federal marginal income tax rates and do not reflect state and local taxes. Actual after-tax returns depend on an investor’s tax situation and may differ from those shown. After-tax returns are shown for class A shares only and will vary for other classes. These after-tax returns do not apply if you hold your fund shares through a 401(k) plan, an IRA, or another tax-advantaged arrangement.

Class B share performance does not reflect conversion to class A shares.

XML 13 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } } XML 14 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document and Entity Information
 12 Months Ended
Dec. 30, 2012
Risk/Return:  
Document Type 485BPOS
Document Period End Date Aug. 31, 2012
Registrant Name PUTNAM GLOBAL HEALTH CARE FUND

Central Index Key 0000357295
Amendment Flag false
Document Creation Date Dec. 28, 2012
Document Effective Date Dec. 30, 2012
Prospectus Date Dec. 30, 2012
GRAPHIC 15 BarChart1.jpg IDEA: XBRL DOCUMENT begin 644 BarChart1.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``8$!08%!`8&!08'!P8("A`*"@D) M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_ MVP!#`0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P``1"`$L`AP#`2(``A$!`Q$!_\0` M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4% M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#I_`/@WPQ= M>!/#EQ<^'-%FGETVVDDDDL8F9V,2DL25R23SFM74?"'A.RLY)QX0TFX9*[DE8\F4GS;GGJVG@Z1Q:P>`;2;5@[K+IRZ?9B6 M((L;,S,6$1&)X3\KD_O!QPVW>TWPGX+U+3K6^LO#>A2VMU$D\+_V;$NY&`*G M!7(R".M8^C:5JNBZC;ZG#HU_+81_;(H-.^TQ27<*SFVD+2.\NULRPSN3YC-^ M]3W"]?X2TV;1_"NC:9@I)=T.3MLRC_P@OA/ M_H5]"_\`!?#_`/$T?\(+X3_Z%?0O_!?#_P#$U>U;2KR^N%DMM>U/3D"!3%:Q MV[*3D_,?,B<\)6&L:QX5T;4[GQ;K2SWME#BR[!=_P`WYB?\(+X3_P"A M7T+_`,%\/_Q-'_""^$_^A7T+_P`%\/\`\365X2L-8UCPKHVIW/BW6EGO;*&Y MD6."R"AG0,0,VY.,GU-:W_"/:G_T-^O?]^;+_P"1Z-.P.ZTYOS$_X07PG_T* M^A?^"^'_`.)H_P"$%\)_]"OH7_@OA_\`B:7_`(1[4_\`H;]>_P"_-E_\CT?\ M(]J?_0WZ]_WYLO\`Y'HLNP7?\WYB?\(+X3_Z%?0O_!?#_P#$T?\`""^$_P#H M5]"_\%\/_P`32_\`"/:G_P!#?KW_`'YLO_D>C_A'M3_Z&_7O^_-E_P#(]%EV M"[_F_,3_`(07PG_T*^A?^"^'_P")H_X07PG_`-"OH7_@OA_^)K*\)6&L:QX5 MT;4[GQ;K2SWME#C_`(1[4_\`H;]>_P"_-E_\CT678+O^;\Q/^$%\)_\`0KZ%_P"" M^'_XFC_A!?"?_0KZ%_X+X?\`XFE_X1[4_P#H;]>_[\V7_P`CT?\`"/:G_P!# M?KW_`'YLO_D>BR[!=_S?F)_P@OA/_H5]"_\`!?#_`/$T?\(+X3_Z%?0O_!?# M_P#$UE>$K#6-8\*Z-J=SXMUI9[VRAN9%C@L@H9T#$#-N3C)]36M_PCVI_P#0 MWZ]_WYLO_D>C3L#NM.;\Q/\`A!?"?_0KZ%_X+X?_`(FC_A!?"?\`T*^A?^"^ M'_XFE_X1[4_^AOU[_OS9?_(]'_"/:G_T-^O?]^;+_P"1Z++L%W_-^8G_``@O MA/\`Z%?0O_!?#_\`$T?\(+X3_P"A7T+_`,%\/_Q-+_PCVI_]#?KW_?FR_P#D M>C_A'M3_`.AOU[_OS9?_`"/19=@N_P";\Q/^$%\)_P#0KZ%_X+X?_B:/^$%\ M)_\`0KZ%_P""^'_XFLKPE8:QK'A71M3N?%NM+/>V4-S(L<%D%#.@8@9MR<9/ MJ:UO^$>U/_H;]>_[\V7_`,CT:=@=UIS?F)_P@OA/_H5]"_\`!?#_`/$T?\(+ MX3_Z%?0O_!?#_P#$TO\`PCVI_P#0WZ]_WYLO_D>C_A'M3_Z&_7O^_-E_\CT6 M78+O^;\Q/^$%\)_]"OH7_@OA_P#B:/\`A!?"?_0KZ%_X+X?_`(FE_P"$>U/_ M`*&_7O\`OS9?_(]'_"/:G_T-^O?]^;+_`.1Z++L%W_-^8G_""^$_^A7T+_P7 MP_\`Q-'_``@OA/\`Z%?0O_!?#_\`$UE>$K#6-8\*Z-J=SXMUI9[VRAN9%C@L M@H9T#$#-N3C)]36M_P`(]J?_`$-^O?\`?FR_^1Z-.P.ZTYOS$_X07PG_`-"O MH7_@OA_^)H_X07PG_P!"OH7_`(+X?_B:7_A'M3_Z&_7O^_-E_P#(]'_"/:G_ M`-#?KW_?FR_^1Z++L%W_`#?F)_P@OA/_`*%?0O\`P7P__$T?\(+X3_Z%?0O_ M``7P_P#Q-+_PCVI_]#?KW_?FR_\`D>C_`(1[4_\`H;]>_P"_-E_\CT678+O^ M;\Q/^$%\)_\`0KZ%_P""^'_XFC_A!?"?_0KZ%_X+X?\`XFLKPE8:QK'A71M3 MN?%NM+/>V4-S(L<%D%#.@8@9MR<9/J:UO^$>U/\`Z&_7O^_-E_\`(]&G8'=: MC_A'M3_Z&_7O^_-E_P#(]%EV"[_F_,3_`(07PG_T*^A?^"^' M_P")H_X07PG_`-"OH7_@OA_^)I?^$>U/_H;]>_[\V7_R/1_PCVI_]#?KW_?F MR_\`D>BR[!=_S?F)_P`(+X3_`.A7T+_P7P__`!-'_""^$_\`H5]"_P#!?#_\ M365X2L-8UCPKHVIW/BW6EGO;*&YD6."R"AG0,0,VY.,GU-:W_"/:G_T-^O?] M^;+_`.1Z-.P.ZTYOS$_X07PG_P!"OH7_`(+X?_B:/^$%\)_]"OH7_@OA_P#B M:7_A'M3_`.AOU[_OS9?_`"/1_P`(]J?_`$-^O?\`?FR_^1Z++L%W_-^8G_"" M^$_^A7T+_P`%\/\`\31_P@OA/_H5]"_\%\/_`,32_P#"/:G_`-#?KW_?FR_^ M1Z/^$>U/_H;]>_[\V7_R/19=@N_YOS$_X07PG_T*^A?^"^'_`.)H_P"$%\)_ M]"OH7_@OA_\`B:RO"5AK&L>%=&U.Y\6ZTL][90W,BQP604,Z!B!FW)QD^IK6 M_P"$>U/_`*&_7O\`OS9?_(]&G8'=:U/\`Z&_7O^_-E_\` M(]%EV"[_`)OS$_X07PG_`-"OH7_@OA_^)H_X07PG_P!"OH7_`(+X?_B:7_A' MM3_Z&_7O^_-E_P#(]'_"/:G_`-#?KW_?FR_^1Z++L%W_`#?F)_P@OA/_`*%? M0O\`P7P__$T?\(+X3_Z%?0O_``7P_P#Q-97AFPUC5-.FN+CQ;K2NE[=VP"06 M0&V*XDB4\VYYVH"??/3I6M_PCVI_]#?KW_?FR_\`D>C3L#NM.;\Q/^$%\)_] M"OH7_@OA_P#B:/\`A!?"?_0KZ%_X+X?_`(FE_P"$>U/_`*&_7O\`OS9?_(]' M_"/:G_T-^O?]^;+_`.1Z++L%W_-^8G_""^$_^A7T+_P7P_\`Q-'_``@OA/\` MZ%?0O_!?#_\`$TO_``CVI_\`0WZ]_P!^;+_Y'H_X1[4_^AOU[_OS9?\`R/19 M=@N_YOS$_P"$%\)_]"OH7_@OA_\`B:/^$%\)_P#0KZ%_X+X?_B:RO#-AK&J: M=-<7'BW6E=+V[M@$@L@-L5Q)$IYMSSM0$^^>G2M;_A'M3_Z&_7O^_-E_\CT: M=@=UIS?F)_P@OA/_`*%?0O\`P7P__$T?\(+X3_Z%?0O_``7P_P#Q-+_PCVI_ M]#?KW_?FR_\`D>I/!-S=76A,U_=27<\5[>6WGR*BLZQ7,L:DA%5<[47H!19= M@N[7N1?\(+X3_P"A7T+_`,%\/_Q-?-/[2VDZ=H_CNPM])L+2Q@;38Y&CM85B M4L991N(4`9P`,^PKZYKY3_:M_P"2AZ=_V"H__1TU9UDN4VPS;GJSZ+^&_P#R M3OPM_P!@JU_]$K71XKGOAO\`\D[\+?\`8*M?_1*UT>*U6QA+=C<48IV*,4R1 MN*YSX;_\D[\+?]@JU_\`1*UTN*YSX;_\D[\+?]@JU_\`1*TNI70Z'%&*=BC% M,D;BC%.Q1B@!N*,4[%&*`&XHQ3L48H`;BC%.Q1B@!N*,4[%&*`&XHQ3L48H` M;BC%.Q1B@!N*,4[%&*`&XHQ3L48H`;BC%.Q1B@!N*,4[%&*`&XHQ3L48H`;B MC%.Q1B@!N*,4[%&*`&XHQ3L48H`;BC%.Q1B@!N*,4[%&*`&XHQ3L48H`;BC% M.Q1B@!N*,4[%&*`,?Q5/I5KX?O9_$4L<6DQH'N#(Q"LH(^4@%-0\.7,,GB#1=+L'U(SV]@TL#V<96"/\`T=D)\N5,NLKK&0%D<[7W M+O/I>L:YI&B^3_;.J6&G^=GR_M=PD6_&,[=Q&<9&<>HK._X3GPC_`-#3H/\` MX,(?_BJAFD;I:(Y_QC=Z=,^2FT@8(D7:O`^ M9.!D8JS\0-*T;Q#I=D'MK349]6>*RLYGQ*$B?+RRP$Y5'$(ED#C[QC0'=A5K M7_X3GPC_`-#3H/\`X,(?_BJNZ3XDT+6+EK?2-9TR_G5#(T=K=)*P4$#<0I)Q MD@9]Q1HPU6MCDKNSFT^_UT:==:G>Q.[76I+;9\V.,(\@@B8')N7+H@Q@K`D0 MRC"-WZOPK=Q7WA^RFMK2.T@"&..&+!B"H2@,1``:(A5 M;9XXYRA$;R(756QP2H()&>V1GU%<[\.5F7PW(MR\IKH-12[DLY%TV>"WNSC9)/"9D7D9R@=">,_Q#UYZ5@_#E95\-2+=/ M').-2U$2/&A16;[;/DA220,]LG'J:GJ5]DZ7%?*7[5W_`"433O\`L%1_^CIJ M^K\5\H_M7_\`)1-._P"P5'_Z.FJ*WPFV&^,^C/AM_P`DZ\+?]@JU_P#1*UT= M<[\-A_Q;KPM_V"K7_P!$K71XJUL92W8E%+BC%,D2N<^&W_).O"W_`&"K7_T2 MM=)BN<^&P_XMUX6_[!5K_P"B5I=2NAT5%+BC%,D2BEQ1B@!**7%&*`$HK/\` M$>JQZ%H5]JLUO<7,-G$T\D=OMW[%Y8C.5RKC46S>HK*\1ZY;:#;6TEPDDTUW M<+:VT$;(K32L"0@9V5`<*Q^9AG&!DD`TCXK@2\6&;3[^.-)8;:YN&\HI:W$H M0I"X#EBQ\V(9160;Q\V`Q!&I6NDCCN#J6HF1(W+JK?;9\@,0"1GO@9]!2ZE6]TZ:OE# M]K#_`)*+IW_8*C_]'35]88KY0_:P_P"2BZ=_V"H__1TU9U?A-L-\9]&_#8?\ M6Z\+?]@JU_\`1*UK:U!8SZ59:-I&G7_`(MCTZXT^T?0)$O;JVTB>%3':[5L%4M`1B)SOED"D!@M MP20K.PKM?A_/-=>`O#=Q=2R37$NF6TDDLC%F=C$I+$GDDGG-3?\`")>'/[._ ML_\`L#2/L'F^?]F^Q1^5YF-N_;MQNQQG&<<5MXH2L.4KHQ]6U2\L;E8K70-3 MU)"@8RVLELJ@Y/RGS)4.>,],"?^)5:?\`HE*Z;%VTTW,5NBP22S,3I5QO#M/#^[_?G=7KG]L30RV]KH^DWUK-NCDCO+YXP\95>&40N#DEP5Z M8`.3N(7G;/PCJ]K&NG27<%[:375C?7.HS2N+@R6RVX(\K:P?>;4$L9`1YAX. MWYJ]QK?BZ'/_`!,=!/\`W"IA_P"W-3>#O$^NWWBY-*U>33);>2RFN5:UM9(6 M5DDA7!W2N"")3V'042@U\2%"M"6D'^9IW_AN\N%OKFWD@M+W]Y%:16[&)%A> M99)@9%&X23[!ND`S&2"@+*7DZ/38;FWTVTAOK@W=W'$B37'EB/S7``9]HX7) MR<#I5S%&*1;=QF.>AHQUX-/Q1BF(9V!P?I1CGH:?BC%`#,=>#1V!P?I3\48H M`9CGH:,=>#3\48H`9V!P?I1CGH:?BC%`#,=>#1V!P?I3\48H`9CGH:,=>#3\ M48H`9V!P?I1CGH:?BC%`#,=>#1V!P?I3\48H`9CGH:,=>#3\48H`9V!P?I1C MGH:?BC%`#,=>#1V!P?I3\48H`9CGH:,=>#3\48H`9V!P?I1CGH:?BC%`#,=> M#1V!P?I3\48H`\S^)_\`R-WAO_KROO\`T9:TW3NU/^*'_(W>&_\`KROO_1EK M3-.[5K1W.#%[HLW_`$K.\'?\E)M?^P5=_P#HZUK1O^E9_@W_`)*5:_\`8*N_ M_1UK55]B,'\:^?Y'J6.O!H[`X/TI^*,5@>D,QST-&.O!I^*,4`,[`X/THQST M-/Q1B@!F.O!H[`X/TI^*,4`,QST-&.O!I^*,4`,[`X/THQST-/Q1B@#+UC4+ MJP\K[+HVH:GOSN^RO`OEXQC/FR)UR>F>ASCC.3\.':;PU++)#)`[ZGJ+-%(5 M+1DWL_RG:2,CIP2/0FNEN9'AMI98X9)W1"RQ1E0TA`^Z-Q`R>G)`]2*YSX;R M/-X9EEDAD@=]3U%FBD*EHR;V?*G:2,CIP2/0FIZE?9.FQ7R=^UC_`,E%T[_L M%1_^CIJ^L\5\F_M9_P#)1M._[!4?_HZ:HJ_":X?XSZ/^&O\`R3GPK_V"K3_T M2M=)7.?#3_DG/A7_`+!-I_Z)6NDQ5K8SENQ**7%&*9(EZ==26EY:64US%,BHQ5 MHT+@8=6!!VX/'0G&#@BCX_N-6TW39M5T^^N(H;2)I#%%#"8@5#,TER7RYA`5 M05A`DP6QN)&WH=;TJUUO2KG3=1222SN4\N5(Y7B+KW7A&>02#P35&]\ M+Z;?>0+LW\T<,2P>2VHW!BE0=I4W[9PUZXM[;4&S-+=P()3;0DH@"(`=TDDS2+;J02R*" MP>1'C;NK:>&ZMHKBUECFMY4$DMK>&UMHK>UBCAMXD$<<4:A510,!0!P`! MQBFD)V8^BEQ1BF2)12XHQ0`E%+BC%`"44N*,4`)12XHQ0`E%+BC%`"44N*,4 M`)12XHQ0`E%+BC%`'F7Q1_Y&[PW_`->5]_Z,M:9IW:I/BE_R-WAO_KROO_1E MK4>G=JVHGGXSXBS?]*H>#/\`DI5K_P!@F[_]'6M7[_I5#P7_`,E*M?\`L$W? M_HZUJJ^Q.#^-?/\`(]5HI<48KG/2$HI<48H`2BEQ1B@!**7%&*`$HI<48H`2 MBEQ1B@"&YF6VMI9Y!(4B0NPCC:1B`,\*H)8^P!)[5SGPWF6Y\,RSQB0)+J>H MNHDC:-@#>SGE6`*GV(!'>NEN9EMK:6>02%(D+L(XVD8@#)PJ@EC[`$GM7-_# M:9;GPS+/&)`DNIZBZB2-HV`-[.>58`J?8@$=Z74JVAT]?)G[6?\`R4;3O^P5 M'_Z.FKZTQ7R9^UI_R4;3O^P3'_Z.FK.K\)KA_C/I'X:#_BW'A7_L$VG_`*)6 MNDQ7.?#/_DG'A3_L$VG_`*)2N@N3,MM*UK'') ME6MC.6X_%&*XK3O$.KZSIOA1+%]/L]0U?23JDTTUN\T2;1!N18Q(AY-P""7. M`F,'.1TOAG4_[;\-Z5JWD^1]OM(KKRMV[9O0-MS@9QG&<"A.X.-C0Q7-_#0? M\6X\*_\`8)M/_1*U?U?Q+H.C7*V^L:WIEA<,@D6*ZNXXF*DD!@&(.,@C/L:H M_#3`^&_A3/'_`!*K3_T2E%]0MH='BC%+QG'?TH&#G';K3)$Q1BERN`AS7.>F)BC%4]7O MSI]NCQ65W?SR-LCM[55+L<$DY9E10`"$L<[?W@VLVUMJN@Y6;V*,57TV[%_9I!7R5CG38^W/!*]5R,-AL, M`0&"G(%G*X!R,'H4_&"PM-0\4>&8K^U@NHA:7S!)HPZ@[[49P>_)_.L MJP\*>'6QNT#23];./_"M_P"*?_(W>&O^O*^_]&6M1:=VK:BD]SS\9.47HS)O MO"?AQ<[=`T@?2RC_`/B:=\.=,L-.^)4(T^QM;3S-)N]_D1+'NQ-;8S@<]3^= M;.H=ZI>"/^2EVW_8)N__`$=:TZT4EHB<'.3FDW_5CUC%&*48.<=NM&5P#D8/ M0YK`]$3%&*7C.._I0,'..W6@!,48IAS1QG'?TH`3%&*48.<=NM&5P M#D8/0YH`3%&*7C.._I0,'..W6@!,48IAS1QG'?TH`3%&*48.<=NM& M5P#D8/0YH`3%&*7C.._I0,'..W6@!,48IAS1QG'?TH`3%&*48.<=N MM&5P#D8/0YH`\Q^*?_(W>&O^O*^_]&6M1:=VJ;XJ?\C=X:_Z\K[_`-&6M0Z= MVK>@>?C/B+-_TJCX*_Y*7:_]@F[_`/1UK5Z_Z51\$_\`)2[7_L$W?_HZUJJ^ MQ&"^-?/\CU?%&*48.<=NM&5P#D8/0YKF/3$Q1BEXSCOZ4#!SCMUH`3%&*7*X M!R,'H:E=V]G:1XWSW$@C1HR1RQL&5U-[.0P(X((YS6OK&OZ-HGE?VSJVGZ?YN?+^U MW*1;\8SC<1G&1GZBLGX;3PW?AF6XM98YK>;4]2DCEC8,KJ;V1"ZJV."5!!(SVR,^H MZU@?#,?\6W\*?]@FT_\`1*5TN*M;&&6!O+ZQ"4,'_DT/3(=&T33]+M6D>WLK>.VC:0@L51 M0H)(`&<#T%7\48H2L#;8F*YKX9C_`(MQX4_[!-I_Z)2NFQ7-?#,?\6W\*?\` M8)M/_1*4=0Z'28HQ2XHQ3)$Q1BEQ1B@!,48I<48H`\Q^*?\`R-_AK_KROO\` MT9:U%IW:I?BI_P`C?X:_Z\K[_P!&6M1:=VK>@>;C?B'ZAWJGX&_Y*9;?]@F[ M_P#1UK5S4.]5/`O_`"4RV_[!-W_Z.M:=?86"^-?/\CUK%&*7%&*YSTRKJ8O/ M[-N_[+^S_P!H>4_V?[1GRO,P=N_;SMSC..<51T[3YM#T2QTO28H[BWL;$6\+ M7,Y1F:-56,,50C#`'6T M(`4+(F,^:!M%T1M*T347@L5L;R.>_D2%U1`@Q^X;>&4$D$#&&)FCTJVU&XCN MH;*WM1<79!^TW\\#;HS(QR517'F8W$LS"_%.O:AXO72M8DTN6WDL9KE6M;62%E:.2%0#NE<$$2GL.@I.#CNAP MKPJ.T7^9U'A'3M4TW39(=;U+^T+AI2RR8Z#"@GG^\P>3;T3S/+7*HI.WBEQ1 MBD6]3S#XI_\`(W>&O^O*^_\`1EK46G=JF^*G_(W>&O\`KROO_1EK4.G=JZ*! MYN-^(EU#O5/P/_R4RV_[!-W_`.CK6KFH=ZI^!O\`DIEM_P!@F\_]'6M.OL1@ MOC7S_(]:Q1BEQ1BN<]03%&*CNIX;2VEN+J:.&WA0R22R,%5%`R6)/``'.34> MFW]GJEE'>:;=V]Y:29V3V\@D1L$@X8$@X((^HI#L6,48K)B\2Z#-I,VJ0ZWI M"?XAZU>M[^SN/LWV>[MY?M,)N(-D@;S8QMR MZX/S+\ZS`]ZE MQ3`3%&*7%&*!"8HQ2XHQ0`F*,4N*,4`)BC%+BC%`"8HQ2XHQ0`F*,4N*,4`> M7_%7_D;O#7_7E??^C+6H=.[5/\5O^1N\-?\`7E??^C+6H-.[5O0/.QOQ%F_Z M52\$?\E,M?\`L$W?_HZUJ[?]*I>"/^2F6O\`V";S_P!'6M57V(P7\1?/\CUG M%&*7%&*YCU!,48I<48H`3%&*7%&*`$Q1BEQ1B@!,48I<48H`3%&*7%&*`$Q7 M-?#\?\2&Z_["VI_^ET];NI:?9ZG926>I6EO>6DF-\%Q&)$;!!&5.0<$`_45S M_P`-;>&U\,2V]K%'#;PZGJ4<<4:A511?3@*`.``.,4NI70ZC%?)/[6__`"4? M3?\`L$Q_^CIJ^M\5\D?M$_^P3:?^B4KIJI;$/<;BC%.HIDC<5S7PR'_%M_ M"G_8)M/_`$2E=/7,_#+_`))MX3_[!-I_Z)2EU*Z'28HQ3J*9(W%&*=10`W%& M*=10!Y=\5?\`D;_#7_7E??\`HRUJ'3NU3_%;_D;_``S_`->5]_Z,M:@T[M71 M0/,QOQ#]0[U4\"?\E,MO^P3=_P#HZUJWJ'>JO@/_`)*;;?\`8)O/_1UK3K[" MP7\1?/\`(]!?^2F6W_8)N_P#T=:U;U'O53P)_R4RV_P"P M3>?^CK6GB-B,%\:^?Y'KF*,4ZBN8]4\N^*O_`"-WAK_KROO_`$9:U!IW:K'Q M7_Y&[PS_`->5]_Z,M:KZ=VKHH'FXWXB74.]5/`O_`"4RV_[!-Y_Z.M:MZAWJ MKX$_Y*;;?]@F\_\`1UK3K[$8+XU\_P`CUO%&*=17,>J97B.YMK'1;B[O+&XU M"*WVS"VMK8W$LCJP9-B`'+!@I!X`(R2`,CD=,%KJWACQ.NK6^L0?VU--'=^7 MITZ$9LT4^2K1^856-`@=T&^16PHW*E;GB_QA;^&;RPM9=.U"^GO4ED1;01?* ML90,6,CH.LBXQGO65'\1?,^YX6\0'_@5G_\`)%*S>P.<8[M+YF"MEKUQ=W'B M75/,34UN+>'1XX-'D(G5(K@!Y8?.+1A_M25949%8`QR.-R>EQ3J*$ M#U&XHQ3J*8AN*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@#RWXK_`/(W M>&O^O*^_]&6M5].[59^+'_(W>&?^O*^_]&6M5M.[5T4#S<;\19O^E4_`_P#R M4RU_[!-Y_P"CK6KE_P!*J>!?^2FVO_8)O/\`T=:T\1L1@OXB^?Y'K6*,4ZBN M8]4IZD+S[%(-,^SB[.%1KC.Q,D`L0.6P,G;D;B,;ESN'-1^)+RR\+>)M1U". MWO9=#\_$MLIABO/*A$C;`2^S#%HC\S8:-NARHZ/6]/?5-)NK&.^O-/,Z;/M- MFRK-&#UV,RD`XR,XR,Y&#@C(L?",$&A7&CW6HZA>Z?<;DEAF\I%,)@\GR%6. M-!'&``P$84[AG/)!3N4K=3!UCQG?^&9;NPU?^S]1U(?9#:&!)+1)S.\P\O;F M9MRK;R.,9+DA%7=@-9B\4W]K]EN;Y;>[T1+2:YO=3@MI(5C$?FE\Q%G:-H_+ MC1HFR[-*2`ODNM:#>#(Y)#=7&L:I-K"O&T6IL(!-"$655546(1$;9YQ\R$_O M#SD+MO6OAJS@M[&!I+B>"UFDNC'*PVSW#R>89I```6#EG"C"!FR%!5-JU'H3 MZ%=W%[%BWBG6;:;6-P[VH**RQRL"09,,&..`'`!8`.VGBLG1?#UCH]]J% MW9+();U]S[FR%&^20JOMYDTS\Y.9",[0JKL4T2QN*,4ZBF(;BC%.HH`@NK>& M[MI;>ZBCFMYD,I1QQ1J%5 M%%].`H`X``XP*Z+4K*+4;*2UN&N$BDQEK>XD@<8(/#QE6'3L1D<=#7/_``T@ M6V\,2P1F1DBU/4D4R2-(Q`OIP,LQ+,?4DDGO2ZE=#J,5\C_M<_\`)2--_P"P M3'_Z.FKZZKY%_:Z_Y*3IO_8)B_\`1TU14^$TH?$?2WPR_P"2;>$_^P3:?^B4 MKI:YOX8_\DV\)_\`8)M/_1*5TM6MB'N<[:>*K6YU:.S6TO$MYKB6SM[Y@GDS MSQ;_`#(U`8R`CRI>615/EG!.5W=#7!Z9H^J1ZMIEG+821V^G:S?:JU\9(S#- M'/\`:MJ(`QDWC[4N=R*OR/AC\N[O:$#2Z"5S7PR_Y)MX3_[!-I_Z)2K^KZ3> MW]RLMKX@U33$"!3#:QVS*QR?F/FPNV><<''`XZYY#X=Z!J4WP_\`#,L?BW7+ M='TNU988XK(K&#$N%&ZW+8'09)/J32Z@EH>BT5Y5XSD\0Z)K^CV-IXOUAXKR MWN9I#+;V18&-H`N,6XX_>MGZ#\9K`:_<8W^,-9&?2WLO_D>N.MF%*A/DG>YZ M.'RFOB*?M86MZGI]%>97ZZ_;YV>,-9/UM[+_`.1ZS_#MUXCU+QC#I,_B[5EM MGL9[DLEO9!]R20J!DV^,8E;/'8?BJ68T:TU3C>['6RC$4:3K3M9>9Z[17-_\ M(YJG_0Z>(/\`OS8?_(U'_".:I_T.GB#_`+\V'_R-7=<\RWFJO@+_DIMM_V" M;S_T=:UTLGP[\S[_`(J\0'_@-G_\CTVP^&ZZ?J:ZC:>*?$$=XL+P"3;9GY'9 M&88-OCDQISC/'UIU:JFM$+#X65*2(/^_-A_P#( MU'_".:I_T.GB#_OS8?\`R-6-SMMYG)?%?_D;O#/_`%Y7W_HRUJOI_:N@U;X> MG5[RVNM0\5^()I[9)(XFV6:[5YIL?PY$?W/%7B`?\``;/_ M`.1ZUI5%#=''B<-*J[Q:_KY&-J/>JO@/_DIMM_V";S_T=:UTDGP[,GW_`!5X M@/\`P&S_`/D>FV'PW73]374+3Q3X@CO%A>`2;;,X1V1F&#;XY,:9R7Q7_`.1N\,_]>5]_Z,M:KZ=VKH-6^'IU>\MKK4/%?B": M>V22.)MEFNU7*%A@6X!R8TZ^GN:;'\.1']SQ5X@'_`;/_P"1ZUI5%#=''B<- M*J[Q:_KY&-J'>JO@/_DIMM_V";S_`-'6M=))\.S)]_Q5X@/_``&S_P#D>FV' MPW73]374;3Q3X@CO%A>`2;;,X1V1F&#;XY,:(/\`OS8?_(U'_".:I_T.GB#_`+\V'_R-6-SMMYG)?%?_ M`)&[PS_UY7W_`*,M:KZ=VKH-6^'IU>\MKK4/%?B":>V22.)MEFNU7*%A@6X! MR8TZ^GN:;'\.1']SQ5X@'_`;/_Y'K6E44-T*?$$=XL+P"3 M;9G".R,PP;?')C3G&>/K3JU5-:(G#X65*2E)K^OD=Y17-_\`".:I_P!#IX@_ M[\V'_P`C4?\`".:I_P!#IX@_[\V'_P`C5C<[;>9TE%><^+-)\:V#V/-SQ7JSURBO)IO^$]_Y8_\)G_P/^Q*G\-67CZ_UWRM8U/Q M#IFE"WD8S2KI;.TVY-BCRT?C:9" MR_\`D>N*MF%*A/DG>YZ6'RFOB*7M86MZGJ5%>:7T>O6X.SQAK)^MO9?_`"/6 M=X?N?$>H^,8=)G\7:NML]C/&?^O*^_P#1EK5;3NU=%J_P\.KW=K=:CXK\033VR21Q M-MLUVJY0L,"W`.3&G7T]S38_AP(_N>*?$`_X#9__`"/6M.HH;HY,1AI57>+1 MD7_2JG@7_DIMM_V";S_T=:UTDGP\,GW_`!5X@/\`P&S_`/D>F6'PX%AJ:ZC: M>*?$$=XL+P"3;9G".R,PP;?')C3G&>/K3JU5-:(G#X65*2E)K^OD=Y17-_\` M".:I_P!#IX@_[\V'_P`C4?\`".:I_P!#IX@_[\V'_P`C5C<[;>9A_&*:XCT_ MP_%;W=Y:K/JGERM:W,D#.HMKAMI9"#CPKE;+3C)C?JGB`_]QN\_^.UV MNL^`I=:6U74_%GB"9;:;SXALLEVOL9,\6XS\KL,'CGZ5#'\.!']SQ3X@'_`; M/_Y'JX2BOB1A7IU)M>SE;[SE[O2A&/DU/Q`/^XW>?_':A\+7-YI_CG0((=3U M26"]GE@GCNKZ:Y5D%O+(,"1F`.Z-#N&#P1G!(/82?#PR??\`%7B`_P#`;/\` M^1Z@A^&44.H6E]'XH\0+=6CF2%\69VL49")K_`(?CT9K+QAK+F]OOLLGFV]D<+Y$TF1BW'.8U]>":AL&\07&- M_B_6!]+>R_\`D>N.OCZ6'ER3O<]##977Q5/VM.UKV/4Z*\UO8M>@7*>,-:/U MM[+_`.1ZQ;74/$LOBC0]-;Q=JH@OKF2&1A;66X!;>60;?W&,YC7J#QFLZ>9T M:DU"-[LUJ9-B*=-U96LO,]?NH$N;:6"0R*DJ%&,7Z(^UR;_<5ZL?K' M\58W@C_DI]M_V"+S_P!'6M;.L?Q5C^!O^2H6W_8(O/\`T=:UGEW^]0^?Y,US M/_<*GR_-'K>*,4[%&*^M/A!N*,4[%&*`&XHQ3L48H`;BC%.Q1B@!N*,4[%&* M`&XHQ3L48H`;BC%.Q1B@!N*,4[%&*`&XHQ3L48H`;BC%.Q1B@!N*,4[%&*`& MXHQ3L48H`;BC%.Q1B@#CM>\0P7U_IVCZ#K=NMS/J)LKV2RDBEGM-L$\N-K!E M5BT&T[U/&[`!P15?Q/>6'P\OM3E/VG4+>[N--@-:PO(D8RVL4N4E98V6*,N6A$023S,%G?#*#)E64Q:;XB\0B*RU.[73[ZRU* MTM18QVA:-9[B5(R"FX>8%!-P\A93MA2)E4LLHKHV\'Z2;:.!&U2(*[2-)#JM MU'+*S!06ED60-(0%507+;0`!@<5I6ND6%I%;^'4M)62'5(]4='99;B.,1J6/S?*O9-K*4R6RA1MS[ MM[;&*I:/I%AHULUOI=K';0LY5_P#^C+6I='[5'\5_^1Q\,?\`7E?_`/HRUJ31^U?+9I_O+]$?;Y-_N*]6 M7-6Z&L3P5_R4^U_[!%Y_Z.M:V]6Z&L7P3_R5"U_[!%Y_Z.M:SR[_`'J'S_)E MYG_N%3Y?FCUG%&*=BC%?6GPHW%&*=BC%`#<48IV*,4`-Q1BG8HQ0`W%&*=BC M%`#<48IV*,4`-Q1BG8HQ0!SGCT:3%X6O;[7]&CUFPT]#=O;-!%,0%!W.JR$+ ME5+'KG&0,DX-:Z\$>"+2VFN;KPSX;@MX4,DDLEA`JHH&2S$K@`#DDTOBK0-4 MOO"WB:PL]2DOKC5;>2W@BOVCBAM1(&4[6BBW$`-T;<3M`R,DU>US2KGQ!HHT MV^/V**YA!NI+2<.R.&1O+4/$5DC;#JV]0"O!4ACM12]3CX['P%-H=GJT'@?3 MWM+G41IOS:1;QO$YN#;AW1]K!?,`&,%P&&5&#C2TZ'P+I/B>[@LM%T?3=0TV M&29[Q+&*`1A40RXD`!7:D\)8G`Q*,$X<+7_X1/7K+P=_9EM=6^IWIUS^T]]] M.(5$0O?M(`,H1WC#!L'AMA*M M@X.UL@87PS69?"\JW4D@)./4]:GT+2O$-AX? MN;:YUJWN-4>;?%5_P#^C+2IM'_AKY?-/]Y?HC[7)_\`<5ZL?K'\58_@;_DJ%M_V"+S_ M`-'6M;&L?Q5D>!?^2HVW_8(O/_1UK6>7?[U#Y_DS7,_]PJ?+\T>NXHQ2XHQ7 MUA\()BC%+BC%`"8HQ2XHQ0`F*,4N*,4`)BC%+BC%`"8HQ2XHQ0`F*,4N*,4` M)BC%+BC%`"8HQ2XHQ0`F*,4N*,4`)BC%+BC%`"8HQ2XHQ0`F*,4N*,4`)BC% M+BC%`"8HQ2XHQ0`F*,4N*,4`>6?%?_D9_[A4^7YH];Q1BEQ1BOK#X4 M3%&*7%&*`$Q1BEQ1B@!,48I<48H`3%&*7%&*`$Q1BEQ1B@!,48I<48H`3%&* M7%&*`$Q1BEQ1B@"&Z,RVTS6L<I`./0]*YGX9&9O" M\K74<<=P=4U(R)&Y=5;[=/D*Q`+#/0D#/H.E=%J37D=E(VF06]Q>#&R*XG:& M-N1G+JCD<9/W3SQQU'/?#(S-X7E:ZCCCN#JFI&1(W+JK?;I\A6(!8`]"0,^@ MZ4=1]#JL5\@_M??\E*TW_L$1?^CIJ^O\5\@_M?\`_)2],_[!$7_HZ:HJ;%TO MB/IKX7_\DT\)?]@BT_\`1*5L:AJEO87-G!/'>.]T^R,P6,[=3(T-QXKTV*99 M)&D\R.8:<)(VW$Y1E=E*?=VG;C;Q73>!;>&QOO%6GV4,=M86FJ+';6T*A(H5 M:SMG*HHX4%W=B`.K,>I-;,/A_1H/[1\G2-.C_M+/V[9;(/M6=V?-P/GSN;[V M?O'UJUIFGV6E64=GIEI;V=G%G9!;Q+'&F22<*H`&22?J:+`V9^L:M>V%RL5K MX>U74T*!C-:26RHIR1M/FS(V>,\#'(YZXH?#'(^&?A+`)_XE%GT_ZXI745S/ MPO\`^2:>$O\`L$6G_HE*.H=#D_BO_P`CEX8_Z\K_`/\`1EI4NC_PU'\6/^1R M\+_]>5__`.C+2I-'_AKYC-/]Y?HC[3)_]Q7JQ^L?Q5D^!/\`DJ-M_P!@B\_] M'6M:VL?Q5D^`_P#DJ-M_V"+S_P!'6M9Y=_O4/G^3-O#))X(Q M^M&3M!VG)QQQD4ZBOK#X4;SN`P<>M`R2>",?K3J*`&Y.T': MM.HH`:,DG@C'ZT9.T':",?K1D[0=IR<<<9%.HH`;SN`P<>M`R2>", M?K3J*`&Y.T':M.HH`:,DG@C'ZT9.T':?^CK6MC5NAK'\"_\E1M?^P1>?^CK M6HR[_>H?/\F7F?\`N%3Y?FCUP9)/!&/UHR=H.TY...,BG45]8?##>=P&#CUH M&23P1C]:=10`W)V@[3DXXXR*.=P&#CUIU%`#1DD\$8_6C)V@[3DXXXR*=10` MWG M8OLFAZCJF_.[[(]NNS&,9\V5.N3C&>ASCC.1\,9'F\+2RR026[OJFILT,A4O M&3?3DJVTEXE%+BC%`A*YCX7_`/),_"7_`&"+ M3_T2E=1BN8^%W_),_"/_`&"+3_T2E'4?0Y+XL?\`(Y>%_P#KRO\`_P!&6E2: M/_#3/BS_`,CEX7_Z\K__`-&6E/T?^&OE\T_WE^B/L\G_`-Q7JQ^L?Q5D^`O^ M2I6W_8(O/_1UK6MK'\597@'_`)*E;?\`8(O/_1UK49=_O4/G^3-4_%S_D5_\`^C+2C1^U M?+YI_O+]$?:Y/_N*]67-6Z&L?P+_`,E2MO\`L$7G_HZUK8U;H:R/`G_)4K;_ M`+!%Y_Z.M*C+_P#>H_/\F7F7^X5/E^:/7Z*7%&*^K/AQ**7%&*`$HI<48H`2 MBEQ1B@!**7%&*`$HI<48H`2BEQ1B@!**7%&*`$HI<48H`ANITMK::>19&2)" M[".-I'(`R=JJ"S'T`!)["N8^&,Z77A:6>-9%275-3=1)&T;@&^G(W*P#*?4$ M`CN*ZBZF2UM9IY!(R1(781QM(Y`&3M5068^@`)/85S'PPF2Z\+2SQB14EU34 MW421M&X!OIR-RL`RGU!`([BEU';0ZNOCW]L+_DIFF?\`8(B_]'35]AXKX]_; M#_Y*9IG_`&"(O_1TU3/8NE\1].?"X?\`%L_"/_8(M/\`T2E=1BN9^%H_XMEX M1_[`]G_Z)2NGQ5(E[B8HQ7`:UXE\0:#>VUGJ(TJ:XU-%-MY$4@2R9KJVM\.2 M^9P#=JV0(<^41A=_R='X5U&]O6U>SU1K:2\TR\%H\]O&T4#GI7U9\.+BC%&1N"Y M&XC(%`()(!!(.#[4`&*,4FY=H;(B>S-PL@E,1[2)@CRAZ]:R[; MP-XEM\;/$FCGZZ-+_P#)56/BG?PW7PV\;P:UICV5M#83K!+?O`8[E]K"-HPL MC$'>(RNX*VYDP,]%^(^DZ%XGTFR5K:QU2YUB2'3[.=L3".*3,DLL!.4C<6XE MD#C[QCCSOPBUS5,-1J2YIQNSKI8RO2AR0G9$=QX,\3W`^?Q'HP^FBR__`"54 MWA#P-J&C>*!K.I:S:7I6SEM$AM[!K?'F/$Q8DROG'E`8P.M.^*>HZ(F@64]_ M>Z:OV/7=,*R32H/(D%S"[8)/RMY+,Q[["3]TFLWQCJ'A-?'5C9?;-.M_%'VR MS>2\DE#7,"&5`EO$,E_WPRI1,(J222/C>39'<3EHHA'(_P`W[EZI=VUE9Q8 MWSW$JQQID@#+,0!DD#ZFN=^&$\-WX6EN;26.>WFU34Y(I8F#(ZF_G(92."". M016SK7B+1-",0UO6--TXRDB/[7=)#OQC.-Q&<;ES]1ZUC_#"XAN_"LMS:31S MV\VJZG)%+$P9'4W\Y#*1P00<@BEU';0ZO%?'?[8G_)3-,_[!$7_HZ>OL7%?' M?[8O_)3=,_[`\7_HZ>IGL53^(^GOA;_R3+PC_P!@>S_]$I6SJ.E6^H75G<3R M7J/:/OC$%Y-`C'(/SJC!9!\HX<$=>.3G'^%H_P"+8^$/^P/9_P#HE*ZC%-;" M>YYZG@G7;B>\FU;Q'97,D[QW`:'2S&?.BGCFMPQ:9B8HS&5$:;,B1V+;V+UU M'AO1Y]+74)KZZCNK_4+G[5)8=0FNHEE6U33C=F?8VSS#LMOG*96/+$;02HR"PSA1:'X!%]!;6]Y MK,GG>6$N(-6U%[8&0`QJTZR&)68,A52P+;TP#O7._K=QXNL-,AMXK;^U[RYF M99;S2K>&V^QPA1R([BX(>0G(4Y*C.YE.W9)SNE>'-5M[!-)AT"2QM[N_TK4E M(NXY8;".VCLP]N[%_,=Q]D=0RHRG0JOR/S\K8L:!:>!O#GB*YN+&6 MZ@O8H9K=KR]N;N2VVKAYD2:9C"67RB6"MN'E/G&QL7?'L>HZYI%QI-IH&JF: M9)%@NOM,"6T MX6XF233&@E1E7R+?>66X.1YC,BAO.N^6#)0J<4[I+[@=6>2:!K]E8IJ/AZVMK7 M4GVP0V=Q()3:P$NY+R$G=)+,T;W#@DLBD*7D1)']%Q5HS:&XHQ3L48IB&XHQ M3L48H`;BC%.Q1B@!N*,4[%&*`&XHQ3L48H`;BC%.Q1B@!N*,4[%&*`&XHQ3L M48H`;BC%.Q1B@!N*,4[%&*`&XHQ3L48H`;BC%.Q1B@!N*,4[%&*`&XHQ3L48 MH`;BC%.Q1B@!N*,4[%&*`&XHQ3L48H`;BC%.Q1B@!N*,4[%&*`&XHQ3L48H` M;BC%.Q1B@!N*,4[%&*`&XHQ3L48H`;BC%.Q1B@!N*,4[%&*`&XHQ3L48H`;B MN8^'7_(OW?\`V&-4_P#2^XK?U/3K+5;&2RU2SMKVSEQO@N(EDC?!!&58$'!` M/U%S_P#1*5U6*Y?X6?\`),?"'_8'L_\`T2E`=#IL48IV*,4`-Q1B MG8HQ0`W%&*=BC%`#<48IV*,4`-Q1BG8HQ0`W%&*=BC%`#<48IV*,4`-Q1BG8 MHQ0`W%&*=BC%`#<48IV*,4`-Q1BG8HQ0`W%&*=BC%`#<48IV*,4`-Q1BG8HQ M0`W%&*=BC%`#<48IV*,4`-Q1BG8HQ0`W%&*=BC%`#<48IV*,4`-Q1BG8HQ0` MW%&*=BC%`#<48IV*,4`-Q1BG8HQ0`W%&*=BC%`#<48IV*,4`-Q1BG8HQ0`W% M&*=BC%`#<48IV*,4`-Q1BG8HQ0!!=6T-W:S6UW#'/;S(8Y8I5#(ZD8*L#P00 M<$&N7^%]M#:>%9;:TAC@MX=5U..**)0J(HOYP%4#@``8`%=+J=A#J5C):7#W M*128RUM<26\@P0>'C96'3L1D<=#7.?"Z!+7PK+;QF1HXM5U.-3+(TCD"_N`- MS,2S'U)))ZDT=1]#J\5\OLG%?&_[9/\`R4[3/^P/ M%_Z.GJ9[%0W/J'X6?\DP\(?]@>S_`/1"5U&*YGX5C_BV'A#_`+`]G_Z(2MG4 M8=4DNK-M-O+*WMD?-TEQ:-,\JY'",)$"'&[DA^HXXP6A,Y^7QQ:6S,M]I>K6 M^!ECB78N\F,EYX%Q,(R/,&0-K[=G0-8CUB&Y_P!%N;.ZM)OL M]S:W.PR0OL5P"49D.4D1LJQ&&P<$$#A=8T;6-:U>XU6RT+4=-S]CFN[>_NH7 M>\:VNX)HD@"32)'M1+D8)C4O,I.>67K?!UG>1S:]J%_9R6)U2_%U':S.C2Q* MMM!#A]C,F2868;6;Y67.#D`N%CH<5R_PL_Y)AX0_[`]G_P"B$K1UG1K[4+I9 M;3Q'JNEQA`IAM([5D8Y)W'S87;/..#C@<=";W2M+L].L/&?B**SM(4M MX(_*L&V(BA5&3;$G``Y)S0!V&*,5S/\`PC&K?]#QXB_[\:?_`/(M'_",:M_T M/'B+_OQI_P#\BT7"QTV*,5P'@K3--6( M4&V)QD\9)K9_X1C5O^AX\1?]^-/_`/D6BX6.FQ1BN9_X1C5O^AX\1?\`?C3_ M`/Y%H_X1C5O^AX\1?]^-/_\`D6BX6.FQ1BN9_P"$8U;_`*'CQ%_WXT__`.1: M/^$8U;_H>/$7_?C3_P#Y%HN%CIL48K@/!6F:YKG@W0=6N_&NO)(O^_&G_P#R+1<+'38HQ7,_\(QJW_0\ M>(O^_&G_`/R+1_PC&K?]#QXB_P"_&G__`"+1<+'38HQ7,_\`",:M_P!#QXB_ M[\:?_P#(M'_",:M_T/'B+_OQI_\`\BT7"QTV*,5P'@K3--6(4&V)QD\9)K9_P"$8U;_`*'CQ%_WXT__`.1:+A8Z;%&* MYG_A&-6_Z'CQ%_WXT_\`^1:/^$8U;_H>/$7_`'XT_P#^1:+A8Z;%&*YG_A&- M6_Z'CQ%_WXT__P"1:/\`A&-6_P"AX\1?]^-/_P#D6BX6.FQ1BN`\%:9KFN># M=!U:[\:Z\ES?V$%U*L5O8!`SQJQ"@VQ.,GC)-;/_``C&K?\`0\>(O^_&G_\` MR+1<+'38HQ7,_P#",:M_T/'B+_OQI_\`\BT?\(QJW_0\>(O^_&G_`/R+1<+' M38HQ7,_\(QJW_0\>(O\`OQI__P`BT?\`",:M_P!#QXB_[\:?_P#(M%PL=-BC M%P"!GC5B%!MB<9/&2:V?^$8U;_H>/ M$7_?C3__`)%HN%CIL48KF?\`A&-6_P"AX\1?]^-/_P#D6C_A&-6_Z'CQ%_WX MT_\`^1:+A8Z;%&*YG_A&-6_Z'CQ%_P!^-/\`_D6C_A&-6_Z'CQ%_WXT__P"1 M:+A8Z;%&*X#P5IFN:YX-T'5KOQKKR7-_8074JQ6]@$#/&K$*#;$XR>,DUL_\ M(QJW_0\>(O\`OQI__P`BT7"QTV*,5S/_``C&K?\`0\>(O^_&G_\`R+1_PC&K M?]#QXB_[\:?_`/(M%PL=-BC%P"!GC5B%!MB M<9/&2:V?^$8U;_H>/$7_`'XT_P#^1:+A8Z;%&*YG_A&-6_Z'CQ%_WXT__P"1 M:/\`A&-6_P"AX\1?]^-/_P#D6BX6.FQ1BN9_X1C5O^AX\1?]^-/_`/D6C_A& M-6_Z'CQ%_P!^-/\`_D6BX6.FQ1BN`\%:9KFN>#=!U:[\:Z\ES?V$%U*L5O8! M`SQJQ"@VQ.,GC)-;/_",:M_T/'B+_OQI_P#\BT7"QTV*,5S/_",:M_T/'B+_ M`+\:?_\`(M'_``C&K?\`0\>(O^_&G_\`R+1<+'38HQ7,_P#",:M_T/'B+_OQ MI_\`\BT?\(QJW_0\>(O^_&G_`/R+1<+'38HQ7`>$M,US6-*GN;GQKKRR1W][ M:@1V]@!MANI85/-L>2L8)]\].E;/_",:M_T/'B+_`+\:?_\`(M%PL=-BC%(O^_&G_P#R+1<+'38HQ7,_\(QJ MW_0\>(O^_&G_`/R+1_PC&K?]#QXB_P"_&G__`"+1<+'38HQ7`>$M,US6-*GN M;GQKKRR1W][:@1V]@!MANI85/-L>2L8)]\].E;/_``C&K?\`0\>(O^_&G_\` MR+1<+'0W5NEU:S6\ID6.5#&QBD:-P",':RD,I]""".H-I-3_`/",:M_T/'B+_OQI_P#\BUJ>&M%C MT'25L8KFYN_WTUP\]SL\R1Y97E+_T?/2EL5#<^H_A6/\`BU_@_P#[`]G_`.B$ MKJ<5R_PJ_P"27^#_`/L#V?\`Z(2NIQ30F)BC%+BC%`A,48I<48H`3%-= M`@;#WDC!7E25X[69TM_+E>)WF95(A0/'(-\A53Y;D$A21TN*\N\=Z9);3>,; M.QTNY/\`PD&@K86(L[1WCDNR]X7$C(I6++7,;%Y"JDNQSPQ!<:.VMO$VE7.L M'3(;B0W.]XE-=`@;#WDC!7E25X[69TM_+E>)WF95(A0/'(-\A53Y;D$A21TN*\N\=Z9) M;3>,;.QTNY/_``D&@K86(L[1WCDNR]X7$C(I6++7,;%Y"JDNQSPQ!<:.VMO$ MVE7.L'3(;B0W.]XE:"YAN]/EAM(%\N0&YBD>-0\Q<1Q@J[?NY)-JX9FKN,47`3%&*7%& M*!"8KF[CQKH$#8>\D8*\J2O':S.EOY&(+C M1Z#?:OI]AJ6FZ?=W<45]J3O':0$Y>8HA=\`=@JDDG@9`SD@&_BO+]1TCQ0OQ M!T74[G2].N4?6"#=P7LN8K-+:\6)6B\C"86=V+%VW2OMR%90GJ.*+@)BC%+B MC%`A,5S=QXUT"!L/>2,%>5)7CM9G2W\N5XG>9E4B%`\<@WR%5/EN02%)'2XK MR[QWIDEM-XQL['2[D_\`"0:"MA8BSM'>.2[+WA<2,BE8LM.UF=+?RY7B=YF52(4#QR#?(54^6Y!(4D=+BO M+O'>F26TWC&SL=+N3_PD&@K86(L[1WCDNR]X7$C(I6++7,;%Y"JDNQSPQ!<: M/09M6LXM8@TLO(]],ADV10O((UYPTC*"L8;:P4N5W%6"Y((J_BO+_#%CJ-EX MPP#K1U&;6+Z?4S.D@M/L#";[/M\D8*\J2O':S.EOY\+B1D4K%EKF-B\A5278YX8@N-'8 MIXMT=]-Q9S&W>5%9GC6?9Y191')D!L@HP/((K?Q7.75M/>_ M$"PD:&3[#IEA+(6E4^6\\[JL;1GH71(IPQX*K.H&0[8Z3%%P$Q1BEQ1B@0F* MP-0\6Z/8W%Q;R37,UU!,8)+>ULYKF4,(XY"=D:,Q4+-%EP-H,B@D$@5T&*XS MQ`D6B^-M,UUK"Y-FUG>07,MC927$C3R-:>672)62:YFNH)C!);VMG-($BT7QMIFNM87)LVL[R"YEL;*2XD:>1K3RRZ1*SG*6[#>1@!%! M(RH)<9IKXNT-[Z"UBOO.\_RPEQ#%));`R`&-6G53$K.&0JK,"WF)@'>N=_%> M->%_"FMQ6>B:#;M]E@B_LJ^UQ;NP<^5/:PVV([>X#JDFXVT:D*KA<2EG!V(? M9L4)@T)BC%+BC%`A,5BWGB?1K*22.[OXH9([^'2RKA@6NI51HXE&/F)65#QD M`9)(VMC;Q7&?$E(K/0(Y;>PN999]8TZXF%C923R/Y5S`[R.(E9CB*'[Q[*J] M=HHN,V+GQ-I5MK`TR:XD%SO2)G%O(T,N=K%>: M:Q:W?]L:WIBV-ZUSJ/B+3=3MG2VD:%K>'[%YC-,!Y:$?9IOE9@QVC`.Y<^F8 MHN%A,48I<48H$)BL6\\3Z-9221W=_%#)'?PZ65<,"UU*J-'$HQ\Q*RH>,@#) M)&UL;>*XSXDI%9Z!'+;V%S++/K&G7$PL;*2>1_*N8'>1Q$K,<10_>/957KM% M%QG1MJ^GKKT>BF[B_M62V:\%L#EQ"K*A<^@W,`,]><9VG%_%+]"T'3=)M-.T![:PMHK6)I8)BY2-0H+$2@9P!G`%7_^ M&I?&W_0+\.?^`\__`,>HN.Q]F45\9_\`#4OC;_H%^'/_``'G_P#CU'_#4OC; M_H%^'/\`P'G_`/CU.XK'V917QG_PU+XV_P"@7X<_\!Y__CU'_#4OC;_H%^'/ M_`>?_P"/47"Q]F45\9_\-2^-O^@7X<_\!Y__`(]1_P`-2^-O^@7X<_\``>?_ M`./47"Q]F45\9_\`#4OC;_H%^'/_``'G_P#CU'_#4OC;_H%^'/\`P'G_`/CU M%PL?9E%?&?\`PU+XV_Z!?AS_`,!Y_P#X]1_PU+XV_P"@7X<_\!Y__CU%PL?9 ME%?&?_#4OC;_`*!?AS_P'G_^/4?\-2^-O^@7X<_\!Y__`(]1<+'V917QG_PU M+XV_Z!?AS_P'G_\`CU'_``U+XV_Z!?AS_P`!Y_\`X]1<+'V917QG_P`-2^-O M^@7X<_\``>?_`./4?\-2^-O^@7X<_P#`>?\`^/47"Q]F45\9_P##4OC;_H%^ M'/\`P'G_`/CU'_#4OC;_`*!?AS_P'G_^/47"Q]F45\9_\-2^-O\`H%^'/_`> M?_X]1_PU+XV_Z!?AS_P'G_\`CU%PL?9E%?&?_#4OC;_H%^'/_`>?_P"/4?\` M#4OC;_H%^'/_``'G_P#CU%PL?9E%?&?_``U+XV_Z!?AS_P`!Y_\`X]1_PU+X MV_Z!?AS_`,!Y_P#X]1<+'V917QG_`,-2^-O^@7X<_P#`>?\`^/4?\-2^-O\` MH%^'/_`>?_X]1<+'V917QG_PU+XV_P"@7X<_\!Y__CU'_#4OC;_H%^'/_`>? M_P"/47"Q]F45\9_\-2^-O^@7X<_\!Y__`(]1_P`-2^-O^@7X<_\``>?_`./4 M7"Q]F45\9_\`#4OC;_H%^'/_``'G_P#CU'_#4OC;_H%^'/\`P'G_`/CU%PL? M9E%?&?\`PU+XV_Z!?AS_`,!Y_P#X]1_PU+XV_P"@7X<_\!Y__CU%PL?9E%?& M?_#4OC;_`*!?AS_P'G_^/4?\-2^-O^@7X<_\!Y__`(]1<+'V917QG_PU+XV_ MZ!?AS_P'G_\`CU'_``U+XV_Z!?AS_P`!Y_\`X]1<+'V917QG_P`-2^-O^@7X M<_\``>?_`./4?\-2^-O^@7X<_P#`>?\`^/47"Q]F45\9_P##4OC;_H%^'/\` MP'G_`/CU'_#4OC;_`*!?AS_P'G_^/47"Q]F45\9_\-2^-O\`H%^'/_`>?_X] M1_PU+XV_Z!?AS_P'G_\`CU%PL?9E%?&?_#4OC;_H%^'/_`>?_P"/4?\`#4OC M;_H%^'/_``'G_P#CU%PL?9E%?&?_``U+XV_Z!?AS_P`!Y_\`X]1_PU+XV_Z! M?AS_`,!Y_P#X]1<+'V917QG_`,-2^-O^@7X<_P#`>?\`^/4?\-2^-O\`H%^' M/_`>?_X]1<+'V917QG_PU+XV_P"@7X<_\!Y__CU'_#4OC;_H%^'/_`>?_P"/ M47"Q]F45\9_\-2^-O^@7X<_\!Y__`(]1_P`-2^-O^@7X<_\``>?_`./47"Q] MF45\9_\`#4OC;_H%^'/_``'G_P#CU'_#4OC;_H%^'/\`P'G_`/CU%PL?9E%? M&?\`PU+XV_Z!?AS_`,!Y_P#X]1_PU+XV_P"@7X<_\!Y__CU%PL?9E%?&?_#4 MOC;_`*!?AS_P'G_^/4?\-2^-O^@7X<_\!Y__`(]1<+'V917QG_PU+XV_Z!?A MS_P'G_\`CU'_``U+XV_Z!?AS_P`!Y_\`X]1<+'V917QG_P`-2^-O^@7X<_\` M`>?_`./4?\-2^-O^@7X<_P#`>?\`^/47"Q]F5\9_MF_\E0TO_L#1?^CYZ/\` MAJ7QM_T"_#G_`(#S_P#QZO,OB;X^U3XBZ]!JVMP64%S#;+:JMHC*A0,[`D,S ,'.7/?TJ9/0J*U/_9 ` end XML 16 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
Label Element Value
Risk/Return: rr_RiskReturnAbstract  
Registrant Name dei_EntityRegistrantName PUTNAM GLOBAL HEALTH CARE FUND

Prospectus Date rr_ProspectusDate Dec. 30, 2012
Document Creation Date dei_DocumentCreationDate Dec. 28, 2012
XML 17 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 11 87 1 true 10 0 false 2 false false R1.htm 000000 - Document - Document and Entity Information Sheet http://www.putnam.com/role/DocumentDocumentandEntityInformation Document and Entity Information false true R2.htm 000011 - Document - Risk/Return Summary {Unlabeled} - PUTNAM GLOBAL HEALTH CARE FUND Sheet http://www.putnam.com/role/DocumentRiskReturnSummaryUnlabeledPUTNAMGLOBALHEALTHCAREFUND Risk/Return Summary - PUTNAM GLOBAL HEALTH CARE FUND false false R9.htm 000019 - Disclosure - Risk/Return Detail Data {Elements} - PUTNAM GLOBAL HEALTH CARE FUND Sheet http://www.putnam.com/role/DisclosureRiskReturnDetailDataElementsPUTNAMGLOBALHEALTHCAREFUND Risk/Return Detail Data - PUTNAM GLOBAL HEALTH CARE FUND false false R10.htm 040000 - Disclosure - Risk/Return Detail Data {Elements} Sheet http://xbrl.sec.gov/rr/role/RiskReturnDetailData Risk/Return Detail Data true false All Reports Book All Reports pghcf1-20121228.xml pghcf1-20121228.xsd pghcf1-20121228_cal.xml pghcf1-20121228_def.xml pghcf1-20121228_lab.xml pghcf1-20121228_pre.xml BarChart1.jpg true true